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ABSTRACT 
 
D-Aminoacylases and Dipeptidases within the Amidohydrolase Superfamily: 
 Relationship Between Enzyme Structure and Substrate Specificity. (December 2010) 
Jennifer Ann Cummings, B.S., Southern Oregon University; 
 M.S., Texas A&M University  
Chair of Advisory Committee: Dr. Frank Raushel 
 
Approximately one third of the genes for the completely sequenced bacterial 
genomes have an unknown, uncertain, or incorrect functional annotation.  
Approximately 11,000 putative proteins identified from the fully-sequenced microbial 
genomes are members of the catalytically diverse Amidohydrolase Superfamily.  
Members of the Amidohydrolase Superfamily separate into 24 Clusters of Orthologous 
Groups (cogs).  Cog3653 includes proteins annotated as N-acyl-D-amino acid 
deacetylases (DAAs), and proteins within cog2355 are homologues to the human renal 
dipeptidase.  The substrate profiles of three DAAs (Bb3285, Gox1177 and Sco4986) and 
six microbial dipeptidase (Sco3058, Gox2272, Cc2746, LmoDP, Rsp0802 and Bh2271) 
were examined with N-acyl-L-, N-acyl-D-, L-Xaa-L-Xaa, L-Xaa-D-Xaa and D-Xaa-L-Xaa 
substrate libraries.  The rates of hydrolysis of the library components were determined 
by separating the amino acids by HPLC and quantitating the products. 
Gox1177 and Sco4986 hydrolyzed several N-acyl-D-amino acids, especially 
those where the amino acid was a hydrophobic residue.  Gox1177 hydrolyzed L-Xaa-D-
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Xaa and N-acetyl-D-amino acids with similar catalytic efficiencies (~10
4
 M
-1
s
-1
).  The 
best substrates identified for Gox1177 and Sco4986 were N-acetyl-D-Trp and N-acetyl-
D-Phe, respectively.  Conversely, Bb3285 hydrolyzed N-acyl-D-Glu substrates (kcat/Km ≈ 
5 x 10
6
 M
-1
s
-1
) and, to a lesser extent, L-Xaa-D-Glu dipeptides.  The structure of a DAA 
from A. faecalis did not help explain the substrate specificity of Bb3285.  N-
methylphosphonate derivatives of D-amino acids were inhibitors of the DAAs examined.  
The structure of Bb3285 was solved in complex with the N-methylphosphonate 
derivative of D-Glu or acetate/formate.  The specificity of Bb3285 was due to an 
arginine located on a loop which varied in conformation from the A. faecalis enzyme.  
In a similar manner, six microbial renal dipeptidase-like proteins were screened 
with 55 dipeptide libraries.  These enzymes hydrolyzed many dipeptides but favored L-D 
dipeptides.  Respectable substrates were identified for proteins Bh2271 (L-Leu-D-Ala, 
kcat/Km = 7.4 x 10
4
 M
-1
s
-1
), Sco3058 (L-Arg-D-Asp, kcat/Km = 7.6 x 10
5
 M
-1
s
-1
), Gox2272 
(L-Asn-D-Glu, kcat/Km = 4.7 x 10
5
 M
-1
s
-1
), Cc2746 (L-Met-D-Leu, kcat/Km = 4.6 x 10
5
 M
-
1
s
-1
), LmoDP (L-Leu-D-Ala, kcat/Km = 1.1 x 10
5
 M
-1
s
-1
), Rsp0802 (L-Met-D-Leu, kcat/Km = 
1.1 x 10
5
 M
-1
s
-1
).  Phosphinate mimics of dipeptides were inhibitors of the dipeptidases.  
The structures of Sco3058, LmoDP and Rsp0802 were solved in complex with the 
pseudodipeptide mimics of L-Ala-D-Asp, L-Leu-D-Ala and L-Ala-D-Ala, respectively.  
The structures were used to assist in the identification of the structural determinants of 
substrate specificity. 
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NOMENCLATURE 
 
a.a. One of the twenty standard amino acids except cysteine 
AHS AmidoHydrolase Superfamily 
ATP Adenosine TriPhosphate 
BLAST Basic Local Alignment Search Tool 
1-8 Numbers 1 through 8 of the -strands within the (/)8-barrel 
Hepes 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
HPLC High-Performance Liquid Chromatography 
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KEGG Kyoto Encyclopedia of Genes and Genomes 
M Alpha Metal 
M Beta Metal 
NAD
+
 -Nicotinamide Adenine Dinucleotide 
NADH -Nicotinamide Adenine Dinucleotide reduced form 
NCBI National Center for Biotechnology Information 
NYSGXRC New York Structural Genomics Research Center 
OD Optical Density 
OPA o-Phthalaldehyde 
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
Tris Tris(hydroxymethyl)aminomethane 
Xaa One of the twenty standard amino acids except cysteine 
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CHAPTER I 
 
INTRODUCTION AND LITERATURE REVIEW 
In the pregenomic era the problem was to answer the question ―what enzyme is 
carrying out a reaction of interest?‖  An enzyme with a given function was identified by 
following an activity of interest during the purification of an enzyme of unknown amino 
acid sequence.  The amino acid sequence of the enzyme could then be determined, and 
perhaps its 3D structure would also be solved in order to help explain the mode of 
substrate binding or aspects of the enzyme mechanism.  In the genomic era, a great deal 
of genetic information is known and the anticipated number of open reading frames 
(ORFs), which code for putative proteins, now exceeds 10.5 million.  With the Protein 
Structure Initiative (PSI), 3D structures of proteins are now being deposited at a faster 
rate than the determination of their function.  Sources of new proteins not only arise 
from purifying targets in sequenced organisms, but they also come from cloning and 
expressing genes from environmental DNA.  The problem now is to answer the question 
―What is the function of a protein with a given 3D structure and/or amino acid 
sequence?‖  The strategies for determining the substrates of enzymes include, but are not 
limited to, annotation based on sequence similarity, in silico screening of crystal 
structures and homology models with metabolite libraries, docking compounds of the 
metabolome into crystal structures, phenotypes of gene knockouts and analysis of the 
genome context of the target of interest. 
____________ 
This dissertation follows the style of Biochemistry. 
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Protein Annotation and Caveats.  Functional annotation of a protein of interest 
based on sequence similarity to another characterized protein is the first step towards 
identifying its substrate.  Sometimes the annotation alone is the only step required before 
experimentally confirming the activity of the enzyme with the substrate.  Proteins within 
an enzyme family perform the same overall reaction and generally have greater than 
30% sequence identity in a pairwise sequence alignment.  Still, functionally divergent 
enzymes emerge as members of a given family despite their having considerably less 
than 30% sequence identity to the other functional members.  To the other extreme, a set 
of proteins can have significantly more than 30% sequence identity and not perform the 
same overall reaction.  Though a high sequence similarity between two proteins does not 
always translate to their accepting the same substrate, the substrates of the two enzymes 
may be similar in structure.  For example, the E. coli K12 allantoinase and L-
Hydantoinase from Arthrobacter aurescens are 38% identical, and they hydrolyze 
hydantoin rings with a different substituent on carbon 5 of the heterocylcic ring as 
depicted in Scheme 1.1 (1, 2). 
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Scheme 1.1 Reactions catalyzed by allantoinase and hydantoinase 
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There are problems associated with predicting the function of a protein based on 
its annotation in the protein databases.  An uncharacterized protein of interest is usually 
given the same annotation as that of a protein with which it has the highest amino acid 
sequence identity (protein #2).  However, protein #2 can be an uncharacterized protein 
annotated by the same method.  There must be an origin to these annotations but locating 
the source can be difficult.  In cases where annotations are based on amino acid 
sequence similarity and not on experimental evidence, the specific journal reference for 
the activity is rarely shown.  Investigation of the journal article for the genome 
sequencing of the organism from which the protein target is from does not always lead 
one to the identity of the protein with the experimental evidence for the annotation.  
Protein sequences often have multiple reference numbers for the same locus tag, but 
different annotations can be associated with the locus tag.  For example the protein with 
locus tag Gox1177 can have the very specific annotation of N-acetyl-D-glutamate 
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deacetylase (gi|58039630) or the broader annotation of D-aminoacylase (gi|58002044).  
The putative deaminase, locus tag EF1061, is annotated as a deaminase (gi|29375640) or 
an N-acyl-D-amino acid family protein (gi|29343101).   
Since the top BLAST (Basic Local Alignment Search Tool) hits of a protein of 
interest are based on those with the highest sequence identity to the protein target, the 
annotation can be incorrect because a difference of as little as one key residue can alter 
the function of the protein or render the protein inactive.  For example it was found that 
1 of the 3 homologues of GTP cyclohydrolase II (GTPCII) in Streptomyces coelicolor, 
Sco6655, was not a true GTPCII enzyme but only catalyzed part of the GTPCII reaction, 
converting GTP to a different product than the other two homologues (3).  Through 
crystallography and site-directed mutagenesis, the difference was attributed to a single 
amino acid change in one of the active site residues.  Unfortunately, due to the inevitable 
lag time between discoveries in activities presented in the literature and updating of 
protein annotations, Sco6655 is still annotated as GTP cyclohydrolase II in the NCBI 
database under three reference numbers, only two of which lead to a link to this work 
(3).  It is safe to assume that this is not an isolated incident and misannotations are 
probably more common than one would hope.  The propagation of these misannotations 
can potentially make it difficult to draw conclusions from genome context if the proteins 
in the genome context are misannotated.  Proteins annotated as chlorohydrolase or 
atrazine chlorohydrolase are a good example of a cluster of Amidohydrolase 
Superfamily (AHS) amino acid sequences that are overannotated. 
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Using Genome Context to Assign Function.  The hutF enzyme from 
Pseudomonas aeruginosa (Pa5106), originally annotated as a chlorohydrolase, is an 
example of a protein which had an ambiguous annotation but whose genome context 
gave clues as to the likely function of the enzyme.  The Pa5106 protein is part of a 
cluster of at least 39 amidohydrolase homologues annotated as chlorohydrolases or hutF.  
Analysis of the genome context of these proteins revealed that these homologues were 
usually close to other proteins annotated as proteins involved in histidine degradation, 
namely hutH, hutU, hutI and hutG (Pa5091).  The product of the hutI reaction, N-
formimino-glutamate, has three potential metabolic fates.  However, the action of hutF 
to convert N-formimino-glutamate to N-formyl-glutamate is the only path that would 
warrant the need for the subsequent hutG protein, N-formyl-glutamate deformylase.  The 
Pa5091 and Pa5106 proteins were experimentally confirmed to be hutG and hutF, 
respectively.  The genome context allowed the researchers to narrow their focus to three 
reactions in the pursuit of assigning function to Pa5106 (4). 
 The genome context of Pa5106 is moderately organized in that the five enzymes 
required to degrade histidine to glutamate are located within a span of 16 genes in the 
genome, and, with the exception of Pa5106, all of the genes are transcribed from the 
same DNA strand (Figure 1.1A).  The genes for enzymes that are metabolically related 
are sometimes split up into smaller clusters in remote locations of the genome in one 
organism and yet condensed in a different organism.  In Bacillus halodurans, three genes 
which code for enzymes involved in the degradation of D-glucuronate, uxuAB and uxaC, 
or D-galacturonate, uxaABC, are located within a span of 3 or 5 genes, respectively and  
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Figure 1.1: Genome context of amidohydrolase superfamily members with recently elucidated 
functions.  (A) hutF in P. aeruginosa and (B) D-galacturonate and D-glucuronate degrading 
enzymes in B. halodurans and E. coli.  
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transcribed from the same DNA strand.  However, in E. coli, the gene clusters uxaAC 
and uxuAB, and the uxaB gene have ~ 1000-1500 open reading frames (ORFs) between  
them.  Furthermore, uxaC (b3092) catalyzes the isomerization of both D-glucuronate and 
D-galacturonate with similar efficiencies, but B. halodurans has a second uxaC 
(Bh0705), appropriately clustered with uxuAB, which is more specialized for the D-
glucuronate than D-galacturonate (5).  The genome contexts for the hut operon in P. 
aeruginosa and D-galacturonate/D-glucuronate metabolism in B. halodurans and E. coli 
are depicted in Figure 1.1.  One can envision a case where a protein of unknown 
function is situated in the genome in a similar fashion to that of b3092 where the genome 
context would not be helpful in determining the protein’s metabolic significance. 
It would be naïve to say that the enzymatic reactions outlined in the literature and 
the KEGG database can define the entire proteome.  Many protein sequence entries have  
less than 40% amino acid sequence identity to any other entries in the protein database 
with known activity.  Begley and coworkers used the genome contexts of the TenA 
(Bacillus halodurans, Bacillus subtilis, Bacillus cereus) and YlmB (B. halodurans) 
genes from soil bacteria to find substrates for the TenA protein.  They had originally 
assigned TenA as a thiaminase II because the enzyme hydrolyzed thiamin to 
hydroxypyrimidine (HMP) and hydroxyethylthiozole (6).  A degratory function did not 
seem logical considering that TenA was clustered with thiamin biosynthetic enzymes 
and/or with putative transporters of HMP analogs, ThiXYZ, or fused with the 
biosynthetic enzyme ThiD.  They hypothesized that soil may degrade thiamin and were 
able to determine that Ylmb hydrolyzed the soil-degraded product of thiamin, 
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formylaminopyrimidine to aminopyrimidine.  By the action of TenA, aminopyrimidine 
was hydrolyzed to HMP which can be reused in thiamin biosynthesis.  TenA hydrolyzed 
aminopyrimidine at a rate ~ 100 times faster vs. that of thiamin.  Furthermore, the ThiY 
protein was found to bind formylaminopyrimidine, Kd = 200 nM.   This is an example  
where genome context and a logic-based hypothesis led to the identification of new 
substrates and ligands of  proteins of unknown function, namely TenA, Ylmb and ThiY, 
when crystallographic information was relatively uninformative (7). 
Prediction of Function from Form: Proof-of-Principle.  With the number of 
crystal structures of AHS enzymes of unknown function continually increasing, there is 
interest in being able to predict substrates for these proteins based on their active sites.  
However, there are several crystal structures of AHS proteins where the substrates are 
known.  The structures of dihydroorotase, adenosine deaminase, N-acetyl-D-
glucosamine-6-phosphate deacetylase, cytosine deaminase, D-hydantoinase, isoaspartyl-
dipeptidase and PTE were used in proof-of-principle docking experiments.  A library of 
ground-state and high-energy intermediates of potential AHS substrates included 
molecules with electrophilic centers of restricted size extracted from the KEGG database 
of metabolites as well as 2009 dipeptides/acyl-amino acids, 14 hydantoins and five 
phosphorus esters for certain enzymes.  The high-energy forms were representations of 
the molecule following attack of the electrophilic center; for hydrolysis of an amide 
bond, the high-energy form would be a tetrahedral intermediate where the oxygen of the 
attacking hydroxyl is negatively charged and the proton of the hydroxyl is transferred to 
the carbonyl oxygen.  Many conformations of each potential substrate were modeled into 
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the active sites of the seven AHS enzymes mentioned above.  The high-energy 
intermediate forms of the known substrates for each enzyme were in the top 10-100 hits 
out of a pool of 3700 molecules (8). 
A similar but less extensive docking experiment was performed using a 
homology model of a protein which had not been crystallized.  One of the subgroups of 
the enolase superfamily are the muconate lactonizing enzymes (MLEs).  Based on 
sequence identity alone, the protein Bc3071 is an L-Ala-D/L-glutamate epimerase (AEE), 
a division within the MLE subgroup.  Another function performed by some members of 
the MLE subgroup is N-succinyl-amino acid racemization.  An AEE from B. subtilis was 
the closest homolog to Bc3071 with a known structure and catalytic reaction, with 35% 
sequence identity to Bc3071.  However, the Arg-24 residue which interacts with the 
glutamate carboxylate side chain and the two aspartates which hydrogen bond to the N-
terminus are not present in Bc3071.  Bc3071 was screened for epimerase activity on the 
libraries L-Xaa-L-Xaa (Xaa = all L-amino acids) and N-succinyl-L-Xaa for a total of 420 
potential substrates.  The best substrate, within this set of compounds, was N-succinyl-L-
arginine.  A homology model of Bc0371 was created based on the structure of the B. 
subtilis protein.  The same library of 420 compounds was docked to the homology 
model.  Rotomer optimization was also performed for those unconserved residues within 
5 Å of each docked compound.  The highest scoring ligand was also N-succinyl-L-
arginine followed by nine other dipeptides with L-arginine or L-lysine at the C-terminus 
within the top 15 hits.  This experiment showed that, at least with a small library of 
10 
 
ligands, docking experiments could accurately identify the most favorable substrates, 
within a library of compounds, for an enzyme based on a homology model (9).  
Prediction of Function from Form: Experimental.  The high energy intermediate 
docking method was applied to the crystal structure of Tm0936, an AHS enzyme similar 
in sequence to another protein ambiguously annotated as a chlorohydrolase.  Out of the 
4,207 metabolites, 9 of the 10 top hits were adenine analogues.  The 5
th
 (5-methyl-
thioadenosine, MTA), 6
th
 (S-adenosyl-L-homocysteine, SAH), 14
th
 (adenosine) and 80
th
 
(adenosine-5-monophosphate, AMP) ranked compounds were selected as substrates and 
their kcat/Km values for deamination activity were in same rank order: MTA (1.4 x 10
5
 M
-
1
s
-1
) > SAH > Adenosine >> AMP.  This MTA deaminase activity gave more meaning to 
the annotation of Tm0938 as a SAM-dependent methyl transferase and to other 
orthologues of Tm0936 that are close to genes with the annotations such as SAM-
dependent methyltransferases, UBiG-methyltransferases, adenosyl homocysteinase, 5'-
methyladenosine phosphorylase and MTA/SAH nucleosidase (10). 
Activity Screening for Substrates.  In silico screening of crystal structures with 
the library of metabolites in the KEGG database is a reasonable task.  In contrast, 
screening a single enzyme for activity against the same library would be impractical.  
Instead, one can choose to focus on a particular group of enzymes.  In doing this one can 
become more familiar with the mechanisms of the enzymes and the types of reactions 
they catalyze.  For example, enzymes in the enolase superfamily are separated into three 
subgroups.  They catalyze the same partial reaction to form an enediolate intermediate, 
by abstraction of a C proton, but have different conserved catalytic residues at varying 
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positions in the structure.  The catalytic residues of these subgroups are known based on 
amino acid sequence alignments and extensive crystallographic information.  What is 
not known for all of the enolases is their substrate specificity.   
Many members of the mandelate racemase (MR) subgroup have the same 
conserved catalytic residues but are not expected to be true MRs based on genome 
context.  Gerlt and coworkers identify members of the MR subgroup that are in potential 
operons for the metabolism of sugars.  They purify the MR enzymes and screen them for 
dehydration, epimerization and C proton exchange against a library of ~ 50 mono- and 
diacid sugars.  These libraries include additional sugars that are not in the KEGG 
database of metabolites.  They were able to identify an enzyme which acted exclusively 
as a dehydratase of D-tartrate as well as another enzyme with a significant preference for 
the dehydration of L-fuconate (FucD) (11, 12).  In the case of FucD, they were able to 
identify two other enzymes involved in the degradation of L-fucose that were in an 
operon with FucD.  In some instances, they have also been able to crystallize the 
enzymes with a ligand bound and provide explanations for the substrate specificity and 
fate of the enediolate intermediate.  Even in the absence of useful information from the 
genome context, it is possible to drastically reduce the pool of candidate substrates to a 
more manageable number.  As described earlier for the Bc3071 protein, the knowledge 
of the types of reactions catalyzed by members of the MLE subgroup made substrate 
screening a viable method to determine substrate specificity. 
Enzyme Superfamilies and the TIM-Barrel Fold.  It is advantageous to focus on a 
particular enzyme superfamily.  The enzymes of different families within a superfamily 
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can catalyze a variety of overall reactions with at least a consistent partial reaction if not 
by the same mechanism entirely.  Enzymes within the same family catalyze the same 
overall reaction (13).  According to the 1.75 June 2009 release of the Structural 
Classification of Proteins (SCOP), there are 1195 folds, 1962 superfamilies and 3902 
families of proteins.  These statistics amount to ~ 2 superfamilies and ~ 3 different 
functions per fold on average.  However, currently 33 superfamilies, structurally 
differentiated into ~ 100 families, are classified as having the TIM-barrel fold.  Clearly, 
TIM-barrel proteins are enriched with functional diversity.  With the aid of tools such as 
amino acid sequence alignments, site-directed mutagenesis and crystallographic analysis 
(especially with substrates or products bound), the key residues involved in substrate 
binding and those required for catalysis can be proposed.  The establishment of a 
canonical correlation between sequence, structure and function can be used to simplify 
the search for substrates of a protein of interest. 
Amidohydrolase Superfamily: Structure.  Holm and Sander recognized the 
marked similarities in the active site framework and protein folds revealed in the three-
dimensional crystal structures of phosphotriesterase (PTE), urease (URA) and adenosine 
deaminase (ADD) (14).  All three of these proteins exhibited a (/)8-barrel (TIM-
barrel) structural fold.  The unwavering characteristic residues of the three active sites 
were the metal ligands—two histidines in the HxH motif at the end of -strand 1 (1), 
histidines at the ends of -strands 5 (5) and 6 (6), and an aspartic acid at the end of -
strand 8 (8).  The ADD enzyme bound one Zn, ligated to the 1, 5 and 6 histidines, as 
well as the 8 aspartic acid.  Urease and PTE have binuclear metal centers with two 
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divalent cations, M, ligated to two histidines (1) and an aspartic acid (8), and, M, 
ligated to two histidines (5 and 6).  The two metals are bridged by a carboxylated 
lysine from -strand 4 (4).  They used the amino acid sequences of URA, PTE and 
ADD as seed sequences to search through the sequence space of ~ 208,000 
nonredundant protein sequences.  They predicted that URA, PTE, ADD, and more than 
70 other proteins in eleven other families (i.e. cytosine deaminase, allantoinase, 
hydantoinase, dihydroorotase, chlorohydrolase, adenine deaminase, arylphosphatase, 
imidazolonepropionase, formylmethanofuran dehydrogenase subunit A, aminoacylases 
and AMP deaminase) are part of an amidohydrolase superfamily (AHS) and would share 
the same active site architecture and structural fold as the three seed sequences (14).  
The validity of some of these predictions are apparent in the three-dimensional structures 
of cytosine deaminase (E. coli), hydantoinase (B. stearothermophilus, A. aurescens), 
imidazolonepropionase (A. tumefaciens) and dihydroorotase (E. coli) (15-19). 
The AHS is a well-characterized family of enzymes which have high catalytic 
diversity.  These enzymes are metal-dependent hydrolases, characterized by a common 
(β/α)8-barrel structural fold of eight alternating α-helices and β-strands (20).  Four 
conserved histidine residues and a catalytic aspartic acid residue serve as ligands to the 
active site metal(s).  The amidohydrolase superfamily is a mechanistically diverse 
superfamily because AHS members cleave more than amide bonds alone.  The types of 
reactions catalyzed by AHS members include the hydrolysis of lactones, C—N bonds, 
organophosphate P—O bonds, 1,2 hydrogen transfers and decarboxylations (20-22). 
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Amidohydrolase Superfamily: Active Site Metal Centers.  As the number of 
crystal structures of AHS members increases, more variations in the mononuclear and 
binuclear metal centers are being discovered.  To date there are ten classes of metal 
centers in the AHS.  Eight of the ten classes contain the HxH motif, and nine have the 
conserved aspartic acid from β8; however, these two histidines and/or aspartate do not 
always ligate a second metal (20).  The first class is represented by such enzymes as 
PTE, urease, isoaspartyl dipeptidase and dihydroorotase (DHO).  In binuclear enzymes, 
M and Mare the buried and more solvent-exposed divalent cations, respectively.  In 
other binuclear metal center classes, the bridging ligand is a glutamate (classes 2, 4 and 
6) or a cysteine on β2 (class 5).  The biological function of the class two type proteins are 
unknown and include the PTE homology protein (PHP) and some of those annotated as 
tatD deoxyribonucleases (20).  In the human renal dipeptidase (class 6), the HxH motif 
is replaced by an HxD motif, where M is ligated to a histidine and an aspartic acid at 
the end of 1, and the aspartate on β8 is not a metal ligand (23).  Studies on the DAA 
from A. faecalis have shown that the enzyme is more active in the mononuclear form 
even though it can bind two metals.  This DAA required the Mβ, ligated by a cysteine 
and the third and fourth histidines, but increased Zn concentrations lead to the ligation of 
the second Mα; Mα was ligated by the two histidines of the HxH motif and the Asp from 
β8 which created a less active binuclear enzyme (24).  It has also been shown that high 
concentrations of Zn in the assay will decrease the activity of E. coli allantoinase even 
though this enzyme has highest activity with more than one equivalent of metal (2, 25). 
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There are mononuclear AHS members that only require one metal for activity.  
The class 3 metal center, represented by the E. coli cytosine deaminase, contains the four 
conserved histidines (1, 5, and 6) and the aspartic acid (8); however, the 6 histidine 
is not a metal ligand (15).  The class 4 metal center is represented by the mononuclear N-
acetyl-D-glucosamine-6-phosphate deacetylases (AGD) from T. maritima and the 
binuclear AGD from B. subtilis (26).  The AGD from E. coli represents the seventh 
class, where the 1 histidines are replaced by a glutamine and asparagine, and the 
enzyme is functional without an HxH or HxD motif (27).  The class 8 metal center is 
that of a uronate isomerase from B. halodurans (Bh0493) where  is a Zn coordinated 
to water, the 8 aspartate, and the histidines from 1 (5).  Two uronate isomerases, 
Bh0493 and Tm0064, are the only structurally characterized AHS members where the 
histidine from 6 is missing. 
The ninth metal center is represented by one active site variety of the three AHS 
members annotated as a tatD deoxyribonuclease in E. coli (PDB ID: 1XWY).  The tatD 
protein has a single Zn ligated to a glutamate (8) and two adjacent residues at the C-
terminal end of 6, namely H152 and C153; the HxH motif and the 5 histidine are 
missing.  In the tatD active site there is an aspartic acid following 8 which does not 
coordinate the Zn but it is within hydrogen bonding distance to a water molecule (likely 
the catalytic water) which is coordinated to the Zn ion.    
The most recently identified tenth variety of an AHS metal center belongs to an 
adenine deaminase from Agrobacterium tumefaciens, Atu4426, with PDB code 3NQB.  
The two Zn ions are bridged by a water and the glutamate at the end of 4.  The 
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coordination of Zn is completed by the two histidines from 1 and the catalytic 
aspartate from 8.  The histidine from 5 and two consecutive residues at the end of 6, a 
histidine and glutamate, are the ligands unique to Zn.  Atu4426 is congruous to tatD 
from E. coli in that the histidine from 6 and the adjacent residue after the 6 histidine 
are both metal ligands.  There are crystal structures of other AHS members where a 
metal is not present in the active site. 
Two AHS proteins, Pa2393 (PDB ID: 3B40) and Pa5396 (PDB ID: 2I5G), are 
sometimes annotated as putative dipeptidases.  Pa2393 has a glutamine in place of the 
histidine on the loop immediately following the C-terminal end of 5.  Both proteins 
have the aspartic acid on 8, but are missing the HxH or HxD motif from 1.  
Technically, the active sites of Pa2393 and Pa5396 are not metal centers because neither 
has a metal in the active site.  A water molecule is within 3-3.5 Å of the glutamine (5), 
histidine (6) and aspartic acid (8) residues; a metal may be able to occupy the position 
of the water.  The different metal site classes are summarized in Table 1.1.  A structural 
example of each of these metal centers is shown in Figure 1.2.  It is clear that the 
definition of an AHS member cannot be confined to the class 1 and 3 active sites first 
outlined by Holm and Sander (14). 
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Table 1.1: Summary of metal centers of AHS members 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a The  amino group is carboxylated 
b These histidines are not metal ligands in the M mononuclear center 
c These residues are not metal ligands 
CLASS 
NUMBER 
METAL 
POSITION 
-strand 
1 2 3 4 5 6 7 8 
1 ,  HxH   K
a
 H H  D 
2 ,  HxH   E H H  D 
3  HxH    H h
c
  D 
4 , or hxh
b
  E  H H   D
b
 
5 ,  HxH C   H H  d
c
 
6 ,  HxD  E  H H  d
c
 
7  qxn
c
  E  H H  d
c
 
8  HxH    H   D 
9       H,C  E 
10 ,  HxH   E H H,E  D 
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Figure 1.2: Stick representations of the ten metal class centers of the amidohydrolase 
superfamily.  (A) Class 1 (dihydroorotase); (B) Class 2 (PTE homology protein); (C) Class 3 
(cytosine deaminase); (D) Class 4 (N-acetyl-D-glucosamine-6-phosphate deacetylases = AGD, 
PDB code 2VHL) where the open circle represents M(Fe) which is not present in the Zn-AGD 
from Thermotoga maritima (PDB code 1O12); (E) Class 5 (D-aminoacylase), (F) Class 6 (renal 
dipeptidase-like), (G) Class 7 (AGD, PDB code 2P50), (H) Class 8 (D-galacturonate isomerase), 
(I) Class 9 (tatD), (J) Class 10 (adenine deaminase, PDB code 3NQB).  The metals and water are 
represented as green and red spheres, respectively.  Residues that are not metal ligands are 
represented with black carbons.  Residues with gray carbons are metal ligands. 
A C 
D E F 
G H I 
J 
   
 

  
   
 
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Amidohydrolase Superfamily: Roles of Divalent Cations and Enzyme 
Mechanism.  The specific roles of M and M were studied with PTE.  The Zn/Cd form 
of PTE is a single hybrid enzyme with Zn bound in the buried α site and Cd in the β site 
(28).  The crystal structure of PTE with the bound inhibitor diisopropyl 
methylphosphonate (DIMP) has also been solved (29).  Based on the crystal structure of 
PTE with bound DIMP and pH rate profile comparisons of Zn/Zn, Cd/Cd and Zn/Cd 
PTE, it has been proposed that M plays a dominant role in lowering the pKa of water 
and M functions primarily to polarize the substrate (28).  This is consistent with the 
crystal structure of dihydroorotase (DHO) with bound dihydroorotate where Zn is 2.9 Å 
from the carbonyl oxygen of the amide bond hydrolyzed by the enzyme (19).  The 
crystal structure of isoaspartyl dipeptidase with the bound aspartate product shows how 
the carboxylate, formed by the cleavage of an amide bond, is positioned with respect to 
the two Zn ions (30).  A catalytic mechanism was proposed for DHO where an activated 
water hydroxyl is the nucleophile and the 8 aspartate bound to M is involved in 
acid/base catalysis.  Aspartate acts as a base during nucleophilic attack on the carbonyl 
carbon of the amide bond in dihydroorotate to form a tetrahedral intermediate.  The 
tetrahedral intermediate is stabilized by the two metals.  Aspartic acid then acts as an 
acid during bond cleavage.  The proposed catalytic mechanism for DHO is depicted in 
Figure 1.3A (19). 
Uronate isomerase from E. coli is proposed to act by a different reaction 
mechanism as outlined in Figure 1.3B.  The crystal structure of URI from B. halodurans 
has a single Zn present (Figure 1.2H), but a metal is not definitively present in the  
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Figure 1.3:  Proposed mechanism of the E. coli dihydroorotase and uronate isomerase.            
(A) Proposed mechanism of the E. coli dihydroorotase.  The  and  metals are represented as 
green spheres and the catalytic aspartate (Asp-250) is from -strand 8 of the (/)8-barrel.                 
(B) Proposed catalytic mechanism of E. coli uronate isomerase. 
 
A 
B 
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uronate isomerase from T. maritima.  Initially, it was not clear as to whether this enzyme 
required a metal ion for activity.  The E. coli uronate isomerase was found to be metal-
dependent, though the Zn’s involvement in the 1,2-proton transfer may not be the 
conventional role proposed for M in other members of the AHS (31). 
Members of enzyme superfamilies generally catalyze different reactions by 
similar reaction mechanisms.  The structural fold and the fundamental active site 
components which allow for the chemistry to take place are present in the proteins of 
different enzyme families within the AHS.  An amino acid sequence can be used as a 
tool to predict whether or not a protein is an amidohydrolase; however, without some 
groundwork, it is difficult to use primary structure to predict protein function.  There 
was experimental evidence for the existence of the reactions catalyzed by the enzyme 
families predicted by Holm and Sander to be amidohydrolases.  At that time, the 
bioinformatics era was beginning, a time when, typically, the 3D structure of an enzyme 
was determined after the substrate of the enzyme was known. 
Amidohydrolase Superfamily: Functional Organization by Amino Acid Sequence.  
In 2004, the amino acid sequences of approximately 1,500 AHS members were 
extracted from ~ 200 fully sequenced genomes.  The amino acid sequences of ~1,500 
putative AHS members were placed into 345 separate groups defined as sets of 
sequences with ≥ 40% amino acid sequence identity.  By 2006, this number had 
expanded to 5,752 putative AHS members (32).  The amino acid sequences of 5,752 
AHS members (AHs) were organized into 875 subgroups within 38 families.  A 
graphical representation of the AHS members is shown in Figure 1.4, where clusters of 
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enzymes are separated based on a BLAST E-value cut-off of 1 x 10
–10
 (13).  Now, in 
2010, there are approximately 1200 sequenced genomes, ~ 3400 other genome 
sequencing projects in progress and ~ 11 million entries in the UniProtKB/TrEMBL 
database.  As predicted from the genomic DNA sequences of the first ~ 1000 fully 
sequenced microbial genomes, there are ~ 11,000 genes which code for  AHS proteins.  
Each AHS member belongs to one of 24 cogs (Clusters of Orthologous Groups).  It is 
estimated that members of the AHS catalyze approximately 100 different reactions, but 
only ~ 38 have been identified thus far (13, 21, 33).  Therefore, a significant fraction of 
these amino acid sequences belong to proteins or enzymes of unknown function, that is, 
there is no experimental evidence for their catalytic activity.   
The number of potential AHS substrates is actually quite large even when only 
considering known metabolites.  For AHS members which act by the same general 
mechanism as DHO, the main limitation as to the types of substrates they could accept is 
that the molecules have an electrophilic center which can be attacked by a hydroxyl 
group.  The existence of uronate isomerases and their proposed reaction mechanism 
expands the group of potential substrates to include acid sugars.  The prospect for further 
diversification of function within the AHS is evidenced by the gray areas in Figure 1.4.  
There are clusters of AHs that are both uncharacterized and not clustered with other 
proteins of known function.   
Structure-Function Relationship of Broadly Annotated AHS Members.  Some 
AHs are broadly annotated, and located within genome contexts which lend no further 
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Figure 1.4: Cytoscape graphical representation of AHS members with a BLAST E-
value cutoff of 1 x 10
-10
.  The D-aminoacylase cluster is circled. 
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information as to their function.  One of these groups of AHs belongs to a set of 
enzymes imprecisely annotated as N-acetyl-D-amino acid deacetylases (DAAs) or N-
acetyl-D-glutamate deacetylases (circled in Figure 1.4), but their substrates are not 
necessarily limited to an acetyl group as the N-acyl- derivative of D-amino acids (34).  
With such a broad annotation, the pool of potential substrates is greater than twenty.  
The biological significance of these enzymes is unclear.  The genome contexts of DAAs 
are not helpful in establishing the substrate specificity of these enzymes.  Furthermore, a 
majority of the DAAs which have been biochemically tested are from organisms whose 
genome sequence is not known.   
It has been proposed that the active site of DAAs have four sites to accommodate 
the C hydrogen, N-acyl group, carboxy terminus and the amino acid side chain (35).  
There is one crystal structure for a DAA from Alcaligenes faecalis, which has a 
preference for N-acetyl-D-methionine, but a substrate, inhibitor or D-amino acid product 
are not bound in the active site (36).  From the current information it is difficult to 
unequivocally assign which residues define the substrate specificity.  There are DAAs 
which preferentially hydrolyze the N-acylated derivatives of D-Asp (37), D-Glu (38, 39), 
D-Met (35, 40), D-Phe (41), D-Val (42) and D-Leu (43).  At least some of these DAAs 
can accept several N-acetyl-D-amino acids as substrates.  These proteins can have high 
sequence identity but preferentially hydrolyze different N-acyl-D-amino acids.  For 
example, Alcaligenes xylosoxydans subspecies A-6 has three biochemically tested DAAs 
with different specificities, namely N-acyl- derivatives of D-neutral amino acids 
(gi|3287876), D-aspartate (gi|3287879) and D-glutamate (gi|3287878) (34, 37, 38, 44).  
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The three DAAs from Alcaligenes xylosoxydans subspecies A-6 are considered 
paralogues which are homologous sequences that reside in the same genome.  The 
pairwise sequence identities of these three proteins are 43-55%, and their overall 
sequence identity is 35%.  The goal here was to purify selected DAAs, determine their 
substrate specificities and three-dimensional structures (in collaboration with Dr. Steve 
Almo’s crystallography laboratory at Albert Einstein College of Medicine), and 
associate these differences with specific amino acid residues. 
Five putative DAAs were chosen for this work, namely the putative DAAs 
Bb3285, Bb2785, Sco4986, bll7304 and Gox1177.  These five proteins belong to four 
subgroups of DAAs when an E-value cutoff of 1 x 10
–70
 is used (as described in Chapter 
II).  Of these, Bb3285 is the closest to the A. faecalis DAA of known structure (PDB ID: 
1M7J).  The active site residues in the A. faecalis DAA are also conserved in Bb3285.  
Each of the other four targets were thought to have variations in active site residues 
based on 1) their amino acid sequence alignments within their respective subgroups of 
putative DAAs and 2) amino acid sequence alignments including other enzymes in the 
Bb3285 subgroup.  Gox1177 and bll7304 were also specifically chosen from their 
subgroup because they were homologues of a protein thought to be involved in a small 
biochemical pathway.     
Gerlt and coworkers discovered a pathway in Geobacillus kaustophilus with 
enzymes for the conversion of D-amino acids to L-amino acids.  As outlined in Figure 
1.5, the three enzymes in this pathway are N-succinyl-CoA:D-amino acid N-
succinyltransferase (GNAT superfamily), N-succinylamino acid racemase (NAAAR)  
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Figure 1.5: Genome context of an N-succinyl amino acid racemase in Geobacillus kaustophilus 
and Amycolatopsis azurea.  Top: Three enzyme pathway for the conversion of D-amino acids to 
L-amino acids in G. kaustophilus.  The genes code for an N-succinyl-CoA:D-amino Acid N-
succinyltransferase (blue), N-succinylamino acid racemase (NSAR, purple) and N-succinyl-L-
Amino acid hydrolase (M20, gray).  Bottom: Genome context of the experimentally verified 
NSAR in A. azurea (purple).  The unshaded M20 and transferase are homologues of the M20 
hydrolase and transferase in G. kaustophilus.  The putative AHS member is outlined in red.    
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and N-succinyl-L-amino acid hydrolase (M20 peptidase/carboxypeptidase G2 family).  
They noticed that in Amycolatopsis azurea, a GNAT superfamily protein, a homologue 
of the NAAAR enzyme and an M20 protein were in an operon context with a member of 
the amidohydrolase superfamily (45).  The complete sequence of the gene for this AHS 
member in A. azurea is only partially sequenced, but the known portion codes for an 
amino acid sequence which is 38% identical to Bll7304 and Gox1177 over an alignment 
of 417 amino acid residues.   
A second subset of AHS enzymes are putative dipeptidases/renal dipeptidase-like 
proteins (RDPs).  Out of the ~1,500 AHS members within the first ~ 200 fully 
sequenced organisms, 62 amino acid sequences were organized into twelve groups of 
putative dipeptidases.  The sequences within each group were ≥ 40% identical in amino 
acid sequence.  Another 6 sequences had less than 40% sequence identity to any other 
sequence and were termed ―singletons.‖  A majority of these 68 proteins have the 
conserved residues outlined for the class 6 proteins in Table 1.1.  However, a small 
subset of ten sequences was missing the HxD motif.  The different clustering of groups 
of RDPs, using an E-value cutoff of 1 x 10
-70
, will be discussed in Chapters III-V.  The 
annotation ―dipeptidase‖ is extremely broad; in only considering the twenty common 
amino acids and the stereochemistry at C, the pool of potential substrates is ~ 1,600.  
There is no consensus within the genome contexts of the RDPs in each group which 
would aid in narrowing down the list of potential substrates.  A majority of these RDP 
annotations are given to microbial proteins which are homologous to the human RDP 
(hRDP). 
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Human RDP hydrolyzes a variety of dipeptides such as Pro-Leu, Pro-Ala, Gly-
Leu, Leu-Gly, Phe-Gly, Gly-Phe, Trp-Gly, Gly-Val, Ala-Ala, Met-Met, Phe-Tyr, Gly-
Gly, Gly-Ser, Gly-His and Leu-Leu (46-48).  The crystal structure of human RDP (PDB 
ID: 1ITQ) was solved prior to this work (23).  Some, but not all, of the amino acid 
residues implicated as part of the active site are conserved to varying extents among the 
different groups of putative RDPs.  One example of a microbial RDP was from 
Brevibacillus borstelensis which hydrolyzed the dipeptides L-Ala- L-Ala, D-Ala-D-Ala, 
L-Asp-D-Ala, L-Asp- L-Asp, and D-Ala-D-Glu, with a preference for L-Ala-D-Ala (49).  
However, the substrate specificity of RDP-like enzymes has never been tested with a 
large pool of potential substrates.  We anticipated that RDPs would have different 
substrate specificities which could be linked to changes in active site residues.    
In this work, the substrate specificities of selected DAAs and putative 
dipeptidases/RDPs were probed with substrate libraries.  These libraries included N-
acyl-amino acid (Xaa) libraries (N-acetyl-L-Xaa, N-acetyl-D-Xaa, N-succinyl-L-Xaa and 
N- succinyl-D-Xaa) and dipeptide libraries (L-Xaa-L-Xaa, L-Xaa-D-Xaa and D-Xaa-L-
Xaa).  The crystal structures of three other RDPs (PDB IDS: 2RAG, 3FDG and 3LU2) 
without substrate or product bound, were also solved during the time-frame of these 
experiments.  The relationships between experimental substrate specificities, amino acid 
sequence alignments and crystallographic information will be discussed for both the 
DAA and RDP-like families of enzymes.  Potential functions of these enzymes will also 
be discussed. 
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CHAPTER II 
 
DEACYLATION OF D-AMINO ACIDS BY MEMBERS OF THE 
AMIDOHYDROLASE SUPERFAMILY 
INTRODUCTION 
 The functional annotation of enzymes based solely on the amino acid sequence is 
a challenging task.  As a consequence of the recent whole organism DNA sequencing 
efforts, the number of genes predicted to code for proteins far exceeds that of those 
which are known empirically.  A majority of the completely sequenced organisms are 
microbes.  It has been estimated that approximately one third of the encoded proteins 
have an uncertain, unknown, or incorrect functional assignment (50).  This indicates that 
the breadth of the capabilities of the microbial proteome is not completely understood. In 
the pre-genomic era most enzymes were identified and characterized based almost 
entirely on the ability to follow and measure a catalytic activity.  In the genomic era the 
ability to accurately infer the function of a protein based on its amino acid sequence is 
becoming increasingly important.  In some cases, the amino acid sequences of 
uncharacterized proteins are homologous to enzymes with a known catalytic activity and 
specific metabolic roles.  Still, the lower the sequence homology of an uncharacterized 
protein to any other protein with an established activity, the more difficult it is to 
accurately annotate its function.  One approach to this problem has been to focus on the 
large number of enzymes of unknown function within the amidohydrolase superfamily 
(4, 5, 10). 
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 The amidohydrolase superfamily (AHS) is a group of enzymes which accept an 
array of diverse substrates within the active sites of a (β/α)8-barrel structural fold (20).  
Over 11,000 protein sequences have been identified as members of the AHS among the 
more than 10 million gene sequences determined thus far.  Members of this superfamily 
have been shown to catalyze the hydrolysis of organophosphate esters, lactones, and 
amides, in addition to decarboxylations, hydrations, and isomerization reactions (20-22, 
51).  However, a significant fraction of the members of this broad superfamily have an 
undefined substrate and reaction specificity (32).  A group of homologous sequences that 
encode for enzymes of uncertain function has been tentatively annotated in public 
databases as N-acyl-D-amino acid deacylases.  These enzymes catalyze the general 
reaction outlined in Scheme 2.1. 
 
Scheme 2.1 General reaction catalyzed by N-acyl-D-amino acid deacetylases 
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The functional role of the N-acyl-D-amino acid deacylases is unclear.  However, 
the addition of acylated D-amino acids in the growth medium of some microorganisms 
has been used to induce the production of these enzymes (37, 43, 52).  D-Amino acids 
are associated with neurotransmission and hormone synthesis in mammals and 
31 
 
protection from proteolysis in bacteria (53).  Certain organisms have the means to 
degrade D-amino acids (e.g. D-amino acid oxidase) and to prevent their incorporation 
into proteins by deacylating aminoacyl-tRNAs with a misincorporated D-amino acid (53, 
54).  D-Amino acids are also incorporated into key sites in some antibiotics (55).  
Enzymes have been identified which preferentially hydrolyze N-acylated derivatives of 
D-aspartate (37), D-glutamate (38, 39), D-methionine (35, 40), D-phenylalanine (41) and 
D-valine (42).  These proteins can have high sequence identity to one another, but a 
structural explanation for the differences in the substrate specificity has not been fully 
elucidated.   
 The only structurally characterized member of this group of enzymes was a D-
aminoacylase (DAA) from Alcaligenes faecalis DA1 (gi|28948588, PDB code 1M7J).  
This enzyme can bind one or two divalent cations in the active site but only a single 
metal ion bound to the β-site is required for the expression of catalytic activity.  The 
single divalent cation at the β-site is bound to Cys-96, His-220, and His-250 (24).  It has 
been proposed that the nucleophilic water molecule is coordinated to the single divalent 
cation and hydrogen bonded to the side chain carboxylate of Asp-366 from β-strand 8.  
In the proposed catalytic mechanism, the carbonyl group of the amide bond is polarized 
via an interaction with the divalent cation bound to the β-site and the water molecule 
utilized for hydrolysis is activated via metal coordination and a hydrogen bonding 
interaction with the carboxylate group of Asp-366.  Once the tetrahedral adduct is 
formed, the leaving group is activated via proton transfer from Asp-366 (36).  This 
enzyme has been reported to preferentially hydrolyze N-acetyl-D-methionine (35).   
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 Here, the relative substrate specificities for three putative N-acyl-D-amino acid 
deacylases from the amidohydrolase superfamily were determined (56).  These proteins 
include Bb3285 from Bordetella bronchiseptica, Gox1177 from Gluconobacter oxydans, 
and Sco4986 from Streptomyces coelicolor.  All of these proteins are currently annotated 
by NCBI as generic D-aminoacylases or more specifically as an N-acetyl-D-glutamate 
deacetylase.  The protein Bb2785 from B. bronchiseptica, also investigated here, is 
annotated as a hypothetical protein but is similar in amino acid sequence to other 
proteins provisionally assigned as putative D-aminoacylases.  A protein sequence 
alignment of Gox1177 with the structurally characterized D-aminoacylase from A. 
faecalis indicates that most of the residues in the active site are highly conserved 
although the sequence identity is only 23%.  In contrast, the Bb3285 enzyme is 48% 
identical to the D-aminoacylase from A. faecalis.  A sequence alignment of Gox1177, 
Bb2785, Bb3285, Sco4986 and the D-aminoacylase from A. faecalis is presented in 
Figure 2.1.  Individual N-acyl-D-amino acids or substrate libraries containing nearly all 
combinations of L-Xaa-D-Xaa, N-acetyl-D-Xaa, N-acetyl-L-Xaa, N-succinyl-L-Xaa, and 
N-succinyl-D-Xaa were utilized to establish the substrate specificities for Bb3285, 
Gox1177, and Sco4986.  It was demonstrated that Bb3285 preferentially hydrolyzes N-
acetyl-D-glutamate and N-formyl-D-glutamate whereas Gox1177 and Sco4986 hydrolyze 
a rather broad spectrum of N-acyl-D-amino acids, including L-Xaa-D-Xaa dipeptides by 
Gox1177.  N-methylphosphonate derivatives of D-amino acids were inhibitors of these 
enzymes with varied degrees of potency.  The three-dimensional structure of Bb3285 
was determined in the presence of the product, acetate, and also with the  
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  Bb3285   MQN--AEKLDFKITGGWIIDGTGAPRRRADLGVRDGRIAAIGELGAHPAR-------HAWDASGKIVAPGFIDVHGHDDLMFVEKPDLRWKTSQGITTVVVGNCG 96  
  1M7J     MSQPDATPFDYILSGGTVIDGTNAPGRLADVGVRGDRIAAVGDLSASSAR-------RRIDVAGKVVSPGFIDSHTHDDNYLLKHRDMTPKISQGVTTVVTGNCG  
  Sco4986  -------MEELVIRDADVVDGSGGDSYRADVVVDGGRIVSIV-KEAAAAGCQRPEARRELDAEGLVLSPGFIDMHAHSDLALLRDPDHSAKAAQGVTLEVIGQDG  
  Gox1177  -------MFDLVIRNGLLVDPETGLEQVGDVAVQDGIIQRVGS-FSGNAQ-------REIDATGLVVAPGFIDLHAHGQ----CVASDRMQAFDGVTTSLELEVG  
  Bb2785   --MHDEQALDLVIRGGLLMDGHGGAPRVADIGVRGALIAEIG---DIAPG-----AAAEIDARGKIVTPGFVDIHTHYDGQIIWNSRLAPSSWHGVTTVVMGNCG  
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  Bb3285   VSAAPAPLP--GNTAAALALLGETPL-------------FADVPAYFAALDAQRPMINVAALVGHANLRLAAMR---DPQAAPTAAEQQAMQDMLQAALEAGAVG 183  
  1M7J     ISLAPLAH--ANP-PAPLDLLDEGGS---FR--------FARFSDYLEALRAAPPAVNAACMVGHSTLRAAVMP---DLRREATADEIQAMQALADDALASGAIG  
  Sco4986  LSYAPVDDRTLGEVRRAIAGWNGHGDDVDFD--------WRSVGEYLDRLDR-GIAVNAAYLIPQGTVRALAVG---WDDREATEAELEHMRRLVAEGLEQGAVG  
  Gox1177  ILPVSNWYARQQERGRVLNYGASVAW----------------AFARISAMIG-RPVEPSLSFMGKCYDDPRWS------ENTASSSELRDILSLVGQGLSEGGLG  
  Bb2785   VGFAPVR---AADRGNLIELMEGVEDIPGIALHEGLDWAWETFPDFLRATERIEHDIDFCAQLPHAALRVYVMGERALRLEMATPEDIARMRSLAAEAMRHGAIG  
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  Bb3285   FSTGLAYQ---------PGAVAQAAELEGLARVAAERRRLHTSHIR----NEADGVEAAVEEVLAIGRGTGCATVVSHHK-----------CMMPQNWGRSR--A 262  
  1M7J     ISTGAFYP---------PAAHASTEEIIEVCRPLITHGGVYATHMR----DEGEHIVQALEETFRIGRELDVPVVISHHK-----------VMGKLNFGRSK--E 
  Sco4986  LSSGLTYT---------PGMYAKDAELTELCRVVASYGGYYCPHHR----SYGAGALKAYEEMVELTREAGCPLHLAHAT-----------MNFGVNKGKAP--E  
  Gox1177  IGIPHAYV---------PG--VGAKELVDLCTLAKRHEVPTYTHIAYSSNIDPRSSIEAYTRLIGYAGATGAHMHICHFN-----------STSLLDIRQAA---  
  Bb2785   FSTSRSINHRSVTGDPMPSLRAAEEELTGIAMGLADAGGGVLEIIID--FDDPDMLEAEFGMMRRLVEKSGRPLSFSLMQKHGNKDGWRRLLALTAQAAADGLPI  
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  Bb3285   TLANIDRAREQGVEVALDIYPYPGSSTI-----LIPERAETIDDIRITWSTPHPECSGE---------------------YLADIAAR---------WGCDKTT- 331 
  1M7J     TLALIEAAMAS-QDVSLDAYPYVAGSTM-----LKQDRVLLAGRTLITWCKPYPELSGR---------------------DLEEIAAE---------RGKSKYD- 
  Sco4986  LLTLLDEALAGGADITLDTYPYTPGCTTLVALLPSWASEGGPEQILKRLADDDTAERIRHHMEVIGSDGSHGVPMEWETIEISGTGDP----ALAEYVGRTVLES 
  Gox1177  --ELVSTAQKQGLNITVEAYPYGTGSTVIG------SPLFGEAAFRERTGSPYTAIQRV---------------------DDGHRFES----------REEVLD- 
  Bb2785   RAQVAPRGVGVLLGLQGSRNVFSDCASYKA-----IAQLALDER-VRRMRDPALRAQLLRELRESQ-----DTPLGKRLNEFDNIFPLGNPPCYDPGPERSIAAL 
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  Bb3285   -AARRLAPA-------------------GAIYFAMDEDEVKRIFQHPCCMVG-SDGLPNDA-----------------RPHPRLWGSFTRVLGRYVREA--RLMT 396  
  1M7J     -VVPELQPA-------------------GAIYFMMDEPDVQRILAFGPTMIG-SDGLPHDE-----------------RPHPRLWGTFPRVLGHYSRDL--GLFP  
  Sco4986  ARLRGESP-----WTVARHLLLADRLAPTILQHVGHEENVRAIMRHRVHTGG-SDGILQGA-----------------KPHPRAYGTFPHYLGHYVREL--GVLP  
  Gox1177  --VQRERPD-----------TLVLWHFLDVESDPSAQDLLDVSVLYPGGVIA-SDAMPWTLPDGSVYEGLDWPLPETAVAHPRSSGTFSRFLREYLRER--SRVS  
  Bb2785   ARRAGADPAELAYDCLLEEDGKALLFSPFANYADQNLDACAQMLADPNTVIGLGDGGAHVA-----------------LISDASFPTF--LLKHWGGGAGRPAFD 
   
  Bb3285   LEQAVARMTALPARVFG-----FAERGVLQPGAWADVVVFDPDTVA---DRATWDEPT------LASVGIAGVLVNGAEVFPQPP-ADG-RPGQVLRAGA----- 
  1M7J     LETAVWKMTGLTAAKFG-----LAERGQVQPGYYADLVVFDPATVA---DSATFEHPT------ERAAGIHSVYVNGAAVWEDQS-FTGQHAGRVLNRAGA---- 
  Sco4986  LEECVAHLTSRPAARLR-----LPDRGLVREGYRADLVLFDPATVA---AGSSFDEPR------VLPTGIPYVLVDGRFVMEDGR-RTDVLAGRSVRRVPR---- 
  Gox1177  LCEAMRRCSLGPAKILETVSPQMRRKGRLQERCDADIVVFDADTIT---DRADFAAMN------RPSEGVRYLLVNGQSVISGGELNRDAFPGQPVRGYCGVV-- 
  Bb2785   LPWLVKRQTADTARAVG-----LHDRGVLEVGKKADINVIDPATIDPGVPVMNMDLPAGKGRYLQKPSGYVATIVSGVVVYRDAA-ATGALPGRLVRMAAEPAAA 
 
Figure 2.1: Amino acid sequence alignment of the DAA from A. faecalis (PDB code 1M7J), Gox1177, Bb3285, Bb2785 and Sco4986.  
The catalytic aspartate and metal ligands are shaded black.  Amino acid residues proposed to play a role in the recognition of the substrate 
in the active site are highlighted green.  The variable substrate specificity loops in Bb3285 (291-301) and the DAA from A. faecalis (292-
302) are highlighted in red and yellow, respectively.  Residues which represent the -strands of the (/)8-barrel are numbered and colored 
light blue.  Residues conserved in the experimentally-verified enzymes are colored gray.  Additional details are provided in the text. 3
3
 
34 
 
methylphosphonate derivative of D-glutamate, a potent inhibitor resembling the 
tetrahedral intermediate formed during substrate hydrolysis (56, 57). 
MATERIALS AND METHODS 
Materials.  Dr. Chengfu Xu synthesized all of the individual compounds and 
substrate libraries which were not purchased commercially.  The N-acetyl derivatives of  
D-amino acids were synthesized as previously described (56-58).  The syntheses of N-
succinyl-D-Glu and N-formyl-D-Glu were conducted according to the method described 
by Sakai et al. (45).  The dipeptide and N-acyl-amino acid libraries did not contain 
cysteine or D-isoleucine.  The N-methylphosphonate derivatives of D-Glu (1), D-Leu (2) 
and D-Phe (3) (Scheme 2.2) and nineteen L-Xaa-D-Xaa libraries were synthesized 
according to the method previously described (56, 57).  The compounds, N-acetyl- D/L-
Asp, N-acetyl-D-Pro, and N-acetyl-D-Asn were purchased from Sigma.  All other N-
acetyl-D-amino acids were purchased from Novabiochem with the exception of N-acetyl-
Gly (TCI America), N-acetyl-D-Arg (Avocado), and N-acetyl-D-Tyr (Bachem).  Resins 
and protected amino acids used for solid phase peptide synthesis were purchased from 
 
Scheme 2.2  N-methylphosphonate inhibitors 
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Calbiochem.  ICP standards were obtained from Inorganic Ventures Inc.  Enzymes and 
chemicals for the acetic acid coupling system assay were purchased from Megazyme.  
Nitrocefin was purchased from Calbiochem.  Metal analyses were conducted using 
inductively coupled plasma mass spectrometry (ICP-MS) as previously described (59).  
Oligonucleotide syntheses and DNA sequencing were performed by the Gene 
Technologies Lab of Texas A&M University. 
Amino Acid Analysis of N-Acyl-Xaa and Dipeptide Libraries.  Amino acid 
analysis was performed as a service provided by the Protein Chemistry Laboratory 
facility at Texas A&M University’s Department of Biochemistry and Biophysics. The 
composition of the substituted amino acid libraries was determined by amino acid 
analysis after acid-catalyzed hydrolysis (except for cysteine and tryptophan).  The 
individual libraries were hydrolyzed by vapor phase 6 M HCl-2% phenol at 150 ºC for 
90 minutes.  The amino acids norvaline and sarcosine were added to the samples before 
hydrolysis as internal standards.  A sample of human serum albumin was hydrolyzed 
under the same conditions as a control to ensure that complete hydrolysis of the mixture 
had occurred.  Amino acid analysis was conducted with a Hewlett Packard AminoQuant 
System (HP 1090L).  Samples were suspended in borate buffer, pH 10, and the free 
amino acids were derivatized with o-phthalaldehyde (OPA) and 9-fluoromethyl-
chloroformate (Fmoc).  The derivatized amino acids were separated on a 5 m reverse 
phase HPLC column (Agilent 79916AA-572) using a gradient of 100% buffer A (20 
mM sodium acetate/0.018% v/v triethylamine/50 mM ethylenediamine/0.3% v/v 
tetrahydrofuran, pH 7.2) to 60% buffer B (1:2:2 100 mM sodium acetate: acetonitrile: 
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MeOH) over 17 minutes at a flow rate of 0.45 mL/minute.  The amino acid derivatives 
were detected using a photodiode array (UV-DAD) spectrophotometer or by 
fluorescence.  The excitation/emission wavelengths for the OPA- and Fmoc- derivatized 
amino acids were 340/450 nm and 266/305 nm, respectively.  Two sets of standards 
containing 2 or 5 nmol of each amino acid and the internal standards were run prior to 
the samples of unknown amino acid composition.       
Cloning of Genes for Amidohydrolase Enzymes.  The genes for five putative N-
acyl-D-amino acid deacylases were cloned into the NdeI/EcoRI or NdeI/HindIII 
restriction sites of the plasmid pET-30a(+) (Novagen).  The gene that encodes the 
protein Bb3285 (gi|33602261) was amplified from the genomic DNA of B. 
bronchiseptica (ATCC  BAA-588) using the primers 5´-GCAGGAGCCATATGCAGA 
ACGCGGAAAAGCTGGATTTCAAGATTACCGG-3´ and 5´-CGCGGAATTCAGGC 
GCCGGCGCGCAGTACC-3´.  The gene for the Bb2785 (gi|33601761) was also cloned 
from the B. bronchiseptica genomic DNA with the primers 5´-GCAGGAGCCATATGC 
ACGACGAACAGGCACTTGATCTTGTCATCCGC-3´ and 5´-CGGCAAGCTTCAG 
GCGGCCGCGGGCTCGGCC-3´.  The gene that encodes the protein Gox1177 
(gi|58039630) was amplified from the genomic DNA of G. oxydans using the primers 
5´-GCAGGAGCCATATGTTTGATCTCGTGATCCGTAATGGTCTGCTGG-3´ and 
5´-CGCGGAATTCACACCACCCCGCAATACCCACGG-3´.  The genomic DNA of 
G. oxydans was a generous gift of Dr. Armin Ehrenreich from the Georg-August 
University, Göttingen, Germany.  The gene for Sco4986 (gi|21223359) was cloned from 
the genomic DNA of S. coelicolor (ATCC BAA471-D) with the primers 5´-GCAGGAG 
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CCATATGGAAGAGCTGGTCATCAGGGACGCCGACGTCGTGGACGG-3´ and 5´-
CGCGGAATTCAGCGCGGAACCCGGCGCACCGACCGTCCGG-3´.  The gene for 
Bll7304 (gi|27382415) was cloned from Bradyrhizobium japonicum USDA 110 with the 
primers 5´-CGAGGAGCATTAATGCATGCTGCATCGGCATCCGCGGCGGTG-3´ 
and 5´CGCGGAATTCAGCCCTCGACGACCGGGCGGCGC-3´.  The genomic DNA 
of B. japonicum was kindly donated by Dr. Hans-Martin Fischer from the Swiss Federal 
Institute of Technology, Zürich, Switzerland.  The DNA polymerase chain reactions 
were performed using Pfx Platinum polymerase from Invitrogen.  The sequences of the 
cloned genes were confirmed by DNA sequencing using the facilities from the Gene 
Technologies Laboratory of Texas A&M University.   
Expression and Purification.  E. coli BL21(DE3) cells harboring the pET-30a(+) 
plasmids containing the gene for the expression of Bb3285 or Bb2785 and Rosetta 2 
(DE3) cells containing a pET-30a(+) plasmid for the expression of Gox1177 or Sco4986 
were grown in Terrific Broth with 50 g/mL kanamycin (additionally 25 g/mL 
chloramphenicol for Rosetta 2 cells) at 30 ºC.  When the optical density of the cells 
reached an OD600 of ~0.6, 2.5 mM zinc acetate was added to the culture and expression 
of Bb3285 was induced with 100 M isopropyl -thiogalactoside (IPTG) or 1.0 mM 
IPTG for the expression of Bb2785, Gox1177 and Sco4986.  Following induction, the 
cells were grown overnight at 16-19 ºC.  Cell lysis was achieved via sonication in 50 
mM Tris, pH 7.5, and 100 g/mL phenylmethanesulfonyl fluoride (PMSF) at 0 oC.  The 
DNA present in the cell lysate was precipitated with protamine sulfate (2% w/w of cell 
mass) and removed by centrifugation.  Solid ammonium sulfate was added slowly to the 
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supernatant solution to a saturation of 60% and the protein isolated after centrifugation.  
The enzymes were further purified by size exclusion chromatography on a 3 L (1 L for 
Bb3285) column of AcA34 gel filtration medium using 50 mM Tris (Hepes for Bb3285) 
buffer, pH 7.5, at 4 ºC.  The fractions which contained the protein of the expected size 
were combined.  The Gox1177 and Bb2785 proteins were further purified by anion 
exchange chromatography on a 6 mL Resource Q column from Pharmacia in 50 mM 
Tris, pH 7.5.  The protein was eluted with a 0-1 M gradient of NaCl.  The NaCl was 
removed in a final gel filtration step using a Superdex 200 size exclusion column in 50 
mM Hepes, pH 7.5.   
A total of 70 mg of Bb2785, 150 mg of Gox1177 and 142 mg of Bb3285 were 
isolated from 41, 36 and 66 grams of cells, respectively.  The three proteins were greater 
than 95% pure as assessed by SDS-PAGE.   The sequences of the first five amino acids 
of Gox1177 and Bb3285 were determined by the Protein Chemistry Laboratory at Texas 
A&M University.  The two sequences matched those expected from the DNA sequence.  
The proteins Bb3285, Bb2785 and Gox1177 were found to contain 2.1, 1.8, and 1.8 
equivalents of Zn as determined by ICP-MS.  The protein Bll7304 was not purified since 
there was no expression from either BL21 (DE3) or Rosetta 2 (DE3) cells.   
The Sco4986 protein was expressed in Rosetta 2 cells but the enzyme was found 
predominantly in the insoluble pellet after centrifugation.  Rosetta 2 cells harboring the 
pET-30a(+) plasmid alone or the pET-30a(+)-Sco4986 plasmid were cultured under 
identical growth conditions and subsequently lysed via sonication in the presence of 50 
mM Hepes, pH 7.5, 100 g/mL PMSF.  After centrifugation to remove insoluble 
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proteins, the small molecules in the lysate (MW <30 kDa) were separated via 
ultrafiltration using a PM-30 membrane (Millipore).  The lysates were frozen and stored 
at -80 ºC.  The protein concentration in the crude cell lysates was determined by the 
Bradford assay (Biorad) with 4-28 g/mL bovine serum albumin as a protein standard. 
Alternatively, Sco4986 was expressed in BL21 (DE3) cells harboring the pET-
30a(+)-Sco4986 and pOFXbad-SL3 plasmids (60).  The cells were grown under the 
same conditions in the presence of 50 g/mL kanamycin and ampicillin.  The pOFXbad-
SL3 plasmid was a generous gift from Olivier Fayet at the Laboratory for Microbiology 
and Molecular Genetics in Toulouse, France.  The pOFXbad-SL3 plasmid contains the 
genes for two molecular chaperones, groES/groEL, but overexpression of these genes 
was not induced.  The cells expressing Sco4986 (0.2 mM IPTG) in the presence of the 
chaperone plasmid were used in the partial purification of Sco4986.  Sco4986 was 
partially purified, through ion exchange, in the same fashion as Gox1177, with the 
exception of the sonication buffer (50 mM Hepes, 10% glycerol, 100 mM NaCl, 5 mM 
dithiothrietol, 100 g/mL PMSF pH 8.5), the amount of protamine sulfate (0.4 % w/w 
cell mass) and the saturation level of ammonium sulfate (50-70% saturation fraction).  
The N-acetyl-D-phenylalanine deacetylase activity of the initial purification steps as well 
as gel filtration fractions was used to identify the protein.  The ion exchange fraction of 
the highest activity was submitted to the Protein Chemistry Laboratory for amino acid 
sequence analysis.  The components of the protein sample were separated by SDS-
PAGE and blotted onto a PVDF membrane.  The protein band which corresponded to 
the expected size (58 KDa) was removed and used for amino acid sequence analysis.  
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The amino acid sequence of this band was identical to that expected for amino acids 2-5 
of Sco4986.  
 Crystallization and Data Collection. Crystallization screens and data collection 
were conducted by Alexander Fedorov and Lena Fedorov in Dr. Steve Almo’s lab at 
Albert Einstein College of Medicine.  Crystals of two different complexes were grown 
by the hanging drop method at room temperature for Bb3285 from B. bronchiseptica: (1) 
wild-type Bb3285, Zn
2+
, acetate, and formate, and (2) wild-type Bb3285, Zn
2+
, and 
inhibitor 1.  The crystallization conditions utilized the following conditions: for Bb3285, 
Zn
2+
, acetate, and formate, the protein solution contained Bb3285 (12.6 mg/mL) in 20 
mM Hepes (pH 8.0), 30 mM NaCl, and 0.05 mM  ZnCl2; the precipitant contained 2.0 M 
sodium formate and 0.1 M sodium acetate (pH 4.6).  For Bb3285, Zn
2+
, and inhibitor 1, 
the protein solution contained Bb3285 (12.6 mg/mL) in 20 mM Hepes (pH 8.0), 30 mM 
NaCl, 0.05 mM ZnCl2, and 10 mM methylphosphonate inhibitor; the precipitant 
contained 1.0 M ammonium phosphate, and 0.1 M sodium citrate (pH 5.6). 
Prior to data collection, the crystals of two Bb3285 forms were transferred to 
cryoprotectant solutions composed of their mother liquids and 20% glycerol and flash-
cooled in a nitrogen stream.  All X-ray diffraction data sets were collected at the NSLS 
X4A beamline (Brookhaven National Laboratory) on an ADSC CCD detector.   
Substrate Specificity of Bb3285, Gox1177, Sco4986 and Bb2785.  The substrate 
specificities for Bb3285 and Gox1177 were determined by mixing each protein with the 
N-acetyl- and N-succinyl-amino acid libraries.  The assays were conducted at 30 ºC in 25 
mM ammonium bicarbonate, pH 8.0, and the concentration of each amino acid 
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derivative in these 17-20 member libraries was ~100 M.  The N-acetyl-D-Xaa, N-acetyl-
L-Xaa, N-succinyl-D-Xaa, N-succinyl-L-Xaa, Gly-D-Xaa, L-Ala-D-Xaa, and L-Asp-D-
Xaa libraries were incubated for 1-24 hours in the absence and presence of variable 
amounts of Gox1177 or Bb3285 (1-2000 nM).  The reactions were quenched by 
removing the enzyme with a Microcon YM-10 (Millipore) membrane.  A sample 
equivalent to ~10 g of the initial N-acyl-Xaa library was dried under vacuum prior to 
submission to the Protein Chemistry Laboratory of Texas A&M University for 
determination of the liberated amino acids after the addition of each enzyme.  The 
chromatographic peaks from the samples of unknown amino acid composition were 
identified by the migration time of the derivatized amino acids from known standards.  
The amino acids were quantified by integration of the chromatographic peaks.  The 
relative substrate turnover rate in each library was determined by plotting the 
concentration of each liberated amino acid, Q, as a function of enzyme concentration (Et) 
at a fixed period of time, fit to equation 1, where A is the total concentration of each 
substrate and k is the rate constant for product formation.  Additionally, single 24-hour 
incubations of Bb3285 or Gox1177 with the Gly-D-Xaa, L-Ala-D-Xaa and L-Asp-D-Xaa 
libraries were prepared and submitted for amino acid analysis as described above.   
     ( -  - (   )  (1) 
Nineteen L-Xaa-D-Xaa dipeptide libraries were incubated at 30 ºC with 0-2000 
nM Gox1177 or Bb3285 for 3 hours and 1 hour, respectively.  The concentration of each 
dipeptide component in these libraries was ~100 M in 50 mM Hepes, pH 7.5.  The free 
amino acids were quantified with ninhydrin by measuring the change in absorbance at 
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507 nm and the rates of hydrolysis as a function of enzyme concentration were 
compared for each L-Xaa-D-Xaa library. 
 For the determination of the substrate specificity of Sco4986, 18 individual N-
acetyl-D-amino acids (except proline and isoleucine) at 1.0 mM were incubated with the 
cell lysates from the pET-30a(+) and pET-30a(+)–Sco4986 transformations.  The final 
protein concentration from the cell lysates was 0.4 mg/mL in 50 mM Hepes, pH 7.5 and 
the solutions were incubated for 14 hours at 30 ºC.  In the same manner, these 18 
substrates were treated with 2 M Bb2785 for 20 hours.  Under the same conditions, the 
rate of hydrolysis of the N-acetylglycine and the N-acetyl- derivatives of D/L-Asp, D-
Cys, D-Ala, D-Glu, D-Phe, D-His, D-Lys, D-Leu, D-Met, D-Asn, D-Gln, D-Arg, D-Ser, D-
Thr, D-Val, D-Trp and D-Tyr were also measured under the same conditions with 1.0 
mM substrate and 0.15 mg/mL of the cell lysate containing Sco4986. 
Measurement of Kinetic Constants.  The deacylation of N-formyl-D-Glu, N-
acetyl-D-Glu, and N-succinyl-D-Glu by Bb3285 was assayed by coupling the formation 
of D-glutamate with the ninhydrin reagent in a manner similar to that previously reported 
(61).  The assays were conducted in 50 mM Hepes, pH 7.5, at 30 
o
C.  Specifically, one 
volume of the enzymatic assay was quenched with four volumes (two volumes for all 
dipeptides) of the ninhydrin reagent.  The ninhydrin reagent consisted of 0.9 % w/v 
ninhydrin and 1:10:80 of 1g/mL CdCl2 : acetic acid : EtOH.  The quenched samples were 
heated at 85 ºC (80 ºC for all dipeptides) for 15 minutes (5 minutes for all dipeptides) 
and the reaction product was detected at 507 nm.  The kinetic parameters for the 
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hydrolysis of N-formyl-D-Phe and the N-acetyl- derivatives of D-Phe, D-Tyr, D-Met and 
D-Trp by the Sco4986 lysate were determined using the same ninhydrin assay.   
The deacetylation of the N-acetyl-amino acid derivatives by Gox1177 was 
monitored by coupling the formation of acetic acid to the formation of NADH with 
acetyl-CoA synthetase (1.1 U/mL, citrate synthase (2.3 U/mL) and malate 
dehydrogenase (16 U/mL) in the presence 5.0 mM NAD
+
, 3.8 mM L-malate, 3.1 mM 
ATP, 3.2 mM MgCl2, and 148 M CoA in 130 mM triethylamine, pH 8.4.  In the case of 
N-acetyl-D-His, N-acetyl-D-Thr, N-acetyl-D-Gln, Leu-D-Leu, Met-D-Leu and Tyr-D-Leu, 
the reactions were monitored by measurement of the liberated amino acid with the 
ninhydrin reaction.  During the course of the kinetic assays of Gox1177 with dipeptide 
substrates, the ninhydrin reagent was kept at 0 
o
C prior to heating. 
The kinetic constants were determined by a fit of the data to equation 2 where v 
is the velocity of the reaction, Et is the total enzyme concentration, kcat is the turnover 
number, A is the substrate concentration, and Ka is the Michaelis constant.   
v /Et  =  kcatA/(Ka + A)                                (2) 
 Inhibition of Gox1177 and  Sco4986 by N-Methylphosphonate Modified Amino 
Acids.  The enzymatic activity of Gox1177 was monitored by the acetic acid coupling 
assay in the presence of 0-90 M of N-methyl phosphonyl-D-Leu (2) at a substrate 
concentration of 3.0 mM N-acetyl-D-Leu.  The partially purified lysate containing 
Sco4986 (0.1 mg protein/mL in the final assay) was pre-incubated with 0-5 M of N-
methyl phosphonyl-D-Phe (3) for 90 minutes at 30 ºC.  The Sco4986 assays were 
initiated by the addition of 1.5 mM N-acetyl-D-Phe (5% of the total assay volume) and 
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the rate of D-phenylalanine formation was measured with the ninhydrin assay.   The 
competitive inhibition constants were obtained from a fit of the data to equation 3.   
v / Et  = kcat A / (Ka (1 + (I /Ki)) + A)           (3) 
 Inhibition of Bb3285 by N-Methylphosphonate Modified D-glutamate. For all 
inhibition studies with Bb3285, the deacylation of N-formyl-D-glutamate was coupled to 
the formation of NADH at 340 nm using 1.2 U/mL formate dehydrogenase (Sigma) in 
the presence of 10 mM NAD
+
 (62).  In the determination of the Ki, assay mixtures were 
prepared 30 and 75 minutes prior to running the assay.  Inhibitor stocks were prepared 
by serial dilutions to make 10X inhibitor stocks ranging from 2.9-600 nM for assays. 
The assay mixtures contained all assay components (NAD
+
, Bb3285, inhibitor 1, and 
Hepes buffer, pH 7.5) except substrate in a total of 225 µL (90% assay volume).  
Following incubation at 30 ºC for 30 or 75 minutes, the 250 L reaction was initiated 
with 25 µL N-formyl-D-Glu to a final concentration of 3 mM.  The control reaction 
contained water in place of inhibitor and was used to obtain v0, the velocity in the 
absence of inhibitor.  Using the data from the 75-minute incubation samples, the velocity 
values at the different inhibitor concentrations, vi, were divided by the value of v0, 
plotted as a function of inhibitor concentration, [I], and fit to equation 4 (57, 63). 
  /     1 – ([Et    [I   [     - (( I         [Et )
2- (4[Et    ))
1/2
/(2[Et )     (4) 
 The first order rate constant for the onset of inhibition, kobs, was determined by 
measuring the formation of NADH after the addition of Bb3285 to assay mixtures 
containing varying amounts of inhibitor 1 (10 to 300 nM).  The concentration of Bb3285 
(1 nM) and substrate (1.5 mM N-formyl-D-Glu) were constant.  The OD340nm (P) was 
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monitored continuously and the timecourse data were fit to equation 5 to obtain kobs at 
varied concentrations of 1, I, where t is time, and vi and vs are the initial and final steady 
velocities, respectively.  If the inhibition of Bb3285 by 1 follows that of the model 
outlined in Scheme 2.3, a fit of the kobs data as a function of the concentration of 
inhibitor to equation 6 can be used to obtain k3 and the apparent (k2/k1).  The data for the 
nonlinear relationship between kobs and inhibitor concentration were fit to equation 6.  
The value for (k2/k1)
app
 was adjusted for competition with substrate using equation 7.  
The value used for the Km (230 M) in equation 7 was determined using the same 
coupling assay (57). 
           ((   -   )/ obs)(1 -  
(- obs )
)           (5) 
Scheme 2.3  Model for binding of inhibitor 1 to Bb3285 
E
k1[I]
k2
EI
k3
k4
E*I
 
 
 3   ( obs –   )(1   (( 2/ 1)
app/[I ))            (6) 
( 2/ 1)
app 
  ( 2/ 1)
app
/ (1   ([  / m))          (7) 
  Network Analysis.  The amino acid sequences which are annotated as N-acyl-D-
amino acid deacetylases make up cog3653.  There are ~ 240 amino acid sequences in 
cog3653  that originate from the predicted protein sequences from the first ~ 1000 
completely sequences microbial genomes.  An all-by-all BLAST of the putative N-acyl-
D-amino acid deacetylases (members of cog3653) was performed using the program 
MUSCLE (64).  A protein similarity network based on the BLAST results was generated 
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using Cytoscape (65).  The nodes (representatives of a single amino acid sequence) were 
arranged using the yFiles organic layout provided with Cytoscape version 2.4.  
Connections between nodes are shown as lines if the E-value of the best BLAST hit 
between two sequences is at least as good as 1 x 10
-70
.   
Sequence Alignment.  The groups of sequences from each of clusters 1, 2, 4 and 5 
were aligned separately using CLUSTALW in Biology Workbench from the San Diego 
Supercomputer Center (http://workbench.sdsc.edu).  Sequences within clusters 1, 2 and 
5 which did not have the ―YPY‖ motif after 7 or the nearly-conserved tyrosine from 4, 
and sequences that were too short (gi|163839586) or too long (gi|32471748 and 
gi|94969636) were not used.  A CLUSTALW profile alignment was then performed with 
the alignments for clusters 1 and 2.  A second CLUSTALW profile alignment was 
conducted with the alignment of the cluster 4 sequences and the combined alignment of 
clusters 1 and 2.  Finally, in a third CLUSTALW profile alignment, the aligned 
sequences from cluster 5 were aligned onto the profile alignment of clusters 1, 2 and 4.  
All of the amino acid sequences not displayed in Figure 2.1 as well as extra gaps were 
removed.   
RESULTS 
Substrate Specificity of Bb3285.  The determination of the substrate specificity of 
Bb3285 was initiated with the N-acetyl-D-Xaa library.  Various concentrations of 
enzyme (0 – 0.1 μM) were mixed with a fixed concentration of the substrate library and 
allowed to react for 1 hour.  The formation of free amino acids was measured with the 
ninhydrin assay and the results plotted as shown in Figure 2.2A.  The maximum 
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absorbance change at 507 nm was ~0.19.  If the entire substrate library had been 
hydrolyzed, the change in absorbance would have been ~3.5 and thus under these 
reaction conditions only a small fraction of the initial substrate library is hydrolyzed.  A 
sample of the partially hydrolyzed reaction mixture was subjected to amino acid analysis 
to determine the identity of the N-acyl-amino acids that are functional substrates for 
Bb3285.  The chromatogram is presented in Figure 2.3 as a continuous red line.  A 
control reaction was conducted in the absence of Bb3285 and the chromatogram is 
shown in Figure 2.3 as a series of black dots.  Relative to the control sample there is 
only a single amino acid, D-glutamate, that is formed from the hydrolysis of the N-
acetyl-D-Xaa library after the addition of Bb3285.  Therefore, the only compound to be 
hydrolyzed in this substrate library is N-acetyl-D-glutamate.  The other members of this 
N-acetyl-D-amino acid library are hydrolyzed at less than 1% of the rate observed for N-
acetyl-D-glutamate.  
Bb3285 was also utilized as a catalyst for the hydrolysis of the N-succinyl-D-Xaa 
library and the results are presented in Figure 2.2B.  Relative to the N-acetyl-D-Xaa 
library, the rate of hydrolysis is measurably slower.  When the concentration of Bb3285 
is increased 20-fold to 2.0 μM, the fraction of the N-succinyl-D-Xaa library that is 
hydrolyzed is approximately equal to that of the N-acetyl-D-Xaa library as illustrated by 
the red circles in Figure 2.2B.  Under these reaction conditions there is no evidence for 
the hydrolysis of the N-acetyl-L-Xaa or N-succinyl-L-Xaa substrate libraries.  Bb3285 
was  
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Figure 2.2: Enzyme courses for the hydrolysis of various substrate libraries by Bb3285.  (A) N-
acetyl-D-Xaa (black circles), N-acetyl-L-Xaa (open circles), and N-succinyl-D-Xaa (red circles).  
(B) N-succinyl-D-Xaa (red circles) and N-succinyl-L-Xaa (open circles).  (C) L-Ala-D-Xaa.  (D) 
L-Asp-D-Xaa.  The enzyme concentration is shown along the abscissa.  In panels A, B, and C, 
the enzyme was incubated with the substrate library for 1 hour whereas in panel D, the substrate 
library was incubated with the enzyme for 24 hours at 30 
o
C.  Additional details are provided in 
the text. 
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Figure 2.3: HPLC chromatogram of the N-acetyl-D-Xaa library treated with no enzyme (black 
dots) and 20 nM Bb3285 (red line) for 1 hour at 30 ºC.  The OPA-derivatized D-glutamate was 
detected at a retention time of 1.7 minutes in the sample treated with Bb3285.  The internal 
standard is labeled as IS.  Additional details are provided in the text.  
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tested with two L-Xaa-D-Xaa dipeptide libraries and the results are shown in Figures 
2.2C and 2.2D.  With the L-Ala-D-Xaa dipeptide library, 1-2 dipeptides are hydrolyzed 
in 1 hour at an enzyme concentration of 0.2 μM.  The hydrolysis of the L-Asp-D-Xaa 
library is considerably slower.  Amino acid analyses of these substrate libraries indicate 
that only those compounds with a D-glutamate at the carboxy terminus are substrates for 
Bb3285 (data not shown).  Bb3285 was subsequently screened for dipeptidase activity 
towards eighteen L-Xaa-D-Xaa libraries. The relative rates of hydrolysis for these 
libraries are summarized in Table 2.1.   
The kinetic constants were determined for the hydrolysis of N-formyl-, N-acetyl-, 
N-succinyl-, N-Met-, and N-Leu-derivatives of D-glutamate by Bb3285 at pH 7.5.  The 
kinetic constants from fits of the data to equation 2 are presented in Table 2.2.  Of the 
compounds tested, N-formyl-D-glutamate exhibited the highest values for kcat (2200 s
-1
) 
and kcat/Km (5.6 x 10
6
 M
-1
 s
-1
).  Somewhat lower values were obtained for N-acetyl-D-
glutamate.   
 Substrate Specificity of Gox1177.  The substrate specificity for Gox1177 was 
initially interrogated with the N-acetyl-D-Xaa library.  The enzyme (0-2 μM) was 
incubated for three hours with the N-acetyl-D-Xaa library, and the reaction was 
quenched by the addition of the ninhydrin reagent to determine the concentration of the 
free amino acids that were released following hydrolysis of the amide bond.  The plot for 
the change in absorbance at 507 nm as a function of enzyme concentration is presented 
in Figure 2.4A.  The maximum absorbance change at the highest enzyme concentrations 
is ~1.1.  This result indicates that approximately one third of the N-acyl-D-amino acids in  
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Table 2.1: Relative rates of hydrolysis of L-Xaa-D-Xaa dipeptide libraries by Bb3285 
                  and Gox1177 
 
Library Bb3285 Gox1177 
L-Ala-D-Xaa 16 48 
L-Arg-D-Xaa 2 3 
L-Asn-D-Xaa 4 26 
L-Asp-D-Xaa 1 0.1 
L-Gln-D-Xaa 2 5 
L-Glu-D-Xaa 1 1 
L-Gly-D-Xaa 64 5 
L-His-D-Xaa 2.6 22 
L-Ile-D-Xaa 5 7 
L-Leu-D-Xaa 86 92 
L-Lys-D-Xaa 5 1 
L-Met-D-Xaa 100 76 
L-Phe-D-Xaa 10 71 
L-Pro-D-Xaa 37 52 
L-Ser-D-Xaa 4 27 
L-Thr-D-Xaa 3 37 
L-Trp-D-Xaa 6 80 
L-Tyr-D-Xaa 7 100 
L-Val-D-Xaa 7 6 
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Table 2.2: Kinetic parameters for Bb3285 with selected substrates at pH 7.5
a 
 
Substrate kcat, s
-1
 Km, M kcat/Km, M
-1
s
-1
 
N-formyl-D-Glu 2200 ± 72 380 ± 35 (5.8 ± 0.6) x 10
6
 
N-acetyl-D-Glu 460 ± 9 88 ± 8 (5.2 ± 0.5) x 10
6
 
N-succinyl-D-Glu 5.8 ± 0.4 60 ± 22 (9.6 ± 3.5) x 10
4
 
L-Leu-D-Glu 3.6 ± 0.1 12 ± 1.4 (3.0 ± 0.4) x 10
5
 
L-Met-D-Glu 2.9 ± 0.1 8.4 ± 1.4 (3.4 ± 0.6) x 10
5
 
 
 
a
These data were obtained from a fit of the data to equation 2. 
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Figure 2.4: Enzyme courses for the hydrolysis of various substrate libraries by Gox1177.  (A) 
N-acetyl-D-Xaa (black circles), N-acetyl-L-Xaa (open black circles) and N-succinyl-D-Xaa (red 
circles).  (B) Gly-D-Xaa.  (C) L-Ala-D-Xaa.  (D) L-Asp-D-Xaa.  In panels A, B, and C the 
enzyme was incubated with the substrate library for 3 hours whereas in panel D the substrate 
library was incubated with Gox1177 for 24 hours. 
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this library were hydrolyzed under these reaction conditions.   A fraction of the 
hydrolyzed N-acetyl-D-Xaa library was subjected to amino acid analysis to determine the 
specific compounds that are substrates for Gox1177.  The HPLC chromatogram is 
presented in Figure 2.5 for samples that were incubated for 90 minutes with either 20 
nM (red) or 200 nM (blue) Gox1177.  This enzyme has substantially broader substrate 
specificity than does Bb3285 and shows a kinetic preference for the hydrolysis of N-acyl 
derivatives of the hydrophobic amino acids leucine, methionine, phenylalanine, 
tryptophan, tyrosine and valine, in addition to alanine, asparagine, glutamine, histidine, 
serine and threonine.  The enzyme was unable to hydrolyze compounds contained within 
the N-acetyl-L-Xaa or N-succinyl-D-Xaa substrate libraries (Figure 2.4A). 
 The breadth of the substrate profile for Gox1177 was further examined by 
utilizing the dipeptide libraries Gly-D-Xaa (Figure 2.4B), L-Ala-D-Xaa (Figure 2.4C) 
and L-Asp-D-Xaa (Figure 2.4D).  A significant fraction of the compounds found in these 
libraries were hydrolyzed as substrates by Gox1177.  To determine the relative ability of 
Gox1177 to hydrolyze dipeptides, Gly-D-Xaa and 18 L-Xaa-D-Xaa (except L-Cys-D-
Xaa) dipeptide libraries were mixed with 0-2 M Gox1177 and the free amino acids 
produced after 3 hours were determined with the ninhydrin reagent.  The relative rates 
are listed in Table 2.1.  For the dipeptide libraries the enzyme has a preference for Tyr, 
Leu, Trp, Met, and Phe at the N-terminus.  The kinetic parameters for the hydrolysis of  
L-Met-D-Leu, L-Leu-D-Leu, L-Tyr-D-Leu, and fourteen N-acyl-D-amino acid substrates 
by Gox1177 are provided in Table 2.3.  At the C-terminal end of these N-acyl-D-amino 
acids, the preferred amino acids are leucine, tryptophan, phenylalanine, and tyrosine.   
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Figure 2.5: HPLC chromatograms for the hydrolysis of the N-acetyl-D-Xaa library treated with 
no enzyme (black dots), 20 nM Gox1177 (red line) and 200 nM (blue line) Gox1177 for 90 
minutes at 30 
o
C.  The OPA-derivatized amino acids are indicated with their single letter code.  
The OPA-derivatized norvaline internal standard is indicated as IS.  The unlabelled peak near 
threonine is likely oxidized methionine.  Additional details are provided in the text. 
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Table 2.3: Kinetic parameters for Gox1177 with selected substrates
a 
 
Compound kcat, s
-1
 Km, mM kcat/Km, M
-1
s
-1
 
N-acetyl-D-Trp 89 ± 2 2.2 ± 0.2 (4.1 ± 0.3) x 10
4
 
N-acetyl-D-Leu 101 ± 3 3.2 ± 0.2 (3.2 ± 0.2) x 10
4
 
N-acetyl-D-Phe 59 ± 2 2.5 ± 0.3 (2.4 ± 0.3) x 10
4
 
N-acetyl-D-Met 40 ± 2 1.8 ± 0.3 (2.2 ± 0.4) x 10
4
 
N-acetyl-D-Tyr 66 ± 2 7.1 ± 0.5 (9.3 ± 0.7) x 10
3
 
N-acetyl-D-His nd nd (8.5 ± 0.2) x 10
3
 
N-acetyl-D-Thr nd nd (6.0 ± 0.1) x 10
3
 
N-acetyl-D-Val 16 ± 1 4.1 ± 0.2 (3.9 ± 0.2) x 10
3
 
N-acetyl-D-Ala 50 ± 4 18 ± 2 (2.9 ± 0.4) x 10
3
 
N-acetyl-D-Gln nd nd (2.7 ± 0.1) x 10
3
 
N-acetyl-D-Asn nd nd 480 ± 20 
N-propionyl-D-Leu 23 ± 1 1.2 ± 0.1 (2.0 ± 0.1) x 10
4
 
N-formyl-D-Leu 13 ± 1 5.9 ± 0.5 (2.2 ± 0.2) x 10
3
 
N-succinyl-D-Leu nd nd 30 ± 1.4 
L-Tyr-D-Leu 19 ± 1 1.3 ± 0.2 (1.5 ± 0.2) x 10
4
 
L-Met-D-Leu 20 ± 1 1.6 ± 0.2 (1.3 ± 0.2) x 10
4
 
L-Leu-D-Leu 31 ± 1 3.3 ± 0.2  (9.2 ± 0.7) x 10
3
 
 
a
From fits of the data to equation 2.  For those entries without values of kcat and Km, 
saturation was not achieved at concentrations up to 10 mM. 
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The N-methylphosphonate derivative of D-leucine (2) was tested as a competitive 
inhibitor of Gox1177.  At pH 8.4 this compound was found to be a competitive inhibitor 
versus N-acetyl-D-leucine with a Ki value of 4.9 ± 0.1 μM from a fit of the data to 
equation 3.   
Partial Purification of Sco4986.  The SDS-PAGE gel of the partially purified 
Sco4986 is shown in Figure 2.6.  The band which was used to confirm the amino acid 
sequence of residues 2-6 is also indicated.   
Substrate Specificity of Sco4986 and Bb2785.  The protein Sco4986 could not be 
purified, but the substrate specificity was measured using clarified cell lysates.  Control 
experiments were conducted using cells that contained the pET-30a(+) plasmid lacking 
the gene for expression of Sco4986.  Incubation of the nineteen N-acetyl-D-amino acids 
with the lysates of Rosetta 2 BL21 (DE3) cells harboring the pET-30a(+) or pET-30a(+)-
Sco4986 plasmids was used to determine if any background D-aminoacylase activity was 
present in E. coli and if the presence of the Sco4986 gene in the plasmid resulted in the 
lysate having D-aminoacylase activity.  There was a significant increase in the rate of 
formation of free amino acids when the substrates and the Sco4986 lysate were together 
in solution vs. either of these components alone.  It was determined that all of the N-
acetyl-D-amino acids were substrates for Sco4986, with the exception of the N-acetyl 
derivatives of D/L-Asp, D-Glu, D-His, D-Lys, and D-Arg.  For the N-acetyl-derivatives of 
D-Ala, D/L-Cys, D-Phe, D-Leu, D-Met, D-Gln, D-Val, D-Trp and D-Tyr, the rate of 
hydrolysis of the substrates by the pET-30a(+) control lysate ranged from 1% to 4% of 
that observed for the lysate containing Sco4986.  The hydrolysis of the N-acetyl-Gly,  
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Figure 2.6:  SDS-PAGE gel of partially purified Sco4986 (lanes 1-7).  The band which was used 
for N-terminal amino acid sequencing is indicated with an arrow.  Lane 8 is the molecular 
weight marker with the molecular weights labeled in kDa.  The calculated molecular weight of 
Sco4986 is 58.1 kDa. 
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 N-acetyl-D-Asn, N-acetyl-D-Ser and N-acetyl-D-Thr substrates by the control lysate was 
11-12% of the rate observed for the lysate containing Sco4986.  The relative rates of 
hydrolysis are summarized in Table 2.4.  The best of these substrates is N-acetyl-D-Phe 
(Km = 0.51 ± 0.04 mM, Vmax = 0.3 ± 0.006 molmin
-1mg-1) followed by N-acetyl-D-Trp 
(Km = 0.28 ± 0.03 mM), N-acetyl-D-Tyr (Km = 9.1 ± 0.5 mM), and N-acetyl-D-Met (Km = 
6.2 ± 1.0 mM).  
The N-methylphosphonate derivative of D-Phe (3) was found to be an inhibitor of 
Sco4986 with a Ki of 87 ± 4 nM.  The inhibition plots for Bb3285, Gox1177 and 
Sco4986 with compounds 1 and 2 and 3 are presented in Figure 2.7.  No hydrolysis 
could be detected upon the incubation of Bb2785 with the 18 N-acetyl-D-amino acid 
compounds.  
Inhibition of Bb3285 by Compound 1.  The N-methylphosphonate of D-glutamate 
was a tight-binding inhibitor of Bb3285 with a Ki of 460 ± 74 pM (Figure 2.7A).  A 
sample of some of the time courses which were fit to equation 5 to obtain the kobs values 
for the onset of inhibition of Bb3285 are displayed in Figure 2.8A.  The kobs values were 
plotted against the concentration of inhibitor (Figure 2.8B), and it appeared that the kobs 
values were approaching a maximum value independent of higher inhibitor 
concentrations.  This suggests that the EI complex could be converting to a more tightly-
bound E*I complex with the forward and reverse rate constants of k3 and k4, respectively 
(Scheme 2.3).  Fits of the kobs data vs. the concentration of 1 to equation 6 (Figure 2.8B) 
gave values of (k2/k1)
app
 = 130 ± 20 nM and k3 = 0.017 s
-1
.  The value of (k2/k1)
app
 
adjusted for competition with the substrate was 18 ± 3 nM. 
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Table 2.4: Relative rates of hydrolysis of N-acetyl-D-amino acids by Sco4986
a
  
 
Substrate Relative Rate 
N-acetyl-D-Phe 100 
N-acetyl-D-Trp 48 
N-acetyl-D-Met 30 
N-acetyl-D-Tyr 25 
N-acetyl-D-Val 8 
N-acetyl-D-Leu 7 
N-acetyl-D-Ala 7 
N-acetyl-D-Ser 7 
N-acetyl-D-Asn 5 
N-acetyl-D-Thr 3 
N-acetyl-D-Gln 3 
N-acetyl-D-Gly 1 
 
a
pH 7.5 at 1.0 mM substrate. 
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Figure 2.7: Inhibition plots of (A) Bb3285, (B) Gox1177 and (C) Sco4986 by the N-
methylphosphonate derivatives of D-glutamate (1), D-leucine (2), and D-phenylalanine (3), 
respectively.  (A) A competitive inhibition constant of 460 pM was obtained from a fit of the 
data to equation 4 at a substrate concentration of 3.0 mM N-formyl-D-Glu.  (B) A competitive 
inhibition constant of 4.9 M was obtained from a fit of the data to equation 3 at a substrate 
concentration of 3.0 mM N-acetyl-D-Leu.  (C) A competitive inhibition constant of 87 nM was 
obtained from a fit of the data to equation 3 at a substrate concentration of 1.5 mM N-acetyl-D-
Phe.  Additional details are provided in the text.   
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Figure 2.8 Time dependence for the onset of inhibition of Bb3285 by 1.  (A) Time course plots 
from select concentrations of 1 for the onset of inhibition of Bb3285 by 1 fit to equation 5 to 
determine the apparent first order rate constant.  The concentrations of 1 shown are 15 nM ( ), 
25 nM ( ), 50 nM ( ) and 80 nM ( ).  (B) Effect of the concentration of 1 on the rate of 
inhibition onset.  The data were fit to equation 6.   
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Three-Dimensional Structure of Bb3285.  The crystal structure of Bb3285 was 
determined to a resolution of 1.5 Å as a homodimer with one zinc, one acetate and two 
formate molecules bound in the active site (Figure 2.9).  The N-terminal residues 1-4 
and the C-terminal residues 479-480 were disordered in both structures and were not 
included in the final model.  In addition to the signature (/)8-barrel (shown in dark 
blue and red) two additional domains are present.  The first of these domains is an 
insertion colored in pink (residues 287-344) between -strand 7 and -helix 7 of the 
(/)8-barrel.  The second domain is a nine stranded β-barrel encompassing residues 5-
61 (colored in teal) and residues 413-478 (colored in yellow) contributed from the N- 
and C-termini of the polypeptide.  A long loop (residues 432-451) is inserted between 
the seventh and eighth -strands of the -barrel.  The single zinc is bound in the β-metal 
site and is ligated by Cys-95, His-218, His-248 and the acetate product as shown in 
Figure 2.10A.   In this complex one of the carboxylate oxygens from acetate is 
positioned 2.3 Å from the zinc and 2.6 Å away from one of the oxygens of the catalytic 
aspartate residue from the end of -strand 8 (Asp-365).   The other carboxylate oxygen 
in the acetate is 2.6 Å away from the phenolic oxygen of Tyr-190 and 2.3 Å from the 
zinc.  The two histidines at the end of -strand 1 (His-66 and His-68) do not ligate a 
second zinc in the α-metal binding site.  One of the formate molecules is interacting with 
Lys-250, Tyr-282, and Arg-376 at distances of 2.7, 2.5, and 2.8 Å, respectively.  The 
other formate forms a polar interaction with the side chain of Arg-295 and Ser-287.    
The second Bb3285 structure had well-defined density for two Zn
2+
, and one 
inhibitor molecule bound in the active site of both molecules in the asymmetric unit.   
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Figure 2.9: Homodimeric structure of Bb3285.  The (/)8-barrel is colored with red -strands 
and dark blue -helices and adjoining loops.  The first insertion domain (from residue 287 to 
344) containing the substrate specificity loop is colored pink.   The second insertion domain 
consisting of residues 5-61 and 413-478 is colored cyan and yellow, respectively.  The active site 
Zn is represented as a green sphere. 
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Figure 2.10: Native mononuclear metal center and binuclear inhibitor-complexed active site of 
Bb3285.  Contacts to the metals (2.0-2.4 Å) are indicated by dashed lines.  (A) Mononuclear Zn 
(green sphere) center with acetate (pink carbons) bound in the active site.  (B) Binuclear Zn 
(green sphere) center active site of Bb3285 with bound inhibitor 1 (pink carbons, orange 
phosphorus).  Enzyme-inhibitor contacts within 2.6-3.1 Å (3.5 Å to D365) are indicated by 
dashed lines.  For clarity, the 2.7 Å contact between the hydroxyl group of Y190 and the 
phosphonyl oxygen coordinated to Zn is not shown.  Additional details are provided in the text. 
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The 3-dimensional structure was solved to 1.8 Å resolution as a binuclear Zn enzyme 
with compound 1, a tight-binding inhibitor of Bb3285, bound in the active site (Figure 
2.10B).  The histidine ligands, His-66 and His-68, at the end of -strand 1 were 
coordinated at 2.1 and 2.0 Å to the Zn in the α-site.  The Zn-metal was ligated by His-
218 and His-248 as in the native structure.  The two metals were bridged by Cys-95 (2.4 
and 2.3 Å) and each phosphonyl oxygen of compound 1 to either Zn (2.0 Å) or Zn (2.0 
Å).  The C-terminal carboxylate of 1 was within hydrogen-bonding distance to Lys-250 
(2.8 Å), Tyr-282 (2.7 Å) and Arg-376 (2.7 Å).  The oxygens of the side-chain 
carboxylate of D-glutamate were 2.7-2.8 Å from the guanidino group of Arg-295.  An 
oxygen of the side chain carboxylate of 1 also contacts the hydroxyl group of Ser-287 at 
a distance of 2.5 Å.  Though not shown, for the purpose of clarity, the hydroxyl oxygen 
of Tyr-190 is 2.7 Å from the phosphonyl oxygen which coordinates to Znβ.  The 
catalytic aspartate at the end of the 8
th
 -strand is 3.5 and 2.6 Å from the amide nitrogen 
of 1 and phosphonyl oxygen that is coordinated to Znα.   
Network Analysis of N-acyl-D-amino Acid Deacylases.  Approximately 240 N-
acyl-D-amino-acid deacylase like sequences were identified in the NCBI database from 
the completely sequenced organisms.  At an E-value cutoff of 1 x 10
-70
, the sequences 
can be separated into 6 main clusters, as shown in Figure 2.11.  Each node in the 
network represents a single amino acid sequence and each line represents a pairwise 
connection between two sequences with a BLA T score of E ≤  1 x 10-70.  The lengths of 
lines are not meaningful, but sequences in tightly clustered groups are more similar to 
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Figure 2.11:  Cytoscape graphical representation of putative D-aminoacylases from cog3653.  
The amino acid sequences (circles) are separated into six clusters based on an e cut-off value of 
1 x 10
-70
.   Circles which are connected by lines have an E-value ≤ 1 x 10-70.  The protein targets 
described in Chapter II are colored teal (Bb3285), yellow (Sco4986), dark red (Bb2785), pink 
(Gox1177) or black (Bll7304).   
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each other than sequences with few connections.  The four proteins discussed here are 
highlighted in Figure 2.11 from clusters 1, 2, 4 and 5. 
With the exception of Gox1177 and Sco4986, which were functionally 
characterized here, all of the proteins that are known to catalyze the deacylation of N-
acyl-D-amino acids are found in cluster 1 (34, 35, 38, 40, 44, 56).  Cluster 4 includes the 
enzyme Bb2785, for which specificity could not be determined on the basis of library 
screening using the N-acetyl-D-amino acid library.  From the alignment in Figure 2.1, it 
appears that Bb2785 is missing some metal ligands as well as key residues implicated in 
the recognition of the N-acyl-D-amino acid substrate.  Cluster 3 does not contain 
characterized enzymes.  As with the sequences from Cluster 4, it is difficult to say 
whether or not the proteins in Cluster 3 have all of the metal ligands and/or substrate-
recognition residues.   
DISCUSSION 
 Five genes coding for putative D-aminoacylases were cloned and four of these 
enzymes were successfully expressed in E. coli: Bb3285, Bb2785, Sco4986 and 
Gox1177.  Each of these enzymes was tested as a catalyst for the hydrolysis of N-acyl-
D/L-Xaa substrates contained within a series of well-defined libraries of N-substituted 
amino acid derivatives.  Using ninhydrin and/or HPLC-based assays, it was possible to 
measure the rate of hydrolysis of each library component by quantifying the specific 
amino acids liberated within these libraries as a function of time or enzyme 
concentration.  Each enzyme was screened against more than 400 compounds.       
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 Specificity of Bb3285.  Bb3285 exclusively hydrolyzes derivatives of D-
glutamate, where this amino acid is substituted with a simple acyl group or another 
amino acid.  This enzyme will hydrolyze N-acetyl-, N-formyl- and N-succinyl-
derivatives of D-glutamate but not the N-acyl-derivatives of any other D- or L-amino 
acid.  Bb3285 hydrolyzes a variety of L-Xaa-D-Glu dipeptides but the best substrates are 
N-formyl- and N-acetyl-D-Glu.  The N-formyl-D-Glu substrate has the highest value of 
kcat (2200 s
-1
) but the values for kcat/Km with this substrate and N-acetyl-D-Glu are 
essentially the same.  The enzyme is less stringent regarding the identity of the L-amino 
acid at the amino-terminus of dipeptide substrates, but it does exhibit a preference for 
leucine or methionine derivatives of D-Glu.   
Specificity of Gox1177.  The second enzyme examined in this investigation, 
Gox1177, was found to deacetylate a broad range of N-acetyl-hydrophobic D-amino 
acids.  Changing the acyl group from N-acetyl- to N-formyl-D-Leu results in a decrease 
in kcat and an increase in Km.  With the L-Xaa-D-Xaa dipeptides, Gox1177 has a clear 
preference for the larger hydrophobic and aromatic residues (Tyr, Trp, Phe, Met and 
Leu) at the amino terminus.  The relatively high Km values for Gox1177 with the 
substrates identified in this investigation calls into question whether N-acetyl-D-amino 
acids are necessarily the physiological substrates for this enzyme.  Perhaps the native 
substrate of Gox1177 has a different functionality attached to the D-amino acid.   
Specificity of Sco4986.  The gene for Sco4986 was expressed in E. coli Rosetta 2 
cells but the protein could not be purified to homogeneity because the protein was 
largely insoluble.  However, the deacetylase activity of this protein could be detected in 
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whole cell lysates.  The relative rates of substrate hydrolysis clearly demonstrate that 
Sco4986 hydrolyzes many of the N-acetyl-D-amino acid derivatives with a preference 
for hydrophobic and aromatic amino acids.  The Michaelis constants for the best 
substrates found with Sco4986 are ~ 5-fold lower than the best substrates for Gox1177.    
Activity of Bb2785.  A catalytic activity for Bb2785 was not identified.  Many of 
the residues whose side chains are expected to bind the substrate could not be identified 
in sequence alignments and thus if this protein has enzymatic activity, the substrates 
were not included in our screening libraries.   
Structural Basis for Substrate Specificity.  The three-dimensional X-ray 
structures of Bb3285 in the presence of potent inhibitor 1, and of the acetate/formate 
complex, have revealed the structural determinants for enzyme specificity of this 
enzyme.  In the complex with acetate and two formate molecules, one of the formate 
molecules is ion-paired with Arg-376 and Lys-250 in addition to a hydrogen bonding 
interaction with the phenolic side chain of Tyr-282.  The arginine and tyrosine residues 
are fully conserved in Bb3285, Gox1177, and Sco4986 and thus these two residues are 
likely required for recognition of the α-carboxylate group at the C-terminus of the 
substrate.  The arginine residue is also fully conserved among all of the enzymes that are 
>40% identical in amino acid sequence to Bb3285, Gox1177 or Sco4986.  The tyrosine 
residue is semi-conserved but the substitution is limited to a histidine in these proteins.  
The lysine is conserved in those enzymes that are >40% identical in sequence to Bb3285 
but is not conserved in those sequences that are more similar to Gox1177 or Sco4986. 
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The second formate in the active site of Bb3285 is ion-paired with the side chain 
guanidino group of Arg-295 and thus this interaction is likely required for recognition of 
the side chain carboxylate of the C-terminal D-glutamate.  This assignment is confirmed 
by the structure of Bb3285 in the presence of compound 1, a mimic of the tetrahedral 
reaction intermediate (Figure 2.10B).  In Bb3285, Arg-295 is found in a loop that starts 
after the end of β-strand 7.  This is the same loop that was proposed to serve as the 
specificity loop for the DAA from A. faecalis DA1, based upon a computational model 
of N-acetyl-D-methionine bound in the active site (36).  The hydrophobic side chain of 
D-methionine was postulated to interact with Leu-298 in this enzyme.  However, the 
corresponding residue, from a sequence alignment with Bb3285, is Glu-297 (see Figure 
2.1) and thus it was not so clear how the side chain carboxylate of D-glutamate 
substrates would be able to interact with Glu-297 in Bb3285.  The answer to this 
dilemma is found in a structural overlay of Bb3285 with the DAA from A. faecalis as 
shown in Figure 2.12 (36, 56).  The specificity loops in these two proteins adopt distinct 
conformations.  In the A. faecalis structure, Leu-298 is pointed towards the active site 
and the side chain of Arg-296 is pointed away from the active site.  However, in the 
Bb3285 structure, Arg-295 is pointed toward the active site.  The conformational 
differences in these two loops are likely the result of a twist in the loop that is initiated 
by Pro-293 in Bb3285.  Presumably, the side chain of N-acetyl-D-aspartate is not long 
enough to interact with Arg-295 and thus Bb3285 is unable hydrolyze substrates with a 
terminal D-aspartate.  The D-glutamate side chain is also in contact with Ser-287, which 
is a glycine residue in Gox1177, Sco4986 and the DAA from A. faecalis.  The main two 
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Figure 2.12:  Structural overlay of Bb3285 (dark gray ribbon, green Zn) with the D-
aminoacylase (PDB entry 1M7J) from A. faecalis (light gray ribbon, purple Zn) showing the 
conformational differences between the loops in the two proteins that determine the differences 
in substrate specificity.  The loop (colored yellow) from the D-aminoacylase from A. faecalis is 
for residues 292-302.  In this structure, Leu-298 points toward the active site and Arg-296 points 
away from the active site.  The loop colored red from Bb3285 is for residues 291-301.  The 
phosphonamidate inhibitor is colored with pink carbons and an orange phosphorus.  In this 
structure, Arg-295 is pointing toward the active site and the guanidino group is ion-paired with 
the inhibitor. 
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residues which contribute to the pocket which bears the methyl group of inhibitor 1 (a 
representative of the methyl group of the N-acetyl- moiety of the substrate) are Leu-367 
and Leu-114. 
Prediction of Functional Specificity for Uncharacterized Members of the N-acyl-
D-Xaa Deacetylase Group.  Conservation of functionally important residues in multiple 
sequence alignments is often used to infer similarity of functional characteristics.  
However, Figure 2.1 is equivocal.  For example, two residues in the ―specificity loops‖ 
of Bb3285, Pro-293 and Arg-295, likely play a role in the exclusive preference for 
derivatives of D-glutamate in this protein.  However, only 7 sequences in Cluster 1 of the 
network show conservation of these residues, suggesting that only a few of these 
unknowns may share this preference.  Bb3285 has 47% amino acid sequence identity to 
the protein with locus tag Rmet_4439 (gi|94313364) which also has the equivalent 
residue to Pro-293 and Glu-294 in Bb3285.  Rmet_4439 has a phenylalanine in place of 
the Arg-295 residue of Bb3285 which would be expected to drastically alter substrate 
preference of the enzyme from that of Bb3285.   
 With the addition of the Bb3285 structure there are now two DAA structures, 
both categorized as members of Cluster 1 (Figure 2.11).  Unfortunately, the two 
substrate specificity loops (both 11 amino acids long) vary in conformation, making it 
difficult to predict the substrate specificity of other proteins in Cluster 1.  This is because 
there is no reason to believe that this loop cannot have other conformations which have 
not been structurally characterized.  Two residues within this loop in the A. faecalis 
enzyme, Lys-293 and Asp-295, are potentially correlated to its conformation. 
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 As illustrated in Figure 2.13A, the free amino group of Lys-293 is 4.1 Å from 
Asp-295, which is 2.9-3.0 Å from the backbone nitrogens of Val-297 and Leu-298.  Two 
DAAs from Alcaligenes xylosoxydans, specific for either N-acyl- derivatives of D-
aspartate (gi|3287879) or D-neutral amino acids (gi|3287876), also have an aspartic acid 
at the position equivalent to Asp-295 of the A. faecalis enzyme (Figure 2.13B dark 
blue).  The D-neutral-specific enzyme has the equivalent residue to Lys-293 as well as 
the active site pocket leucine equivalent to Leu-298 in the A. faecalis enzyme (Figure 
2.13B purple highlight).  The enzyme specific for the N-acyl-D-aspartate, has an arginine 
at both positions equivalent to Lys-293 and Leu-298 of the A. faecalis enzyme.  Since 
the substrate specificities of these two enzymes relate well to the structure and substrate 
specificity of the DAA from A. faecalis, the substrate specificity loops may be in the 
same conformation.  It could be that the Asp-295:Val-297 backbone interaction is more 
significant than the potential salt bridge between Lys-293 and Asp-295.  There are 
several amino acid sequences within Cluster 1 that have the combination of a positively 
charged residue at the position equivalent to Lys-293 and an aspartate equivalent to Asp-
295.  The reverse is also true in that several sequences have  lysine and aspartate 
residues which are in opposite positions to the Lys-293/Asp-295 combination (Figure 
2.13B, pink shading).  One can envision that these two residues may still be able to 
contact each other, but the positively charged residue would no longer hydrogen bond 
with a backbone nitrogen.  DAAs specific for either N-acyl- derivatives of polar 
(uncharged) or positively charged D-Lys/Arg D-amino acids have yet to be identified in 
the literature.  Based on the above hypothesis, there are a few putative DAAs from  
75 
 
 
 
Figure 2.13: Potential determinants of the position of the substrate specificity loop in the D-
aminoacylases from A. faecalis (1M7J) and Bb3285.  (A)  Representation of the superposed 
Bb3285 (dark gray ribbon except for red specificity loop, red carbons) and 1M7J (light gray 
ribbon except for yellow specificity loop, yellow carbons).  (B) Amino acid sequence alignment 
of 1M7J sequence, Bb3285 and several proteins within 40% amino acid sequence identity to 
Bb3285.  Those proteins which have been tested empirically have the sequence specificity loop 
highlighted yellow, if the substrate specificity loop is expected to be akin to 1M7J, or red if the 
loop is anticipated to be more similar to Bb3285.  Residues with side chains shown in panel A 
are shaded gray.  Those residues which are in proteins of unknown structure, but are predicted to 
be facing into the active site and influencing substrate specificity, are highlighted black or 
purple.  The potential determinants of the loop conformation in 1M7J discussed in the text are 
colored dark blue and pink. 
                 7       K293/D295 
1M7J          LDAYPYVAGSTMLKQDRVLLAGR 
gi|121610272  MDMYPYVAGSTVLREDLVDGVID 
gi|89899734   MDVYPYVAGSTVLREDLVDGVID 
gi|3287876    LDAYPYVAGSTMLKQDRVLLAGR   
gi|91786568   MDVYPYVAGSTVLREDLVDGVID 
gi|116695068  LDCYPYTAGSTMIRTDRGMLDGR 
gi|94314012   LDCYPYTAGSTMIRTEPAMLEGR 
gi|163855111  LDAYPYVAGSTMLKKDRVLLAGR 
gi|163796100  LDVYPYHASSTVLKHDSIVHATR 
gi|121608826  LDCYPYTAGSTMIRTDRSMMEGR 
gi|172063970  LDCHPYPATSTMLRADRIRQSSR 
gi|170737613  LDCHPYPATSTMLRADRIHQSSR 
gi|3287879    LDCHPYPATSTMLRLDRARLASR 
gi|163856640  LDCHPYPATSTMLRLDRVLLAQR 
gi|84502478   LDCYPYTASSTILTLDHAKNSGR 
gi|148252503  LDCYPYNASSTMLHTDPAKLQVK 
gi|37545840   LDCYPYTAGSTMILTDPDMLKNR 
gi|89899782   LDCYPYTAGSTILSADRAATSTR 
gi|156977565  CDCYPYSASSSTLDLKQVTDEID 
gi|17549408   CDCYPYTASSSTLDLKQVTDEFD 
gi|116695153  CDCYPYTASSSTLDLKQVTSDFD 
gi|83745626   CDCYPYTASSSTLDLKQVTDAFD 
gi|70734272   CDCYPYAASSSTLDLKQVTDAYR 
gi|134296936  CDCYPYSRSSSTLDLKQVSGDID 
gi|94313694   CDCYPYTASSSTLDLKQVTNDFD 
gi|77456951   CDCYPYAASSSTLDLKQVTDAHR 
gi|157368796  CDCYPYSASSSTLDLKQITDDFD 
gi|89069229   LDLYPYTAGSSVLDLKTVADTER 
gi|167835453  CDCYPYSRSSSTLDIKQATGDID 
gi|27367023   CDCYPYSASSSTLDLTQVTEEID 
gi|187477460  LDCYPYNASSTVLTQTLVANAAT 
gi|163855070  LDCYPYPASSTILTYSHAVGSSR 
gi|90578685   CDCYPYSASSSTLDLNQVTDDFD 
gi|149200352  MDCYPYAAGSSTLDLGQVDERVK 
gi|187925684  LDCYPYNASSTMLHLAEDRLTGK 
gi|91790639   LDCYPYPASSTILSAHRAVNATR 
gi|94313364   LDVYPYTASSTVLLPEFVGEAER 
gi|116694482  LDCYPYAASSTMLRPERVHQCDR 
gi|187478912  LDIYPYPGSSTILIPERAEQIEA 
gi|3287878    LDIYPYPGSSTILIPERADQIDD 
Bb3285        LDIYPYPGSSTILIPERAETIDD 
                             R295 
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Cluster 1 which might be specific for such compounds because the equivalent residue to 
Leu-298 is replaced by an aspartate (gi|121610272, gi|89899734, gi|91786568, black 
shading in Figure 2.13B). 
As mentioned above for proteins in Cluster 1, the ability to predict the substrate 
specificities of proteins within this class of enzymes is problematic even when structural 
data is available.  The structural coverage of cog3653 has not yet been expanded to 
include proteins from any of the other five clusters (Figure 2.11).  In Bb3285, the 
substrate specificity loop is part of an insertion region between 7 and 7 of the (/)8-
barrel and there are 82 amino acid residues between the tyrosine from 7 and the 
catalytic aspartate from 8.  The number of amino acids between these two residues is 87 
in Gox1177 and 129 in Sco4986.  From Figure 2.1 it is clear that the alignment of this 
region between the proteins from Clusters 1, 2, 4 and 5 is poor.  In the absence of the 3-
dimensional structure of Gox1177 and Sco4986, it is difficult to comment on their 
substrate-specificity determinants.  One observation which cannot be reconciled from the 
alignment in Figure 2.1, is the fact that the trends seen in the data presented in Tables 
2.1, 2.2, and 2.3, suggest that the acyl group pocket of Gox1177 is larger than that for 
Bb3285.   
There is also the potential for structural differences between Gox1177 and 
Bb3285.  In Clusters 1 and 2 there is a specific conserved arginine and glutamate 
(Figure 2.1, brown shading); the arginine immediately following the histidine from 5 
(Arg-220 in Bb3285) forms a salt bridge with a glutamate (Glu-232 in Bb3285).  This 
interaction may cause the loop after 6 to turn away from the active site before turning 
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back in, making Glu-222 an accessory structural residue in contact with Lys-250.  This 
Arg-Glu combination, highlighted in brown in Figure 2.1, is not expected to be present 
in Gox1177, though it is seen in some of the other amino acid sequences in Cluster 5.   
With the exception of Gox1177 and Sco4986 characterized here, all of the DAAs which 
have been experimentally characterized and are of known amino acid sequence are part 
of Cluster 1.  With the exception of those enzymes specific for N-acyl- derivatives of D-
Asp and D-Glu, these empirically-tested enzymes have broad specificity towards neutral 
amino acids.  A network similar to the one depicted in Figure 2.11 was created by 
Patricia Babbitt (University of California San Francisco) using a more stringent E-value 
cut-off of 10
-135
 and the sequences separated into smaller clusters.  The substrate 
specificity of the experimentally tested DAAs could not be correlated to organismal 
lineage, genome context, the identity of the bridging metal ligand, or variations in 
sequence length and the positions of associated inserts (56). 
 There are at least 50 microbial species with multiple N-acyl-D-aminoacylase-like 
sequences.  DAAs from up to three clusters have been observed in the same organism.  
As observed in A. xylosoxydans, multiple DAAs from a single organism can have 
varying specificities and perhaps functions.  This is analogous to a recently-reported case 
for the uronate isomerases, another group in the AHS, where multiple representatives of 
this sequence group within a single organism had different substrate specificities (5). 
Bb2785, the only protein from Cluster 4 that has been experimentally screened, 
showed no catalytic activity with N-acetyl-D-amino acid compounds.  This was not 
surprising considering that Bb2785 appears to be missing the residues which contact the 
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substrate (two tyrosines, an arginine and a lysine).  From the multiple-sequence 
alignment in Figure 2.1, this protein appears to be an outlier.  Bb2785 also seems to be 
missing the last two histidine metal binding ligands.  Under these circumstances, one 
might expect that the protein would bind one metal.  However, there were 1.8 
equivalents of Zn in the purified Bb2785 protein.  An alignment of the amino acid 
sequences within Cluster 4 does show that there are histidines which are nearly 
conserved and may be candidates for the histidine ligands from -strands 5 and 6.  
Bb2785 is not expected to be a D-aminoacylase based on the results outlined here.  
 In regards to the physiological functions of the Cluster 2 sequence group, the 
genome context does provide some possible clues. The gene for Sco4986 is adjacent to 
another open reading frame (Sco4987) that is currently annotated as a D-amino acid 
deaminase.  The top five BLAST hits to the Sco4986 gene from different organisms 
show approximately 60% identity to this gene. All five are also adjacent or nearby to an 
ORF annotated as a D-amino acid deaminase, amino acid racemase-like protein or D-
amino acid aldolase and these proteins are 38-50% identical in sequence to Sco4987.  
The similarities in genome context for homologues of these two genes among multiple 
organisms could suggest that the deacylase is liberating a free D-amino acid and then a 
second enzyme, the gene product of Sco4987, is racemizing or deaminating the D-amino 
acid.  N-acylated-D-amino acids have been shown to be components of lipopolypeptide 
antibiotics, and the presence of the acyl group on such compounds can be an important 
component of the molecule with respect to its antibiotic potency (66, 67).  
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Acetyltransferases for D-amino acids are known and it is possible that this small cluster 
of genes is a simple two-enzyme system to metabolize N-acetyl-D-amino acids. 
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CHAPTER III 
 
SUBSTRATE PROFILE AND STRUCTURE OF Sco3058: THE CLOSEST 
MICROBIAL HOMOLOGUE TO THE HUMAN RENAL DIPEPTIDASE 
INTRODUCTION 
 The mammalian renal dipeptidase catalyzes the general reaction outlined in 
Scheme 3.1 (68-73). This enzyme is also able to catalyze the hydrolysis of leukotriene 
D4 (48, 69, 70) as well as the oxidized degradation product of glutathione and L-Cys-Gly 
(69-71).  Human renal dipeptidase (hRDP) is the only enzyme in humans which has been 
shown to catalyze the hydrolysis of -lactams such as SCH 29482, imipenem, 
meropenem and DA-1131 (74, 75).  However, dipeptides are consistently better 
substrates for hRDP than are -lactams.  Glycine is the preferred amino acid at the C-
terminus, relative to an amino acid in the L-configuration and 
glycyldehydrophenylalanine is a better substrate for hRDP than glycylphenylalanine 
(48).  With rat renal dipeptidase, L-Ala-Gly is hydrolyzed faster than L-Ala-L-Ala and 
Gly-D-Ala is hydrolyzed faster than Gly-L-Ala (70).  Mammalian renal dipeptidases and 
some of their microbial homologues have been assayed with various substrates, but a 
complete substrate specificity profile for these types of enzymes has not been 
determined (48, 49, 69-71, 73, 76). 
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Scheme 3.1  General reaction catalyzed by human renal dipeptidase 
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 The crystal structure of hRDP has been solved with the inhibitor cilastatin bound 
in the active site (PDB code 1ITU) (23).  Cilastatin is considered to be a dipeptide 
analog, but it does not contain a free amino group at the N-terminus and it is not 
hydrolyzed by hRDP.  The metal center in the active site consists of two Zn ions that are 
bridged by a molecule from solvent (water or hydroxide) and the side chain carboxylate 
of Glu-125.  The alpha-Zn is additionally ligated by His-20 and Asp-22 whereas the 
beta-Zn is coordinated to His-198 and His-219.  It has been suggested that the water 
which bridges the two metal ions attacks the carbonyl of the peptide bond to form a 
tetrahedral intermediate that is stabilized by an electrostatic interaction with His-152.  
This residue is found at the end of -strand 4 of the (β/α)8-barrel structure and has been 
shown to be important for the binding of the cilastatin inhibitor (23, 77). 
 The structure of hRDP confirmed that this enzyme is a member of the 
amidohydrolase superfamily (AHS).  This is a rather large enzyme superfamily that has 
been shown to catalyze the hydrolysis of ester and amide bonds found within 
carbohydrate, peptide, and nucleic acid containing substrates (20).  The hRDP is 
contained within a large cluster of proteins designated as cog2355.  This cluster of 
proteins is typified by an HxD motif at the end of β-strand 1 that is used to coordinate 
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one of the two metal ions in the active site, whereas most of the other enzymes in this 
superfamily have an HxH motif.  In hRDP the invariant aspartate at the end of β-strand 8 
is not coordinated to the alpha-metal, whereas, in nearly all of the other members of the 
AHS that have been structurally characterized this residue is a direct ligand to the alpha-
metal ion.  The proposed chemical mechanism for the hydrolysis of dipeptides by hRDP 
is at variance with those mechanisms of amide bond hydrolysis proposed previously for 
other members of the AHS (19, 28, 78).  In hRDP the carbonyl group of the amide bond 
about to be hydrolyzed is proposed to be polarized by an electrostatic interaction with 
His-152 whereas in other members of the AHS this function is contributed by a direct 
interaction with the beta-metal ion (23).  The renal dipeptidase-like enzyme BCS-1 from 
Brevibacillus borstelensis has a tryptophan in place of the residue equivalent to His-152.  
BCS-1 is  reported to have respectable activity (kcat/Km = 2 x 10
5
 M
-1
s
-1
), which supports 
the conclusion that either His-152 does not play a crucial role in the chemical 
mechanism or that the mechanism for substrate hydrolysis of enzymes such as BCS-1 
vary from that of hRDP (49).   
 The putative dipeptidase Sco3058 from Streptomyces coelicolor is the closest 
bacterial homologue to the human enzyme from a completely sequenced microbial 
organism.  The sequence identity is ~41%.  S. coelicolor is a member of soil bacteria 
known for its versatile metabolism and production of antibiotics and pharmaceutical 
agents (79).  Here, the substrate specificity of Sco3058 was unraveled by determining its 
catalytic activity with 55 L-Xaa-L-Xaa, L-Xaa-D-Xaa and D-Xaa-L-Xaa dipeptide 
libraries.  The results demonstrate that this enzyme is a rather promiscuous dipeptidase 
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which is able to hydrolyze a large fraction of the ~1000 compounds screened.  
Nevertheless, Sco3058 showed some degree of specificity and the best substrate 
identified was L-Arg-D-Asp (kcat/Km = 7.6 x 10
5
 M
-1
s
-1
).  The structure of Sco3058 was 
determined to a resolution of 1.3 Å in the presence and absence of dipeptide mimics 
(80). 
MATERIALS AND METHODS 
Materials.  All chemicals were obtained from Sigma Aldrich, unless otherwise 
stated.  All of the compounds and substrate libraries which were not commercially 
available were synthesized by Dr. Chengfu Xu.  The coupling enzymes, glutamate-
oxaloacetate transaminase and malate dehydrogenase, were purchased from Sigma 
Aldrich  and Calbiochem, respectively.  Glycyl-D-Leu was purchased from TCI 
America.  Metal analyses were conducted using inductively coupled plasma mass 
spectrometry (ICP-MS) as previously described (59).  ICP-MS standards were obtained 
from Inorganic Ventures Inc.  Nitrocefin was purchased from Calbiochem.  
Oligonucleotide syntheses and DNA sequencing were performed by the Gene 
Technologies Lab of Texas A&M University.  
Synthesis of Dipeptide Libraries. The L-Xaa-D-Xaa and L-Xaa-L-Xaa dipeptide 
libraries were synthesized as described previously (56, 80, 81).  The 17 D-Xaa-L-Xaa 
libraries were synthesized in the same manner as the L-Xaa-L-Xaa libraries except that 
N-Fmoc-D-Xaa-OH amino acids were substituted for N-Fmoc-L-Xaa-OH amino acids.  
These compound libraries contain a single amino acid at the N-terminus and all of the 
common amino acids at the C-terminus.  However, the amino acids L-Cys, D-Cys and D-
84 
 
Ile were not incorporated into any of the dipeptide libraries.  A sample of these libraries, 
expected to contain ~2 nmol of each library component, was submitted for amino acid 
analysis (AAA) to quantify the amount of every amino acid in these libraries except for 
tryptophan.  The amount of tryptophan in these libraries was determined by the 
absorbance at 280 nm.   
Synthesis of Phosphinate Pseudodipeptides.  Six racemic phosphinate 
pseudodipeptide mimics of the putative tetrahedral intermediates for the hydrolysis of 
Ala-Asp (4), Phe-Asp (5) and Tyr-Asp (6), Ala-Ala (7), Leu-Ala (8) and Leu-Glu (9) 
were made as potential inhibitors of Sco3058.  These compounds were synthesized 
according to previously described protocols (82-85).  The structures of these compounds 
are presented in Scheme 3.2.       
 
Scheme 3.2  Phosphinate pseudodipeptide mimics  
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Cloning and Expression of Sco3058.  The gene for Sco3058 (gi|21221500) was 
amplified from Streptomyces coelicolor A3(2) genomic DNA with the primers 5'-
GCAGGAGCCATATGACATCGCTGGAGAAGGCCCGCGAGCTGCTGCGC-3' and 
5'-CGCGGAATTCAGCCTTCCGGCTGCTCGGCGGCCGTGCCG-3'.  The Pfx 
platinum polymerase (Invitrogen), 0.05 units/L PCR reaction, was used according to 
the manufacturer’s instructions except the annealing step was deleted.  The PCR product 
was digested with NdeI and EcoRI and ligated into the pET30a(+) vector (Novagen) with 
T4 ligase (New England Biolabs).  E. coli BL21 Rosetta 2 (DE3) cells were electro-
transformed with the pET30a(+)-Sco3058 plasmid.  Cells harboring the pET30a(+)-
Sco3058 plasmid were grown at 30 ºC in Terrific Broth containing 25 g/mL and 50 
g/mL chloramphenicol and kanamycin, respectively.  When the optical density at 600 
nm reached ~0.6, 2.5 mM Zn(acetate)2 was added, and the expression of Sco3058 was 
induced with 1.0 mM isopropyl--thiogalactoside (IPTG).  The cells were grown 
overnight at room temperature.   
Purification of Sco3058.  The cells containing Sco3058 were suspended in a 
purification buffer (20 mM Tris with 100 g/mL phenylmethanesulfonylfluoride, pH 
7.5) and lysed via sonication at 0 ºC.  The cell lysate was obtained by centrifugation and 
subsequently treated with protamine sulfate (2% w/w of cell mass) and removed by 
centrifugation.  The protein was precipitated at 60% ammonium sulfate (371 g/L at 0 
ºC), isolated by centrifugation, resuspended in 20 mM Tris, pH 7.5 and purified by size 
exclusion chromatography using a 3 L column of AcA34 in 20 mM Tris, pH 7.5, at a 
flow rate of 1.0 mL/min.  The fractions containing the protein of expected size, as 
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assessed by SDS-PAGE, were combined.  Sco3058 was further purified by ion exchange 
chromatography with a Resource Q column (Pharmacia) using a gradient of NaCl in 50 
mM Tris, pH 7.5.  A final gel filtration step, with a column of Superdex 200 (Amersham 
Biosciences) in 50 mM Hepes, pH 7.5, was utilized to remove the salt.   
Ninhydrin-Based Enzyme Assays.  The measurement of dipeptidase activity was 
conducted in 50 mM Hepes, pH 7.5.  For measurement of the inhibitory properties of the 
phosphinate pseudodipeptides, 0.40 mM L-Leu-D-Ala was used as the substrate and the 
inhibitor concentrations were varied from 0-100 μM.  All assays were done at 30 oC.  
The formation of free amino acids was quantified using a ninhydrin-based assay as 
previously described (61).  One volume of the enzymatic reaction was mixed with two 
volumes of ice-cold Cd-ninhydrin reagent (0.9 % w/v ninhydrin dissolved in 1:10:80 1 
g/mL CdCl2: acetic acid: EtOH), heated at 80 ºC for 5 min and cooled prior to reading 
the absorbance at 507 nm.  The correlation between the absorbance at 507 nm and the 
concentration of free amino acids was determined for each amino acid.  
-Lactamase Assay.  Sco3058 was tested for its ability to hydrolyze the -lactam 
nitrocefin.  The hydrolysis of nitrocefin was monitored by the increase in absorbance at 
486 nm ( = 20,500 M-1cm-1) in the presence of 100 mM potassium phosphate, pH 7.0.  
The kcat/Km was estimated by fitting the data to equation 2. 
Coupled Enzyme Assays.  The substrate used for the coupled enzyme assays was 
L-Arg-L-Asp, unless otherwise stated.  The hydrolysis of L-Arg-L-Asp was monitored by 
coupling the formation of L-aspartate to the oxidation of NADH in a system that 
includes glutamate-oxaloacetate transaminase and malate dehydrogenase.  The change in 
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the concentration of NADH was measured spectrophotometrically using a 
SPECTRAmax-340 plate reader (Molecular Devices Inc.) by following the decrease in 
absorbance at 340 nm.  The standard assay conditions contained 100 mM Tris, pH 7.5, 
varying concentrations of L-Arg-L-Asp, 0.36 mM NADH, 7 units of glutamate-
oxaloacetate transaminase, 1.0 unit of malate dehydrogenase, 3.7 mM α-ketoglutarate, 
100 mM KCl and Sco3058 in a final volume of 250 μL at 30 ºC.  This assay was used to 
determine the kinetic parameters of L-Arg-L-Asp, L-Ala-L-Asp.  
N-terminal Substrate Specificity of Sco3058.  Dipeptide library screens were 
conducted in 50 mM Hepes, pH 8.0, at 30 ºC.  Enzyme-course studies (variable enzyme 
concentrations for a fixed time period) were performed by incubating 19 L-Xaa-L-Xaa, 
19 L-Xaa-D-Xaa and 17 D-Xaa-L-Xaa libraries with 2-2000 nM Sco3058 for 6.5, 6.5, 
and 18 hours, respectively.  For the L-Xaa-L-Xaa and L-Xaa-D-Xaa dipeptide libraries, 
the absorbance at 507 nm, Q, was plotted as a function of Sco3058 concentration, Et, and 
fit to equation 1 (Chapter II).  In the case of the D-Xaa-L-Xaa libraries, the free amino 
acids were quantified by measuring the absorbance at 507 nm and the linear rates of 
hydrolysis as a function of enzyme concentration were compared for each D-Xaa-L-Xaa 
library.  
 C-terminal Substrate Specificity of Sco3058.  Enzyme-course assays for seven 
dipeptide libraries: L-Arg-L-Xaa, L-Trp-L-Xaa, L-Ala-L-Xaa, L-Met-L-Xaa, L-Glu-L-
Xaa, L-Arg-D-Xaa and D-Leu-L-Xaa were analyzed by HPLC for determination of the C-
terminal specificity.  With the exception of the D-Leu-L-Xaa library, each library was 
incubated at 30 ºC for 5 hours, with and without enzyme, in 25 mM (NH4)HCO3, pH 8.0.  
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The D-Leu-L-Xaa library was incubated under the same conditions for 18 hours.  The 
concentrations of enzyme used were 0-1000 nM (L-Ala-L-Xaa), 0-200 nM (L-Arg-D-
Xaa), 0-250 nM (L-Arg-L-Xaa, L-Trp-L-Xaa and L-Met-L-Xaa) or 20-4000 nM (D-Leu-
L-Xaa).  The sample preparation and data analysis were conducted as described 
previously in Chapter II (56). 
Data Analysis.  The kinetic parameters, kcat, Km, and kcat/Km, were determined by 
fitting the initial velocity data to equation 2 (Chapter II) where ν is the initial velocity, Et 
is the total enzyme concentration, kcat is the turnover number, A is the substrate 
concentration, and Km is the Michaelis constant.  The kinetic constants for the inhibition 
of Sco3058 by the pseudodipeptide mimics were obtained by a fit of the data to equation 
3 where Ki is the competitive inhibition constant.                                   
Crystallization and Data Collection.  Crystallization screens and data 
collection/analysis for the native Sco3058 and Sco3058 complexed with 4 were 
conducted by Alexander Fedorov and Lena Fedorov in Dr. Steve Almo’s lab at Albert 
Einstein College of Medicine as previously described (80).  The wild-type Sco3058Zn2+ 
complex was crystallized in a solution containing 14.0 mg/mL Sco3058 (in 50 mM 
Hepes, pH 7.5), 22% polyacrylic acid (precipitant), 0.1 M Hepes pH 7.5 and 20 mM 
ZnCl2.  Crystals of the Sco3058Zn
2+
 complex were soaked for 4 hours in a cryo-buffer 
consisting of 22% polyacrylic acid, 0.1 M Hepes pH 7.5, 0.5 mM ZnCl2, 30% Ethylene 
Glycol, and 50 mM pseudodipeptide inhibitor 4 in order to obtain the ternary complex of 
Sco3058Zn2+pseudodipeptide 4. 
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Crystallization and data collection/analysis of the Sco3058Zn2+citrateglycerol 
complex were conducted by Tinh Nguyen as previously described (80).  Crystals were 
grown by hanging drop vapor diffusion at room temperature using 0.7-0.9 M citrate, 0.1 
M imidazole, pH 8.0, and 12.0 mg/mL enzyme.  Data for the Sco3058Zn2+citrate 
glycerol complex were collected to a maximum resolution of 1.7 Å.   
 Network analysis.  An all-by-all BLAST of the ~ 400 amino acid sequences 
within cog2355 was conducted in a similar manner as that described for the members of 
cog3653 in Chapter II.  A protein similarity network based on the BLAST (Basic Local 
Alignment Search Tool) results was generated using Cytoscape (65).   
RESULTS 
Cloning, Expression and Purification of Sco3058.  The gene for Sco3058 was 
successfully cloned into the pET30a(+) vector.  The protein was expressed at moderate 
levels and purified to homogeneity.  The identity of Sco3058 was confirmed by 
sequencing the first five amino acids from the N-terminus of the purified protein.  The 
amino acid sequence (90% MTSLE and 10% TSLEK) matched that of MTSLEK 
predicted from the DNA sequence for this enzyme.  ICP-MS confirmed the presence of 
2.0 equivalents of Zn per subunit.   
 N-terminal Substrate Specificity of Sco3058.  The substrate specificity of 
Sco3058 for the amino acid at the N-terminus of the various dipeptide libraries was 
determined by measuring the composite rate of dipeptide hydrolysis in these libraries.  A 
typical enzyme-course plot for the hydrolysis of the L-Arg-L-Xaa library is presented in 
Figure 3.1A.  An enzyme-course plot for the slower hydrolysis of the D-Xaa-L-Xaa 
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Figure 3.1:  Typical enzyme course plots for the hydrolysis of dipeptide libraries.   
(A) L-Arg-L-Xaa treated with various concentrations of Sco3058.  (B) D-Val-L-Xaa treated with 
various concentrations of Sco3058.  Additional details are found in the text.   
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dipeptide libraries using D-Tyr-L-Xaa as an example is presented in Figure 3.1B.  The 
relative hydrolysis rates for the L-Xaa-L-Xaa, L-Xaa-D-Xaa and D-Xaa-L-Xaa dipeptide 
libraries are presented in Figures 3.2A-C.  These libraries contain a fixed amino acid at 
the N-terminus and 17 to 19 different amino acids at the C-terminus.  For the L-Xaa-L-
Xaa dipeptide libraries the N-terminal preference was for a leucine residue with slightly 
lower turnovers for methionine, arginine, and glutamine.  For the L-Xaa-D-Xaa series of 
dipeptides the preference at the N-terminus is for arginine, glutamine, methionine, and 
leucine.  With the series of D-Xaa-L-Xaa dipeptide libraries, the preferred amino acids at 
the N-terminus are methionine, leucine, arginine, and lysine.   
 C-terminal Substrate Specificity for Sco3058.   The observed rates for the 
liberation of specific amino acids from the C-terminus of the dipeptides contained within 
the L-Arg-L-Xaa, L-Arg-D-Xaa, L-Ala-L-Xaa, L-Trp-L-Xaa, L-Met-L-Xaa, L-Glu-L-Xaa 
and D-Leu-L-Xaa are presented in Figures 3.3A-G, respectively.  The relative rates were 
obtained from fits of the data to equation 1.  Within each library, dipeptides that 
terminated with aspartate were hydrolyzed the fastest.  Proline was not detected in any of 
the hydrolysis products and thus dipeptides that terminate in proline are not hydrolyzed.  
Dipeptides with L-Val, L-Thr, L-Arg or L-Lys at the C-terminus were consistently 
hydrolyzed more slowly than the remaining 14 L-amino acids given the same amino acid 
at the N-terminus. 
 Kinetic Constants for Selected Substrates.  The kinetic constants, kcat, Km and 
kcat/Km, for 25 dipeptide substrates are presented in Table 3.1.  Of the compounds tested 
L-Ala-L-Asp has the highest value for kcat (1400 s
-1
) and L-Arg-D-Asp has the highest 
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Figure 3.2:  N-terminal specificity of Sco3058 against 55 dipeptide libraries.  (A) Relative rates 
of hydrolysis for 19 L-Xaa-L-Xaa dipeptides.  (B) Relative rates of hydrolysis for 19 L-Xaa-D-
Xaa dipeptide libraries.  (C) Relative rates of hydrolysis for 17 D-Xaa-L-Xaa dipeptide libraries. 
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Figure 3.3: C-terminal specificity of Sco3058 with seven dipeptide libraries.  The k (nM
-1
) for 
the hydrolysis of each dipeptide within the (A) L-Arg-L-Xaa, (B) L-Arg-D-Xaa, (C) L-Ala-L-Xaa, 
(D) L-Trp-L-Xaa, (E) L-Met-L-Xaa, (F) L-Glu-L-Xaa and (G) D-Leu-L-Xaa dipeptide libraries.  
All L-amino acids are shaded in gray except for L-Asp (red).  The D-amino acids are shaded in 
yellow except for D-Asp (blue). 
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Table 3.1: Kinetic constants for select substrates of Sco3058
a 
 
Substrate kcat, s
-1
 Km, mM kcat/Km M
-1
s
-1
 
L-Arg-D-Asp 107 ± 3.2 0.14 ± 0.02 (7.6 ± 0.9) x 10
5
 
L-Met-D-Glu 340 ± 4 0.89 ± 0.04 (3.8 ± 0.2) x 10
5
 
L-Met-D-Leu 194 ± 4 0.56 ± 0.03 (3.5 ± 0.3) x 10
5
 
L-Leu-D-Glu 135 ± 2 0.55 ± 0.03 (2.5 ± 0.1) x 10
5
 
L-Leu-D-Ala 160 ± 3 0.75 ± 0.04 (2.1 ± 0.1) x 10
5
 
L-Leu-D-Ser 400 ± 10 2.0 ± 0.2 (2.0 ± 0.1) x 10
5
 
L-Ala-D-Ala 750 ± 25 4.4 ± 0.3 (1.7 ± 0.1) x 10
5
 
L-Tyr-D-Leu 24 ± 0.2  0.17 ± 0.01  (1.5 ± 0.07) x 10
5
 
L-Met-L-Leu 310 ± 6  2.3 ± 0.1 (1.4 ± 0.1) x 10
5
 
L-Asn-D-Glu 288 ± 10  2.4 ± 0.2 (1.2 ± 0.1) x 10
5
 
L-Arg-L-Asp 515 ± 4  4.3 ± 0.1 (1.2 ± 0.4) x 10
5
 
L-Ala-L-Asp 1400 ± 60 13.8 ± 0.9 (1.0 ± 0.1) x 10
5
 
L-Leu-L-Leu 140 ± 6  1.4 ± 0.1 (1.0 ± 0.1) x 10
5
 
L-Leu-L-Asp 160 ± 11 2.0 ± 0.3 (8.3 ± 1.4) x 10
4
 
L-Leu-D-Leu 21 ± 0.3 0.37 ± 0.03 (5.6 ± 0.4) x 10
4
 
Gly-D-Leu   (3.3 ± 0.1) x 10
4
 
L-Ala-L-Glu  220 ± 14 9.5 ± 1.0 (2.4 ± 0.3) x 10
4
 
L-Arg-Gly   (2.2 ± 0.1) x 10
4
 
L-Ala-L-Ala   (1.4 ± 0.04) x 10
4
 
L-Ala-L-Gln 140 ± 17 16 ± 3.3 (8.4 ± 1.9) x 10
3
 
L-Ala-L-His   (4.5 ± 0.1) x 10
2
 
L-Ala-L-Arg   (1.8 ± 0.1) x 10
2
 
D-Ala-D-Ala   (1.3 ± 0.05) x 10
2
 
L-Ala-L-Lys   (7.2 ± 0.2) x 10
1
 
D-Ala-L-Ala   (2.2 ± 0.05) x 10
0
 
 
a
From fits of the data to equation 2.  For those entries without values of kcat and Km, 
saturation was not achieved at concentrations up to 5 mM. 
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value for kcat/Km (7.6  x 10
5
 M
-1
 s
-1
).  For the four enantiomers of the dipeptide Ala-Ala, 
the relative rates of hydrolysis are of the order L-Ala-D-Ala > L-Ala-L-Ala > D-Ala-D-
Ala > D-Ala-L-Ala.  The rates of hydrolysis of N-formyl-D-Glu, N-acetyl-D-Glu and N-
propionyl-D-Leu at a concentration of 2.0 mM were less than 2 x 10
-3
 s
-1
.  Nitrocefin was 
slowly hydrolyzed by Sco3058 but the value of kcat/Km was less than 0.1 M
-1
s
-1
.  The 
phosphinate pseudodipeptide mimics 4, 5, 6, 7, 8 and 9 were found to be competitive 
inhibitors of Sco3058 (Figure 3.4) with Ki values of 390 ± 21 nM, 2.3 ± 0.3 μM, 1.1 ± 
0.2 μM, 1.8 ± 0.2 μM, 270 ± 10 nM and 1.7 ± 0.1 μM, respectively.     
Structure of Sco3058.  The crystal structures of Sco3058, Sco3058 with 
glycerol/citrate bound and Sco3058 in complex with the pseudodipeptide of L-Ala-D-
Asp (4) in the active site were determined to 1.3, 1.7 and 1.4 Å, respectively.  A ribbon 
representation of the (β/α)8-barrel structure is presented in Figure 3.5.  The zinc in the α-
site (M) is coordinated to His-20 and Asp-22 from the HxD motif that originates from 
the end of β-strand 1.  The zinc in the β-site (M) is ligated to the two conserved 
histidines (His-191 and His-212) from the ends of β-strands 5 and 6, respectively.  The 
two metals are bridged by Glu-123 from β-strand 3 and a hydroxide/water molecule.  
The next nearest water molecule to either of the two metal ions is 2.4 Å away from Mβ.  
The conserved aspartate (Asp-320) from the end of β-strand 8 is 3.6 Å from Mα and thus 
does not coordinate this metal.  However, this residue interacts with the bridging solvent 
molecule at a hydrogen bonding distance of 3.0 Å.  The binuclear metal center is shown 
in Figure 3.6A. 
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Figure 3.4:  Inhibition plots for Sco3058 with pseudodipeptide mimics.  The fractional velocities 
were plotted as a function of the concentration of compounds 4 (A), 5 (B), 6 (C), 7 (D), 8 (E) 
and 9 (F). 
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Figure 3.5:  Ribbon diagram of the Sco3058 structure.  The (/)8-barrel is colored with blue -
strands and red -helices and loops.  Insertion regions 1 (residues 98-115 between 2 and 3) 
and 2 (residues 251-295 between 7 and 7) are colored yellow and teal, respectively.  The C-
terminus (residues 351-391) is colored pink.  The active site metals are shown in green. 
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Figure 3.6:  Binuclear metal center of Sco3058.  Contacts between the zinc ions (green spheres) 
and water (red sphere) or active site residues are 1.9-2.2 Å and indicated with dashed lines.  (A) 
Metal center within the native structure of Sco3058.  (B) Structure of the binuclear metal center 
with citrate and glycerol (pink carbons) in the active site.  (C) Structure of the binuclear metal 
center with the phosphinate pseudodipeptide 4 (gold carbons, orange phosphorus) bound in the 
active site.   
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The active site of Sco3058 in the presence of glycerol and citrate is shown in 
Figures 3.6B and 3.7A.  In the glycerol/citrate bound structure, the α-metal is tetrahedral 
in coordination while the β-metal exhibits a distorted trigonal bipyramidal geometry.  In 
addition to the four ligands described for the native structure, the β-metal is additionally 
coordinated to the C3-carboxylate of citrate.  This carboxylate is also ion-paired with 
Arg-223 and occupies the same position as the water molecule, which is 2.4 Å from M 
in the native structure.  The carboxylate of citrate from the pro-S arm is ion-paired to 
His-150 while the carboxylate from the pro-R arm is interacting with Thr-324.  The 
hydroxyl group attached to C3 of citrate is 2.8 Å from Asp-320 and is also hydrogen 
bonded with the C2 hydroxyl group of glycerol.  In addition, the C1 hydroxyl group of 
glycerol is within hydrogen bonding distance (3.0 Å) to Asp-22 and 2.4 Å from the α-
metal.     
 The two chiral centers that mimic the C stereocenters of the N- and C-terminal 
ends of a dipeptide are both in the R-configuration.  This would correspond to the 
dipeptide L-Ala-D-Asp.  In this complex the β-zinc is coordinated by five ligands in a 
distorted trigonal bipyramidal arrangement.  One of these interactions originates from 
the phosphinate group and another is from the carboxylate that would correspond to the 
C-terminal carboxylate of a dipeptide substrate.  The α-metal is in a distorted square 
pyramidal arrangement and the -amino group of the inhibitor is 2.3 Å away from this 
metal ion.  The C-terminal carboxylate of the inhibitor is ion-paired with the guanidino 
group of Arg-223.  His-150 makes polar interactions with the phosphinate moiety at a 
distance of 2.7 Å.  The side chain carboxylate of the inhibitor interacts with Thr-324 at a  
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Figure 3.7: Interactions of citrate and pseudodipeptide inhibitor 4 with active site metals and 
residues within Sco3058.  (A) Polar contacts between citrate (pink carbons) bound in the active 
site of Sco3058 (gray carbons).  (B) Polar contacts between inhibitor 4 (gold carbons and orange 
phosphorus) and Sco3058 (gray carbons).  Polar contacts are indicated with dashed lines with 
distances displayed in Å.  The zincs and bound water molecule are represented as green and red 
spheres, respectively.  The distance between K247 and 4 is shown for the purpose of discussion. 
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distance of 2.7 Å.  The orientation of inhibitor 4 in the active site of Sco3058 is 
presented in Figures 3.6C and 3.7B. 
Network Analysis of cog2355.  Approximately 400 microbial renal dipeptidase-
like amino acid sequences were identified in the NCBI database from the completely 
sequenced organisms.  At an E-value cutoff of 1 x 10
-70
, the sequences can be separated 
into 27 clusters of 3 or more sequences as shown in Figure 3.8.  Each node in the 
network represents a single amino acid sequence and each line represents a pairwise 
connection between two sequences with a BLA T score of E ≤  1 x 10-70.  Sco3058 can 
be found in Cluster14. 
DISCUSSION 
 Substrate Specificity.  The substrate specificity of Sco3058 was determined using 
an array of dipeptide libraries.  It is evident from the data presented in Table 3.1 that this 
enzyme has the ability to hydrolyze a rather broad range of dipeptides having amino 
acids of either the D- or L-configuration.   However, at the N-terminus, amino acids of 
the L-configuration are greatly preferred over those of the D-configuration.  For example, 
the values of kcat/Km for L-Ala-D-Ala and L-Ala-L-Ala are 2-3 orders of magnitude 
greater than their D-Ala-D-Ala and D-Ala-L-Ala counterparts.  Conversely, at the C-
terminus, amino acids of the D-configuration are preferred over those of the L-
configuration.  Thus, the values of kcat/Km for L-Arg-D-Asp and L-Ala-D-Ala are about 
an order of magnitude greater than those of L-Arg-L-Asp and L-Ala-L-Ala, respectively.  
At the N-terminus there is a preference for arginine, methionine, glutamine, and leucine 
whereas at the C-terminus there is a clear preference for glutamate and aspartate.  The  
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Figure 3.8:  Cytoscape graphical representation of putative renal dipeptidase-like proteins from 
cog2355.  The amino acid sequences (circles) are separated into clusters based on an E-value 
cut-off of 1 x 10
-70
.   Circles which are connected by lines have an E-value ≤ 1 x 10-70.  Proteins 
with a crystal structure are shaped as diamonds.  The protein targets described in Chapters III, IV 
and V are colored blue (Gox2272), green (LmoDP), orange (Bh2271), yellow (Rsp0802), purple 
(Cc2746), and dark red (Sco3058).  Three other targets mentioned in the text are colored pink.  
Two proteins within a smaller unstudied subset of cog2355 which have deposited structures in 
the PDB are colored black (PDB codes 2I5G and 3B40).  Other amino acid sequences with the 
same shape are examples of multiple sequences within cog2355 from the same species and strain 
(i.e. paralogues), such as four sequences from Sinorhizobium meliloti or Ruegeria pomeroyi 
(triangles). 
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very best substrates have kcat/Km values that exceed 10
5
 M
-1
 s
-1
.  N-acyl derivatives of D-
amino acids are hydrolyzed approximately 5 orders of magnitude more slowly than are 
the corresponding dipeptide substrates and thus this enzyme appears to be a true 
dipeptidase rather than a carboxypeptidase.      
  Structural Determinants of Substrate Specificity.  The three dimensional 
structure of Sco3058 was determined in the absence of ligands and also in the presence 
of citrate and a pseudodipeptide analog bound in the active site.  The analogue of the 
proposed tetrahedral intermediate was synthesized without regard for the 
stereochemistry at the two chiral centers.  The structure of the inhibitor bound in the 
active site is a mimic of the dipeptide L-Ala-D-Asp.  As a structural mimic of the 
tetrahedral addition complex, this analogue is compromised since the amide nitrogen has 
been substituted with a methylene group to maintain hydrolytic stability of the inhibitor.  
Nevertheless, the structure of this complex indicates that the free α-amino group at the 
N-terminus of the pseudodipeptide interacts with M and the side chain carboxylate of 
Asp-22.  Conversely, the free α-carboxylate at the C-terminus interacts with Mβ and the 
side chain guanidino group of Arg-223.  The phosphinate group of the inhibitor interacts 
with Mβ and the side chain of His-150.  The side chain carboxylate of the inhibitor 
interacts with Thr-324 and is in close proximity to the ε-amino group of Lys-247.   
In an overlay of the Sco3058citrateglycerol and Sco3058pseudodipeptide 4 
complexes (RMSD = 0.3 Å), using MatchMaker tool in Chimera, free amino groups of 
the Lys-247 residues are 2.2 Å apart.  The carboxylate from the pro-R arm of citrate is 
2.7 Å from Lys-247 from the pseudodipeptide 4 complex.  The hypothetical position of 
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the side chain of a C-terminal L-Asp was modeled with the pseudodipeptide complex by 
building a CH2COOH side chain onto the chiral carbon of compound 4 that represents 
the C carbon of a dipeptide.  In this model, the side chain carboxylate of the ―L-Asp‖ 
side chain was 2.7 Å and 3.3 Å from the side chain nitrogens of Asn-151 and Lys-247, 
respectively.  The oxygen and nitrogen of the side chain of Asn-151 are in opposite 
positions within these two structures (Figure 3.7).  Realistically, the position of the 
oxygen and nitrogen atoms of the Asn-151 side chain should be positioned as they are in 
Figure 3.7A where the carbonyl is 3.1 Å from N

 of the histidine ligand from 5 (H191).  
 A similar set of interactions is apparent in the binding of citrate in the active site 
of Sco3058.  In many ways the structure of citrate mimics the pseudodipeptide inhibitor.  
Thus, the carboxylate at C3 interacts with Mβ and Arg-223 in much the same way as the 
free α-carboxylate of the inhibitor.  The carboxylate from the pro-R arm of citrate 
interacts with Thr-324 similar to how the side chain carboxylate of the inhibitor interacts 
with this residue.  The carboxylate from the pro-S arm of citrate interacts with His-150 
in a fashion that duplicates the interactions with the phosphinate moiety with this same 
residue.  The closest residue to the hydroxyl group of citrate is the side chain carboxylate 
of Asp-320.  However, there are certain interactions that are missing and this may 
explain why the pseudodipeptide inhibitor binds with a dissociation constant that is 
about 4 orders of magnitude tighter than citrate (80). 
 The dipeptides L-Ala-D-Ala and D-Ala-L-Ala were docked into the Sco3058Zn2+ 
structure by Peter  olb from Dr.  choichet’s lab at University of California  an 
Francisco as previously described (80).  The dipeptides were docked as their high energy 
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intermediates following attack by a hydroxide, where the carbon of the amide bond is 
tetrahedral and bonded to a hydroxyl group and a negatively-charged oxygen.  Overlays 
of both of these docked structures with the Sco3058Zn2+inhibitor 4 complex are 
presented in Figure 3.9.  The pose of the D-Ala-L-Ala dipeptide (Figure 3.9A) suggests 
that the free amino group of the N-terminal D-amino acid contacts the backbone of Gly-
323 instead of the aspartate from 1, and the methyl group of D-Ala is closer in position 
to the free amino group of inhibitor 4.  The -carboxylates of D-Ala-L-Ala and inhibitor 
4 are almost in the exact same position, but the oxygens which originate from hydroxide 
attack are distant from each other.  Conversely, in Figure 3.9B, the -carboxylates of L-
Ala-D-Ala and inhibitor 4 are oriented differently, but the two phosphinate oxygens are 
in a very similar position to the oxygens bonded to the carbon of the scissile bond.  If all 
D-Xaa-L-Xaa dipeptides were to orient with the C carbon in the same position as the 
methyl group modeled in Figure 3.9A, one would expect that the rate of hydrolysis of 
the D-Ala-L-Xaa library would be at least comparable to the rates observed for the D-
Leu-L-Xaa and D-Met-L-Xaa libraries.  The substrate profile of Sco3058 with the D-Xaa-
L-Xaa was quite polarized with preferences for D-Met, D-Leu, D-Lys and D-Arg, but the 
reason for this is not completely clear.  Still, D-Xaa-L-Xaa dipeptides are not considered 
to be physiologically relevant substrates of Sco3058.      
 Genome Context for Sco3058 and Cluster 14 Proteins in cog2355.  The genome 
context of Sco3058 would not have been useful in predicting the general reaction of this 
protein or the substrate specificity.  The neighboring protein in the genome, Sco3057, 
has ~40% amino acid sequence identity to Sco3058, but Sco3057 does not have a single  
106 
 
 
 
Figure 3.9: Overlay of the active sites of the L-Ala-D-Asp pseudodipeptideSco3058 complex 
(dark gray carbons, pink Zn and gold inhibitor carbons) and Sco3058 docked with Ala-Ala 
dipeptides.  (A) The docked D-Ala-L-Ala-Sco3058 complex (light gray carbons, teal Zn, and 
light blue substrate carbons).  (B) The docked L-Ala-D-AlaSco3058 complex (light gray 
carbons, teal Zn, and green substrate carbons).  
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metal-binding residue in common with Sco3058.  The Sco3058 gene is also adjacent to 
PurE (Sco3059) and PurK (Sco3060) which code for proteins annotated as 
phosphoribosylaminoimidazole carboxylase catalytic and ATPase subunits, respectively.  
It is conceivable that Sco3058 could either hydrolyze a molecule such as 4-[(N-
succinylamino)carbonyl]-5-aminoimidazole ribonucleotide (SAICAR) to liberate 
aspartate or supply aspartate for the SAICAR synthetase reaction through the cleavage 
of a Xaa-L-Asp dipeptide (86).  However, the immediate proximity of PurE/PurK to 
genes which code for renal dipeptidase-like proteins is not a common feature of the 
genome contexts of these proteins.   
 To the best of my knowledge, the protein encoded by the SirJ gene from 
Leptosphaeria maculans (gi|46403052) is one of only two renal dipeptidase-like proteins 
most closely associated to Cluster 14 which have been suggested to be involved in a 
biosynthetic pathway based on genome context.  The SirJ gene is clustered with genes 
involved in the biosynthesis of fungal phytotoxin sirodesmin (87).  The second is the 
putative protein product of the GliJ gene, coding for a homolog of SirJ, located in a 
putative gene cluster for the biosynthesis of gliotoxin (88).  Though the SirJ protein was 
not part of the network analysis, it has connections to some sequences in Cluster 14 with 
E-values of 10
-67–10-69.     
 Part of the biosynthesis of sirodesmin includes the formation of a derivatized 
cyclic dipeptide intermediate from the amino acids L-Tyrosine and L-Serine, presumably 
via the putative nonribosomal peptide synthetase (NRPS) SirP.  SirP was said to be 
missing the final cyclization domain.  Prior to condensation with L-Serine, the phenol 
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group of L-Tyr residue is modified by an O-prenyltransferase coded for by the SirD 
gene.  The SirD protein only modifies L-Tyr but not the cyclic L-Tyr-L-Ser dipeptide 
(89).  In general, the adenylation (A) domains of NRPSs are considered to be responsible 
for the selection of the amino acid with the correct side chain and chirality for the 
growing peptide which sidesteps the need for a substrate-specific condensation (C) 
domain.   However, there have been observations to the contrary where the A-domain 
has a more relaxed specificity, and the C-domain has an editing function (90).  The 
fidelity of the A and C domains of SirP  has not been determined empirically with 
purified protein.  Therefore, whether or not SirP is specific for O-prenyl-L-Tyr and L-Ser 
is not known.  The biosynthetic pathway could be relying on the ability of an L-Tyr A-
domain to accept an L-Tyr derivative, in which case the undesirable L-Tyr-L-Ser is likely 
to be synthesized and would need to be recycled.  The SirJ sequence has the critical 
residues in common with the active dipeptidases within cog2355.   
 Given that sirodesmin and cyclo-L-Tyr-L-Ser both lack the functional groups 
which make polar contacts with the enzyme, namely the free amino group or the -
carboxylate, it seems unlikely that the function of SirJ would be to cleave the cyclic 
dipeptide or the amide bonds within the toxin.  On the basis of the structures of Sco3058 
complexed with citrate and inhibitor 4, it is hypothesized that Lys-247 is considered to 
be a residue which can make polar contacts with the C-terminal side chain of a 
dipeptide.  In SirJ, Lys-247 is replaced by a glutamate which could conceivably make a 
polar contact to the side chain of a C-terminal serine side chain.  It would be reasonable 
to conclude that this protein would be able to hydrolyze L-Tyr-L-Ser or (O-prenyl-L-
109 
 
Tyr)-L-Ser.  It is unclear as to whether there is any other specific function of the 
microbial renal dipeptidase-like proteins within Cluster 14, beyond their ability to serve 
as true dipeptidases.   
 Conservation of Residues Within cog2355.  There are ~400 amino acid sequences 
from the completely sequenced bacterial genomes which are categorized as part of 
cog2355.  Approximately 70% of these sequences can be classified as renal dipeptidase-
like because of the conservation of the complete set of metal ligands for the binuclear 
active site.  Arginine-223 recognizes the -carboxylate of the dipeptide, and the 
equivalent residue to Arg-223 is conserved in greater than 97% of the sequences found 
in cog2355.  Within the renal dipeptidase subset of cog2355, the residue equivalent to 
His-150 in Sco3058 is semi-conserved with approximately 30% of the sequences having 
a histidine and 70% a tryptophan at this position.  In the case of the renal dipeptidase-
like protein from Rhodobacter sphaeroides (Rsp0802, PDB code 3FDG, gi|218766909) 
this tryptophan residue is structurally equivalent to His-150 from Sco3058 with the 
nitrogen of the tryptophan side chain being in the same position as the N

 of the 
histidine.  The other residues which contact or are close to citrate or the phosphinate 
inhibitor (i.e. Thr-324, Asn-151, and Lys-247) and those which are in the vicinity of the 
active site (e.g. Tyr-68, Val-245, and Phe-248) are not conserved among hRDP and the 
cluster of renal dipeptidase-like sequences.  Lys-247 is actually quite rare within 
cog2355.  All of these residues are at the ends of or immediately follow the -strands of 
the (/)8-barrel, which is a common location for substrate-contacting residues of AHS 
enzymes (20). 
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 Given the lack of conservation of putative substrate recognition residues within 
the subset of human renal dipeptidase and its microbial homologues, there is an 
opportunity to identify enzymes with varying substrate specificities and define the 
structure-functional relationship of these enzymes.  Therefore, the substrate specificity 
profiles and the 3-dimensional structures of several microbial renal dipeptidase-like 
proteins were further investigated using the same methods applied to Sco3058.  Chapter 
IV will focus on two additional microbial dipeptidases, Gox2272 and Cc2746, from 
Clusters 1 and 8, respectively (Figure 3.8).  Chapter V will address three proteins from 
Clusters 2 and 3 where the equivalent active site residue to His-150 in Sco3058 has been 
replaced by a tryptophan. 
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CHAPTER IV 
 
SUBSTRATE PROFILES AND NATIVE STRUCTURES OF  
TWO MICROBIAL RENAL DIPEPTIDASE-LIKE PROTEINS 
INTRODUCTION 
 Sco3058 from S. coelicolor is a dipeptidase which is able to hydrolyze a majority 
of the dipeptides to which it was exposed, though the enzyme was partial to L-Xaa-D/L-
Asp substrates.  A majority of the active site residues in Sco3058, besides the metal 
ligands, catalytic aspartate and arginine from 6, are not conserved within the amino acid 
sequences found in cog2355.  An amino acid sequence alignment of Sco3058 and four 
structurally-characterized proteins within cog2355  is displayed in Figure 4.1.  The 
sequences are from S. coelicolor (Sco3058), Caulobacter crescentus (Cc2746, 
gi|16126978), Gluconobacter oxydans (Gox2272, gi|58040697), Homo sapiens 
(crystallized portion of hRDP from PDB code 1ITU, gi|23200144) and Pseudomonas 
aeruginosa (crystallized portion of Pa2393 from PDB code 3B40, gi|160286472).  As 
shown for Sco30584 and hRDPcilastatin complexes, the residues highlighted in red 
make polar contacts to compounds bound in the proteins, namely, compound 4, glycerol, 
citrate, cilastatin (Scheme 4.1) or a sulfate (23, 80). 
 
 
 
 
  
 
 1        
 Sco3058    ---------------------------------MTSLEKARELLREFPVVDGHNDLPWALREQVRYDLD-ARDIAADQSA---HLHTDLARLRSGG 59 
 Gox2272    ---------------------------------------MTDLHDTLLTLDSHIDIPWP----------DRQDAWAEETP----RQVNVPKTRKGG 43 
 hRDP-1ITU  ---------------------------------DFFRDEAERIMRDSPVIDGHNDLPWQLLDMFNNRLQDERANLTTLAG----THTNIPKLRAGF 59 
 Cc2746     MSRPLLFALTALSLTAASLAHAADKKAADKPAPSAVSKADKALHDKFLTLDTHLDTPAHFGR-------PGWDIADHHEVEHDFSQVDLPRMNQGG 89 
 Pa-3B40    -------------------------SLSEAGYPRKVMQHAEELHERILSFDSRITVPLDFGT-------TGNEVDKD-----GPGQLDLVKAGRGR 90 
                                                                     *                           * 
                2                                                                                                        3 
 Sco3058    VGAQYWSVYVRSD---------------LPGAVTATLEQIDCVRRLIDRHP-GELRAALTAADMEAARAEGRIASLMGAEGGHSIDNSLATLRALY 139 
 Gox2272    LRAVCLAAYIPQ---------SPRDEAGHAEGWERVQGMLDVIAGLEGRQGDHGARVCRTAADVRAAYKAGDLAVIPAIENGHGLGGRPERIAELA 130 
 hRDP-1ITU  VGGQFWSVYTPCD-------------TQNKDAVRRTLEQMDVVHRMCRMYP-ETFLYVTSSAGIRQAFREGKVASLIGVEGGHSIDSSLGVLRALY 141 
 Cc2746     LDGGFFVVYIGQ---------GELTEKGYTYARDYALHRTIEIREMLAANP-DTFEMALTSDDARRIAKAGKKFAFVSMENSWPVGEDLSLVETFY 175 
 Pa-3B40    LSGAALAIFGWPEMWNGPNAPHKPTPGFVDEARHQQEIRYKILTGMVRDFP-NQVGIAYSPEDFRRLAMEGKFAIVMSMLNAYPLGDDLSQLDKWA 185 
         
4                                                                       5                             6 
 Sco3058    AL-GVRYMTLTHNDNNAWADSATD-------EPGVGGLSAFGREVVREMNREGMLVDLSHVAATTMRDALDTSTAPVIFSHSSSRAVCDHPRNIPD 227 
 Gox2272    RRYGVRYMTLTHNGHNALADAAIPRKDLADNETLHGGLSDLGRETIAQMNRSGVLVDVSHAAKSTMMQATEVSSTPVFASHSCARALCDHPRNLDD 226 
 hRDP-1ITU  QL-GMRYLTLTHSCNTPWADNWLVDT--GDSEPQSQGLSPFGQRVVKELNRLGVLIDLAHVSVATMKATLQLSRAPVIFSHSSAYSVCASRRNVPD 234 
 Cc2746     KE-GLRMAGPVHFRNNQLADSSTDPK-----GKIWNGYSPLGLRWLAEANRLGIVIDVSHASDDVVDQSVALSKAPIIASHSGPKAVYDHPRNLDD 265 
 Pa-3B40    AR-GVRMFGFSYVGNNDWADSSRPLPFFNDSPDALGGLSPLGKQAVERLNDLGVIIDVSQMSTKALEQVAALSRAPIVASHSAPRALVDIKRNLSD 280 
                                     
7           nsertion     L272 
 Sco3058    DVLERLSANGGMAMVTFVPKFVLQAAVDWTAEADDNMRAHGFHH-----------------LDSSPEAMKVHAAFEERVPRPVATVSTVADHLDHM 306 
 Gox2272    EQLDRLKETGGLIQVTAMGSFLKKGG--------------------------------------------------------GGTVEDLVRHVSYI 266 
 hRDP-1ITU  DVLRLVKQTDSLVMVNFYNNYIS--------------------------------------------------------CTNKANLSQVADHLDHI 274 
 Cc2746     ARLKKIADAGGAICINSI--YLTDTTPSPERKAALEALGR-------------APDMKTATPEAVKAYADKRAAIDKAHPAARGDFDLYMKSMLHV 346 
 Pa-3B40    HEMQLIKDSGGVIQVVGFPAYLRPLSKPTLDKLDALRARFDLPPLEGLDYALMPGDPIITIWPEQRFGEYASALYGILEEEPKAGLKELVDAIDYT 376 
                             * **                                              
8 
 Sco3058    REVAGVDHLGIGGDYDGTPFTPDGLGDVSGYPNLIAELLDRGWSQSDLAKLTWKNAVRVLDAAEDVSRGLRAARGPSNATIEQLDGTAAEQPEG-  400 
 Gox2272    ADRIGVEHVGISSDFDGGGG-IPGWKDATETANVTRALQAAGFSDEDISAIWGGNMLRLLETAERAAEKV-------------------------  335 
 hRDP-1ITU  KEVAGARAVGFGGDFDGVPRVPEGLEDVSKYPDLIAELLRRNWTEAEVKGALADNLLRVFEAVEQASNLTQAPEEEPIPLDQLGGSCRTHYGYSS  369 
 Cc2746     LKVAGPKGVCVGADWDGGGG-MDGFEDITDLPKITARLKAEGYSDADIEAIWSGNVLRIVDAAQAYAKSVTK-----------------------  417 
 Pa-3B40    VKKVGIDHVGISSDFNDGGG-VDGWKDVSEIRNVTAELITRGYSDADIAKLWGGNFLRAWGEVQKRAKPTATP----------------------  448 
                             **** 
 
Figure 4.1: Amino acid sequence alignment of human renal dipeptidase (hRDP) and four structurally characterized microbial proteins 
within cog2355.  The five underlined residues following 2 and residues 1-31 of Pa-3B40 (locus tag Pa2393) are not in the structure.  The 
metal ligands/catalytic aspartate are shaded black.  Residues which either make polar contacts to bound inhibitors/molecules or are 
predicted to contact the substrate are shaded red.  Residues whose side chains contribute to the binding pocket of the N- (dark blue) or C-
terminal (purple) sides of a dipeptide are also colored. Other conserved residues are colored gray and the -strands of the (/)8-barrel are 
shaded light blue.  Additional details are provided in the text.
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Scheme 4.1 Structure of cilastatin inhibitor of human renal dipeptidase 
O
NH
O2C
S
+H3N
CO2
 
 
 A residue following 8 (Sco3058-T324), two residues on a single-turn -helix 
following 7 (Sco3058-K247/F248), and the residue preceding the turn (Sco3058-V245), 
are part of the active site pocket for the side chain of the C-terminal amino acid of a 
dipeptide substrate.  In hRDP, the equivalent residue to Phe-248 is tyrosine (Tyr-255) 
which contacts the carboxylate moiety of cilastatin equivalent to the backbone 
carboxylate of a dipeptide.  Given that this tyrosine provides another polar contact to the 
-carboxylate of cilastatin, in addition to Zn and an arginine, it was thought that 
proteins with this residue may be more effective dipeptidases than those with a 
phenylalanine in this position.  The hRDP enzyme has reported catalytic efficiencies on 
the order of 10
6
 M
-1
s
-1
 for the dehydrophenylalanine substrate.   
 The equivalent residue to Tyr-255 in hRDP is not common among the microbial 
proteins within cog2355, but all but one sequence in cluster 8 (Figure 3.8) have this 
residue.  A protein in cluster 8 from Xanthomonas campestris (Xcc4228, gi|21233645) 
has the equivalent residue to Tyr-255 in hRDP.  However, the gene for Xcc4228, cloned 
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into the pET30a(+) vector, failed to overexpress in E. coli.  Cc2746 from cluster 8 is a 
microbial protein that also has this tyrosine residue (Tyr-284).  Cc2746 was purified as a 
His-tag protein by NYSGXRC, and its structure has been deposited into the PDB (PDB 
code 2RAG).  However, in Cc2746, which lacks the single-turn -helix (curved arrow in 
Figure 4.1) following 7, Tyr-284 is in nearly the same position as Tyr-255 (hRDP) 
with respect to the active site. 
 The genomic DNA of G. oxydans was obtained in order to acquire the Gox1177 
deacetylase (Chapter II), but Gox2272 from this organism is part of cog2355.  At the 
time, Gox2272 had less than 40% amino acid sequence identity to any other protein from 
a completely sequenced organism.  Gox2272 is currently part of cluster 1 (Figure 3.8), 
which can be separated into two subclusters, 1a and 1b.  The six proteins in cluster 1a 
are putatively the fusion of two proteins from cog2355 and cog2071, but Gox2272 is 
from cluster 1b.  Gox2272 lacks the insertion regions observed between 7 and 7 in 
Cc2746  or immediately following 2 in Rsp0802 (PDB code 3FDG).  Both of these 
insertion regions were partly undefined in the structures.  The residues that influence the 
character of the active site for the binding of the N-terminal (blue) or C-terminal (purple) 
portion of a dipeptide are colored in Figure 4.1.  Between Gox2272 and Sco3058, the 
residues shaded blue are identical, but the purple-colored residues are different, with the 
exception of the asparagine following 4.    
 The following describes the analysis of the crystal structures and substrate 
specificity profiles of Gox2272 and Cc2746 against dipeptide libraries and individual 
dipeptide substrates.  The pseudodipeptides 4-9 (Scheme 3.2) are inhibitors of these two 
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enzymes.  The structures of the Gox22729 complex and Cc2746 with either 4, 5 or 6 
bound, were desired but not obtained during the course of this work.  It was the hope that 
the insertion region would be completely defined in a structure of the complex of 
Cc2746 with an inhibitor.  In Sco3058, Leu-272 is part of the same insertion region and 
is at the perimeter of the 10 Å radius from the C-terminal C of 4; it is possible that the 
residues of undefined structure in Cc2746 are participating in the formation of the 
substrate-binding pocket.  The structural overlays with other proteins within cog2355 
were compared and amino acid side chains were modeled into Gox2272 and Cc2746 
from the position of the inhibitor in the Sco30584 complex. 
MATERIALS AND METHODS 
Cloning of Gox2272.  The Gox2272 gene (gi|58040697) was amplified from the 
Gluconobacter oxydans  genomic DNA with the primers 5'-GCAGGAGCCATATGACT 
GATCTGCACGACACGCTCCTGACGC-3' and 5'-CGCGGAATTCAAACCTTCTCT 
GCAGCCCGCTCGGCCGTCTCC-3'.  The G. oxydans genomic DNA was kindly 
provided by Dr. Armin Ehrenreich from Georg-August University, Göttingen, Germany.  
The Pfx platinum polymerase (Invitrogen), 0.05 units/L PCR reaction, was used 
according to the manufacturer’s instructions.  The PCR products were digested with 
NdeI and EcoRI and ligated (separately) into the pET30a(+) vector (Novagen) with T4 
ligase (New England Biolabs).    
Overexpression of Zn-Gox2272.  E. coli BL21 cells were electrotransformed with 
the pET30a(+)-Gox2272 plasmid.  E. coli cells harboring the pET30a(+)-Gox2272 
plasmid were grown at 30 ºC in Terrific Broth (TB) containing 50 g/mL kanamycin.  
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When the optical density at 600 nm reached ~0.5, 2.0 mM Zn(acetate)2 was added and 
the overexpression of Gox2272 was induced with 250 M isopropyl--thiogalactoside 
(IPTG).  Following the addition of IPTG, the cells were grown overnight at room 
temperature (21 ºC).  
Purification of Gox2272.  E. coli BL21-Gox2272 cells were suspended in the 
purification buffer (50 mM Hepes/100 g/mL phenylmethanesulfonylfluoride, pH 7.5) 
and lysed via sonication at 0 ºC.  The cell lysate was obtained by centrifugation (~ 
28,000g) and treated with a protamine sulfate solution.  The protamine sulfate solution 
was equal in volume to the cell lysate and contained a mass of protamine sulfate, equal 
to 2% of the starting mass of cells.  The soluble portion of the cell lysate/protamine 
sulfate mixture was separated by centrifugation (~17,000g).  The impurities that 
precipitated between zero and 60% ammonium sulfate (371 g/L at 0 ºC) were removed 
by centrifugation (17,000g).   The Gox2272 protein was precipitated in the 60-75 % 
ammonium sulfate fraction.  The precipitated proteins were removed by centrifugation, 
resuspended in a minimal amount of ice cold purification buffer, and eluted through a  1 
L AcA34 gel filtration column at a flow rate of 1 mL/min.  The fractions containing the 
protein of expected size, as assessed by SDS-PAGE, were combined.  The purified 
protein was submitted to the Protein Chemistry Laboratory at Texas A&M University 
Department of Biochemistry for amino acid sequencing.   
Purification of Mn-Gox2272.  Mn-Goxx2272 was obtained by the same 
overexpression and purification methods as the Zn-Gox2272 with a few exceptions.  
During the growth of the BL21-Gox2272 cells, 200 M bipyridyl was added when the 
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optical density at 600 nm was ~ 0.1-0.2.  Manganese chloride was added to a final 
concentration of 1.0 mM instead of Zn(acetate)2.  During the purification, 100 M 
MnCl2 was added to the buffer through the resuspension of the precipitated Mn-
Gox2272 with 75% saturation of (NH4)2SO4.  The metal content of purified Zn-Gox2272 
and Mn-Gox2272 were determined by ICP-MS. 
Overexpression of Cc2746.  E. coli Rosetta-2 (DE3) cells (Novagen) were 
electrotransformed with the plasmid containing the Cc2746 gene (gi|16126978).  E. coli 
cells harboring the plasmid with the Cc2746 gene were grown in a 5 mL LB/kanamycin 
culture at 37 °C for 8 hours and used to innoculate Terrific Broth containing 50 g/mL 
kanamycin and 25 g/mL chloramphenicol.  The cells were grown in 
TB/kanamycin/chloramphenicol at 30 °C.  When the optical density at 600 nm reached 
~0.5, 1.0 mM Zn(acetate)2 was added and the overexpression of Cc2746 was induced 
with and without 10, 20, 50, 100 M isopropyl--thiogalactoside (IPTG).  Following 
induction, the cells were grown at 20-22 °C overnight.  The proteins were separated by 
SDS-PAGE, and it was concluded that the Cc2746 gene did not overexpress.  In a 
similar manner, overexpression of Cc2746 was attempted in Rosetta 2 (DE3) cells with 
10, 20, 20, 50, 100 and 500 M IPTG.  Following the addition of IPTG, the cells were 
grown overnight at ambient temperature (21 ºC).  Low levels of overexpression were 
obtained at 20 M IPTG, but overexpression was less at 10, 50, 100 and 500 M IPTG; 
this phenomenon was observed twice.  In preparation of a larger cell stock for the 
isolation of the protein, at the time of induction, the medium was spiked with an 
additional 0.4 mL each of 25 mg/mL chloramphenicol and 50 mg/mL kanamycin per 
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liter of culture, and 2 mM Zn(acetate)2 was added (2 mL of a sterile 1.0 M Zn acetate 
solution). 
Purification of His-tagged Cc2746 for Assays.  The Rosetta 2 (DE3)-Cc2746 
cells were lysed at 0 °C, via sonication, in 20 mM Tris/5 mM imidazole/0.5 M NaCl/100 
g/mL PMSF, pH 7.9.  The ratio of sonication buffer to cell paste was ~ 5 mL per gram 
of cells.  The cell lysate was harvested by centrifugation at ~ 28,000 g.  A 25-mL Ni-
Sepharose 6 Fast Flow column (Amersham Biosciences) was generated according to the 
manufacturer’s instructions and equilibrated with the binding buffer.  The sterile-filtered 
cell lysate (0.45 m filter) was loaded onto the equilibrated Ni-column and eluted by 
gravity.  The column was washed with the binding buffer (the sonication buffer without 
PMSF) until the OD280nm of the flowthrough was less than 0.05 (~ 15 column volumes).  
The undesired proteins were eluted with eight column volumes of 20 mM Tris/0.5 M 
NaCl/100 mM imidazole, pH 7.9.  The pure Cc2746 protein was eluted with ~ four 
column volumes of 20 mM Tris/0.5 M NaCl/200 mM imidazole, pH 7.9.  The fractions 
containing Cc2746 were concentrated using a Centriprep ultracel YM-10 membrane 
(Amicon) and the imidazole was removed via gel filtration on a Superdex 200 High-load 
26/60 column (Amersham Biosciences).   
Synthesis of Dipeptide Libraries.  The L-Xaa-D-Xaa dipeptide libraries were 
synthesized as described in Chapter II.  The L-Xaa-L-Xaa and D-Xaa-L-Xaa libraries 
were synthesized as described in Chapter III.   
-Lactamase Assay.  Gox2272 and Cc2746 were tested for their ability to 
hydrolyze the -lactam nitrocefin.  The hydrolysis of nitrocefin was monitored by the 
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increase in absorbance at 486 nm ( = 20,500 M-1cm-1) in the presence of 100 mM 
potassium phosphate, pH 7.0.  The values of kcat, Km and kcat/Km of Gox2272 or an 
estimation of the kcat/Km for Cc2746 were determined with the nitrocefin substrate by 
fitting the initial velocity data to equation 2. 
Ninhydrin-based Enzyme Assay.  Unless otherwise stated, assays were conducted 
at 30 °C in 50 mM Hepes, pH 7.5.  The ninhydrin method was used to measure the 
concentration of free amino acid products at 507 nm as previously described for 
Sco3058 with dipeptides in Chapter III (61).  Mn-Gox2272 was assayed with 1.0 mM L-
Asn-D-Glu in the absence of additional metal in the assay and in the presence of 0.01, 
0.1, 1, 5, 10, 50 and 100 M MnCl2.  Other assays conducted with Mn-Gox2272 were 
supplemented with 20 M MnCl2.   
N-terminal Substrate Specificity of Gox2272 and Cc2746.  Enzyme course 
studies were performed by incubating the enzymes with nineteen L-Xaa-L-Xaa (0-2 M 
Zn-Gox2272 for 8 hours or 0-2 M Cc2746 for 5 hours), nineteen L-Xaa-D-Xaa (0-2 M 
Zn-Gox2272 for 8 hours or 0-1.5 M Cc2746 for 2.5 hours) and seventeen D-Xaa-L-Xaa 
(0-5 M Mn-Gox2272 for 4 hours or 0-2 M Cc2746 for 16 hours) libraries.  The D-
Xaa-L-Xaa screens with Mn-Gox2272 were supplemented with 20 M MnCl2.  The free 
amino acids were measured using the ninhydrin assay as described previously.  For the 
L-Xaa-L-Xaa and L-Xaa-D-Xaa libraries, the absorbance at 507 nm (A507nm), Q, was 
plotted as a function of enzyme concentration, Et, and fit to equation 1.  The rate 
constants, k (nM
-1
), were compared for each N-terminal amino acid within each set of 
libraries with the same incubation time.  The hydrolysis of the D-Thr-L-Xaa and D-Val-
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L-Xaa libraries by Cc2746 was too slow to fit to equation 1. The rates of hydrolysis of 
each of the D-Xaa-L-Xaa libraries by Mn-Gox2272 were obtained from the slope of 
linear relationship between the A507nm and the Mn-Gox2272 concentration. 
C-terminal Substrate Specificity of Gox2272.  Enzyme-course assays for two 
dipeptide libraries, L-Asn-L-Xaa and L-Asn-D-Xaa, were analyzed by HPLC for C-
terminal specificity of Zn-Gox2272.  Each library was incubated at 30 ºC for 5 hours, 
with and without enzyme, in 25 mM (NH4)HCO3, pH 8.0.  The concentrations of 
enzyme used were 0-2 M (L-Asn-L-Xaa) and 0-1 M (L-Asn-D-Xaa).  The sample 
preparation and data analysis were performed in the same manner as described for 
Gox1177 and Bb3285 (Chapter II). 
C-terminal substrate specificity of Cc2746.  Enzyme course assays for three 
dipeptide libraries, L-Arg-L-Xaa and L-Arg-D-Xaa, and D-Phe-L-Xaa were analyzed by 
HPLC for C-terminal specificity of Cc2746.  Each library was incubated at 30 ºC for 5 
hours, with and without enzyme, in 25 mM (NH4)HCO3, pH 8.0.  The concentrations of 
enzyme and incubation times used were 0-0.75 M (L-Arg-L-Xaa, 2.5 hours), 0-0.5 M 
(L-Arg-D-Xaa, 2 hours) and 0-2.5 mM (D-Phe-L-Xaa, 16 hours).  The sample preparation 
and data analysis were performed in the same manner as described for Gox1177 and 
Bb3285 (Chapter II). 
Kinetic and Inhibition Constants of Cc2746 and Mn-Gox2272.  The kinetic 
constants Km, kcat and kcat/Km were assessed for the two dipeptidases with various 
concentrations of several dipeptide substrates.  Mn-Gox2272 assays contained 20 M 
MnCl2.  The kinetic constants were determined by a fit of the data to equation 2 where v 
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is the velocity of the reaction, Et is the total enzyme concentration, kcat is the turnover 
number, A is the substrate concentration, and Ka is the Michaelis constant.     
For determination of the inhibition constants of the pseudodipeptide inhibitors 
(Scheme 3.2) with Cc2746, 0.5 mM L-Leu-D-Glu (compounds 4-6 and 9) or 0.4 mM L-
Met-D-Leu (compounds 7 and 8) substrates were used, and the assays were conducted at 
room temperature (25 °C).  Cc2746 was assayed in the absence of  inhibitor and up to 
100 M (compounds 4-8) or 200 M (compound 9) inhibitor in the assay.  The activity 
of Mn-Gox2272 (in 20 M MnCl2, substrate = 0.5 mM L-Met-D-Glu) was measured at 
30 °C without inhibitor and with up to 75 M of compounds 4-9.  The inhibition data for 
both enzymes were plotted in a similar fashion to Figure 3.4, and the Ki values were 
determined from fits of the data to equation 3.     
Superposition of Multiple Dipeptidase Structures.  The superposition of 
structures was performed using the MatchMaker tool in Chimera.  Initial matches were 
made between two sets of structures.  Residues in the regions with more variation in the 
position of the backbone were deleted and rematched.  Trial and error was used, deleting 
sections which 1) were not present in one or the other proteins or 2) showed more 
variation in the backbone, and rematching the structures.  The quality of the 
superposition of two structures was gauged by the position of the histidine ligands, the 
arginine at the end of 6 (Gox2272-R222), and the histidine/tryptophan following 4 
(Gox2272-H142).  In this fashion, the pairs of structures Gox2272/Cc2746, 
Rsp08027/Sco30584 complexes, Cc2746/Pa2393, Sco30584 complex/Cc2746, 
Rsp08027/LmoDP8 complexes, and Sco30584/hRDPcilastatin were overlayed.  The 
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pairs of overlays were used to create a master multiple overlay of the structures of these 
seven proteins within cog2355.  
The pseudodipeptide 4 bound in the Sco3058 structure served as a starter 
molecule from which to model different side chains from the carbon atoms in 4 that 
correspond to the N- (carbon ―a‖ in Scheme 4.2) and C-terminal C carbons of a 
dipeptide.  A methyl group was built onto 4 in place of the hydrogen on the chiral carbon 
representing C at the C-terminus (carbon ―b‖ in Scheme 4.2) of a dipeptide.  Scheme 
4.1 represents the structure of 4 with this methyl group (red) added.   
 
Scheme 4.2: Structure of phosphinate inhibitor 4 with an added methyl group (red) for 
modeling of the position of a C-terminal L-amino acid side chain.  
P
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Free amino acid molecules were introduced into the structure.  To model an L-
amino acid side chain at the N-terminus, the C–C bond of the inserted amino acid was 
superimposed onto the bond colored green in Scheme 4.2.  Positions for different C-
terminal amino acids on 4 were fashioned by manually overlaying the C–C bond of the 
inserted amino acid onto the bond colored red, for L-amino acids, or blue for D-amino 
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acids.  The ―Rotomers‖ editing tool in Chimera was used on the added amino acid to 
find potential contacts to the protein.    
Structural Overlay of Cc2746 with Sco3058 and Pa2393.  There is an insertion 
region between 7 and 7 of the (,-barrel in three of the eight proteins from cog2355 
which have crystal structures.  Sco30584 was superimposed onto the truncated 
coordinates of Cc2746 where residues 282-334 of Cc2746 were deleted.  Pa2393 was 
truncated, removing residues 101-115/298-365, and matched onto the same truncated 
Cc2746.  The complete structures of Cc2746 and Pa2393 were then superimposed onto 
their respective truncated reference structures.  This particular overlay was used to 
compare the position of the insertion region between 7 and 7 of the (,-barrel. 
RESULTS 
 Cloning, Overexpression and Purification of Gox2272 and Cc2746.  The gene 
for Gox2272 was successfully cloned into the pET30a(+) vector.  The purified Zn-
Gox2272 was found to contain 1.5 equivalents of Zn and 0.5 equivalents of Fe.  The Mn-
Gox2272 had 1.1 equivalents of Mn and 0.2 equivalents each of Zn and Fe.  The purified 
Cc2746 had 1.3 equivalents of Zn and 0.4 equivalents of Ni.     
 N-terminal Specificity of Gox2272.  The relative rates of hydrolysis of the L-Xaa-
L-Xaa, L-Xaa-D-Xaa and D-Xaa-L-Xaa libraries are compared in Figures 4.2A, C and E.  
The enzyme hydrolyzed a broad spectrum of L-L, L-D and, to a lesser extent, D-L 
dipeptides.  The L-Asn-D-Xaa library was hydrolyzed the fastest, with the L-Asn-D-Xaa 
library being preferred over the other L-Xaa-D-Xaa libraries.  From the high absorbance 
values of the control it was apparent that the L-Gln-L-Xaa library had degraded.  The  
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Figure 4.2: Substrate profile results for Zn-Gox2272.  (A, C and E)  Results of N-terminal 
specificity profile screens with 18 L-Xaa-L-Xaa (panel A, red), 19 L-Xaa-D-Xaa  (panel C, dark 
blue) and 17 D-Xaa-L-Xaa (panel E, olive green) libraries.   (B, D and F)  Results of C-terminal 
specificity profile screens of three selected dipeptide libraries.  The liberated C-terminal amino 
acids within the library marked with an asterisk on the left side panel (A and B) were 
quantitatively separated by HPLC to obtain the C-terminal specificity profile in the panel to its 
right (panels B and D).  The value of k is given for the bar marked with an asterisk in panels A 
and C.  The incubation times are presented for the comparison of the rates of hydrolysis of the L-
Asn-L-Xaa/L-Asn-D-Xaa (panel A and C) libraries and the individual dipeptide components 
within these same two libraries (panels B and D).  The C-terminal L-amino acids (gray) and D-
amino acids (light blue) are shaded differently.  
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hydrolysis of L-Gln-D-Xaa was used to gauge the preference for L-Gln at the N-terminus 
in comparison to the other L-Xaa-D/L-Xaa libraries.  Gox2272 was able to hydrolyze the 
D-Xaa-L-Xaa libraries to some extent, but the hydrolysis of these dipeptides was much 
slower.  The L-Asn-L-Xaa and L-Asn-D-Xaa libraries were selected for HPLC analysis. 
C-terminal Specificity of Gox2272.  In preparation of the libraries for HPLC 
analysis, the L-Asn-L-Xaa and L-Asn-D-Xaa libraries were incubated with Gox2272 for 
the same amount of time so as to make the rates comparable.  The rates of hydrolysis of 
the individual dipeptide components within these two libraries are presented Figures 
4.2B and 4.2D.  Among the 34 substrates which can be compared within these two 
libraries, the best substrate was L-Asn-D-Ala, though it is only marginally preferred over 
L-Asn-D-Glu with a rate of hydrolysis within the standard deviation of the L-Asn-D-Ala 
value.  Within the L-Asn-L-Xaa library, glycine was preferred over any of the L-amino 
acids at the C-terminus. 
 Kinetic and Inhibition Constants of Gox2272.  The specific activities of Mn-
Gox2272 are plotted in Figure 4.3 for various concentrations of MnCl2 in the assay.  
The kinetic constants for Mn-Gox2272 with several dipeptide substrates and nitrocefin 
are summarized in Table 4.1.  The highest catalytic efficiency was observed with both 
the L-Asn-D-Glu and L-Met-D-Glu substrates (kcat/Km = 4.7 x 10
5
 M
-1
s
-1
).  The top two 
inhibitors (Scheme 3.2) were compounds 4, the dipeptide mimic of Ala-Asp (Ki = 112 ± 
9.6 nM), and 8, the phosphinate mimic of Leu-Ala (Ki = 270 ± 6 nM).  Mn-Gox2272 
was also inhibited by compounds 5 (Ki = 300 ± 31 nM), 6 (Ki = 550 ± 44 nM), 7 (Ki = 
560 ± 4 nM) and 9 (Ki = 350 ± 18 nM).    
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Figure 4.3: Activity of Mn-Gox2272 at various concentrations of MnCl2 in the assay.  The 
substrate was 1.0 mM L-Asn-D-Glu.  
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Table 4.1: Kinetic constants for select substrates of Mn-Gox2272
a 
 
Substrate kcat, s
-1
 Km, mM kcat/Km M
-1
s
-1
 
L-Asn-D-Glu 160 ± 5  0.34 ± 0.03  (4.7 ± 0.4) x 10
5
 
L-Met-D-Glu 270 ± 3.5  0.58 ± .03  (4.7 ± 0.2) x 10
5
 
L-Met-D-Leu 280 ± 7.5  2.3 ± 0.2  (1.2 ± 0.09) x 10
5
 
L-Ala-D-Ala 480 ± 13  4.2 ± 0.2  (1.2 ± 0.07) x 10
5
 
L-Arg-D-Asp 280 ± 4.2  2.4 ± 0.09  (1.2 ± 0.05) x 10
5
 
L-Leu-D-Ala 240 ± 5.3 2.3 ± 0.1  (1.0 ± 0.06) x 10
5
 
L-Leu-D-Ser 140 ± 3.9  1.5 ± 0.1  (9.5 ± 0.8 ) x 10
4
 
L-Leu-D-Glu 69 ± 1.5  0.87 ± 0.06   (7.9 ± 0.6) x 10
4
 
L-Arg-Gly 380 ± 52  8.6 ± 1.9  (4.4 ± 1.1) x 10
4
 
L-Tyr-D-Leu 140 ± 1.4  5.2 ± 0.1  (2.6 ± 0.06) x 10
4
 
L-Leu-D-Leu 160 ± 12  6.3 ± 0.9 (2.5 ± 0.4 ) x 10
4
 
L-Arg-L-Asp 21 ± 0.7  1.2 ± 0.1  (1.8 ± 0.2) x 10
4
 
L-Ala-L-Asp 27 ± 0.9  2.0 ± 0.2  (1.3 ± 0.1) x 10
4
 
L-Ala-L-Glu 6.6 ± 0.3 0.5 ± 09  (1.3 ± 0.2) x 10
4
 
L-Ala-L-Gln    (6.8 ± 0.1) x 10
3
 
Nitrocefin (2.0 ± 0.2) x 10
-3
 0.12 ± 0.004  (1.7 ± 0.07) x 10
1
 
 
a
From fits of the data to equation 2.  For those entries without values of kcat and Km, 
saturation was not achieved at concentrations up to 6 mM. 
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N-terminal Specificity of Cc2746.  The rates obtained from the enzyme course 
data for the hydrolysis of the 54 dipeptide libraries by Cc2746 are summarized in 
Figures 4.4A, C and E.  Cc2746 has a preference for L-Asn-, L-Met- and L-Arg-Xaa 
over the other L-L dipeptide libraries, and L-D dipeptides were hydrolyzed more rapidly 
than their L-L counterparts.  The L-Arg-D-Xaa library was hydrolyzed at least 2.5-fold 
faster the other L-D libraries and Gly-D-Xaa.  Cc2746 hydrolyzed D-Xaa-L-Xaa 
substrates much more slowly.  Dipeptides with a D-aromatic residue were favored over 
other D-L dipeptides.   
C-terminal Specificity of Cc2746.  The slopes from the linear correlation between 
nmol of product and enzyme concentration were used to compare the rates of hydrolysis 
of the individual library components; these rates are summarized for L-Arg-L-Xaa, L-
Arg-D-Xaa and D-Phe-L-Xaa in Figures 4.4B , D and F, respectively.  The top six 
substrates within these three libraries were in the order of L-Arg-Gly > L-Arg-D-Glu > L-
Arg-D-Leu ≈ L-Arg-L-Glu ≈ L-Arg-L-Asp > L-Arg-D-Ala.  Within the L-Arg-L-Xaa 
library, glycine was preferred over any of the L-amino acids at the C-terminus. 
Kinetic and Inhibition Constants of Cc2746.  The kinetic constants for  Cc2746 
with selected dipeptide substrates and nitrocefin are summarized in Table 4.2.  The 
highest catalytic efficiency was observed with the L-Met-D-Leu substrate (kcat/Km = 4.6 x 
10
5
 M
-1
s
-1
), but the enzyme hydrolyzed several dipeptides with comparable activity.  The 
top two inhibitors (Scheme 3.2) were compounds 5, the dipeptide mimic of Phe-Asp (Ki 
= 570 ± 43 nM), and 8, the phosphinate mimic of Leu-Ala (Ki = 710 ± 78 nM).  Cc2746  
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Figure 4.4: Substrate profile results for Cc2746.  (A, C and E)  Results of N-terminal specificity 
profile screens with 18 L-Xaa-L-Xaa (panel A, red), 19 L-Xaa-D-Xaa  (panel C, dark blue) and 
17 D-Xaa-L-Xaa (panel E, olive green) libraries.   (B, D and F)  Results of C-terminal specificity 
profile screens of three selected dipeptide libraries.  The liberated C-terminal amino acids within 
the library marked with an asterisk on the left side panel (A, B and C) were quantitatively 
separated by HPLC to obtain the C-terminal specificity profile in the panel to its right (panels B 
and D and F).  The value of k is given for the bar marked with an asterisk in panels A, C and E.  
The incubation times are presented for the comparison of the rates of hydrolysis of the L-Arg-L-
Xaa/L-Arg-D-Xaa (panel A and C) libraries and the individual dipeptide components of three 
dipeptide libraries (panels B, D and F).  The C-terminal L-amino acids (gray) and D-amino acids 
(light blue) are shaded differently. 
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Table 4.2: Kinetic constants for select substrates of Cc2746
a 
 
Substrate kcat, s
-1
 Km, mM kcat/Km M
-1
s
-1
 
L-Met-D-Leu 82 ± 2 0.18 ± 0.02 (4.6 ± 0.5) x 10
5
 
L-Asn-D-Glu 43 ± 1 0.15 ± 0.02 (3.0 ± 0.4) x 10
5
 
L-Arg-D-Asp 31 ± 1 0.13 ± 0.01 (2.4 ± 0.3) x 10
5
 
L-Met-D-Glu 68 ± 3 0.31 ± 0.04 (2.2 ± 0.3) x 10
5
 
L-Leu-D-Ala 28 ± 0.5 0.16 ± 0.01 (1.8 ± 0.1) x 10
5
 
L-Ala-D-Ala 132 ± 7 0.81 ± 0.1 (1.6 ± 0.2) x 10
5
 
L-Met-L-Leu 73 ± 3 0.49 ± 0.06 (1.5 ± 0.2) x 10
5
 
L-Leu-D-Ser 51 ± 2 0.33 ± 0.04 (1.5 ± 0.2) x 10
5
 
L-Arg-Gly 50 ± 2 0.36 ± 0.04 (1.4 ± 0.1) x 10
5
 
L-Leu-D-Leu 41 ± 2 0.4 ± 0.05 (1.0 ± 0.1) x 10
5
 
L-Leu-D-Glu 18 ± 1 0.18 ± 0.03 (1.0 ± 0.1) x 10
5
 
L-Ala-L-Ala 140 ± 6 1.7 ± 0.2 (8.1 ± 1) x 10
4
 
L-Tyr-D-Leu 18 ± 0.4 0.32 ± 0.03 (5.7 ± 0.6) x 10
4
 
L-Ala-L-Asp 85 ± 1 2.9 ± 0.01 (3.0 ± 0.1) x 10
4
 
L-Ala-L-Glu 34 ± 0.8 1.3 ± 0.1 (2.5 ± 0.2) x 10
4
 
D-Ala-D-Ala   (6.4 ± 0.1) x 10
1
 
D-Ala-L-Ala   (1.5 ± 0.2) x 10
1
 
Nitrocefin   < 0.1 
 
a
From fits of the data to equation 2.  For those entries for dipeptides without values of 
kcat and Km, saturation was not achieved at concentrations up to 8 mM. 
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was also inhibited by compounds 4 (Ki = 1.8 ± 0.1 M), 6 (Ki = 2.0 ± 0.1 M), 7 (Ki = 
1.0 ± 0.1 M) and 9 (Ki = 20 ± 2.1 M).    
Structure of Zn-Gox2272.  The structure of the Zn-Gox2272SO4 complex was 
solved to 1.8 Å resolution by collaborators at the Albert Einstein College of Medicine. 
The binuclear Zn center of Gox2272 is shown in Figure 4.5.  The two metals are 
bridged by water (2.0-2.1 Å) and Glu-114 (2.0-2.2 Å) at the end of -strand 3.  The 
tetrahedral coordination of Zn is completed by contacts to His-14 (2.1 Å) and Asp-16 
(2.1 Å) from 1, whereas Zn has a trigonal bipyramidal geometry with additional 
contacts to a sulfate oxygen (2.3 Å), His-190 (2.1 Å) from 5 and His-211 (2.1 Å) from 
6.  The sulfate ion which coordinates Zn is 3.0 Å from N

 of Arg-222, and a second 
sulfate oxygen is 2.8 Å from N

 of His-142.  The catalytic aspartate from 8 is 2.8 Å 
from the bridging water. 
 Surface and stick representations of Gox2272 (with 4 positioned in the active site 
from the superposition of the structure onto the Sco30584 complex) are pictured 
alongside Sco3058 in Figure 4.6B.  The side chains of residues (C for glycine) whose 
side chains are within 10 Å of chiral carbon ―a‖ (Scheme 4.2) and closer to carbon ―a‖ 
than carbon ―b‖ are colored blue.  In the same fashion, the side chains within 10 Å of 
carbon ―b‖ are colored purple.  The N-terminal half of a dipeptide is considered to be 
represented by the aminoethylphosphonyl moiety of 4, and the rest of the inhibitor 
molecule symbolizes the C-terminal half.  The residues from Gox2272 anticipated to be 
in the immediate vicinity of the N-terminal half of the substrate are Asp-16, Tyr-52, His- 
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Figure 4.5: Ribbon representation and metal center of Zn-Gox2272.  (A) Ribbon representation 
of ZnGox2272.  The (/)8-barrel is shown in blue and red.  The two Zn ions (green spheres), C-
terminal -helix (pink) and the insertion region between 2 and 3 (yellow) are also colored.  (B) 
Metal center of Zn-Gox2272 with a tetrahedral Zn and pentacoordinate Zn Zinc ion, a bridging 
water (red sphere) and ligating sulfate (yellow sulfur).  Oxygens and nitrogens are colored red 
and blue, respectively.  Distances between atoms are shown in Å.  Though not shown, the sulfate 
oxygen noted with an asterisk is 2.8 Å from His-142 from -strand 4, and the oxygen which 
ligates to Zn is also 3.0 Å from Arg-222.    
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142 and Gly-283.  The nearest residues to the C-terminal half of the substrate are Asn-
143, Arg-222, Met-244, Ser-246, Phe-247, Asp-280 and Gly-284. 
Structure of Cc2746.  The three dimensional structure of the homotetrameric 
Cc2746 enzyme (Figure 4.7A) has been deposited into the PDB with a resolution of 2.0 
Å.  A surface representation of one subunit is shown in Figure 4.7B.  The metal center 
(Figure 4.7C) contains two Zn ions.  Zn is coordinated to His-53, O
1
 and O
2
 from 
Asp-55, and an ordered water.  A chloride ion, His-229 and His-250 are unique ligands 
to Zn.  The two metals are bridged by Glu-159.  A bridging water between the two 
metals was not observed.  On the basis of the superposition of Cc2746 onto the 
Sco30584 complex, the ordered water coordinated to Zn is analogous to the free amino 
group of 4.  The chloride ion is located between the position of the two carboxylate 
oxygens of 4 that indicate the position of the -carboxylate of a dipeptide. 
 The surface and active site stick representations of Cc2746 are shown in Figure 
4.6C and were created for comparison to Sco3058 by the same method as Gox2272 in 
Figure 4.6B.  The difference is that Cc2746 has an insertion region, colored orange, 
between 7 and 8 of the (/)8-barrel.  The active site residues in Cc2746 expected to 
influence the quality of the binding pocket for the N-terminal half of the substrate are 
Asp-55, Pro-57, Ala-58, Tyr-98, His-186 and C from Gly-363.  The residues presumed 
to be closest to the C-terminal half of the substrate are Phe-187, Arg-261, I-283, Tyr-
284, Asp-360 and Gly-264.  Though not shown in Figure 4.6, the backbone oxygen 
from the first glycine following 8 (Sco3058-G323, Gox2272-G283, Cc2746-G363) is in 
proximity (2.4-3.3 Å) to the methylene group adjacent to the phosphorus of 4 that 
  
 
 
 
Figure 4.6: Surface and stick representations of the active sites of Sco30584 (A), Gox2272 (B) and Cc2746 (C) in the same orientation.  
The placement of inhibitor 4 (pink carbons, orange phosphorus) in B and C is from the superposition of Gox2272 and Cc2746 onto the 
Sco30584 complex.  Side chains of residues which make up the pockets for the N- and C-terminal sides of a dipeptide are colored blue 
and purple, respectively.  The aspartate from 8 is colored red.  Surfaces of the histidine/glutamate ligands, atoms within hydrogen-
bonding distance to 4 (yellow), the insertion region (teal or orange), and the Zn ions (black spheres) are also colored.  The clipped plain is 
depicted as a transparent mesh surface.  The residues of each active site are labeled below the surface representation.  Other residues 
discussed in the text are colored gray. 
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Figure 4.7: Representations of the metal center, tertiary and quaternary structure of Cc2746.  
Zinc ions are illustrated as green spheres.  (A) Ribbon representation of tetrameric Cc2746.  The 
(/)8-barrel is shown in blue and red.  The insertion region (residues 285-334) is colored teal.  
The C-terminal -helix (pink) and the insertion region between 2 and 3 (yellow) are also 
colored.  (B) Surface representation of one subunit of Cc2746 where the insertion region 
(residues 285-334) is colored orange with black dashed lines depicting the missing segment of 
residues 294-303.  (C) Metal center of Cc2746 with  and  Zinc ions, an additional water (red 
sphere) and chloride ion (purple sphere) ligands.  Oxygens and nitrogens are colored red and 
blue, respectively.  Distances between atoms are shown in Å.  
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symbolizes the nitrogen of the amide bond to be cleaved. 
 
DISCUSSION 
The dipeptidases Cc2746 and Gox2272 were successfully overexpressed and 
purified from E. coli.  The Zn-Gox2272 protein contained a significant amount of iron, 
despite the extreme excess of Zn in the growth medium.  A more active Mn-Gox2272 
enzyme was purified by chelating Fe from the medium with bipyridyl and 
supplementing the culture with MnCl2.  The substrate profiles of the two enzymes were 
established by screening the proteins for activity against 54 dipeptide libraries.  Both 
enzymes hydrolyzed a significant fraction of the dipeptides in the libraries, but had a 
marked preference for L-D dipeptides.   
Substrate Specificity Determinants of Gox2272.  Gox2272 has a moderate 
preference for L-Asn-Xaa dipeptides and D-Ala or D-Glu are favored over other amino 
acids at the C-terminus.  On the basis of a model of D-Glu as the C-terminal amino acid 
of a dipeptide, the side chain oxygens of D-Glu were near the hydroxyl group of Ser-246 
(3.3 Å) or the side chain amine of Asn-142 (3.2 Å).  If the dipeptide were L-Gln-Xaa or 
L-Asn, the side chain heteroatoms were 2.3-2.9 Å or 2.4 Å from the phenolic oxygen of 
Tyr-52, respectively. 
Substrate Specificity Determinants of Cc2746.  For dipeptides with an L-amino 
acid at the C-terminus, Cc2746 has a slight preference for L-Asn-L-Xaa dipeptides, 
followed closely by L-Met-L-Xaa and L-Arg-L-Xaa.  The enzyme had a more 
pronounced preference for L-Arg-D-Xaa dipeptides.   Even though the Arg-Gly substrate 
within the L-Arg-L-Xaa library was hydrolyzed the fastest, it should be noted that Arg-
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Gly was in competition with poorer L-Arg-L-Xaa substrates; the rate of Arg-Gly 
hydrolysis was significantly less in the presence of more favorable L-Arg-D-Xaa 
dipeptides.  The same concept applies to differences in the rates of hydrolysis of L-Asn-
Gly in the L-Asn-L-Xaa and L-Asn-D-Xaa libraries by Gox2272.  When the C-C bond 
of L-Arg was modeled onto the C–C bond of the aminoethyl moiety of 4, a rotomer of 
the L-Arg side chain was within hydrogen-bonding distance to the hydroxyl group of 
Tyr-98 (2.8-3.0 Å).  The side chain oxygens of a modeled C-terminal D-Glu or L-Asp 
were 2.9 Å from the phenolic oxygen of Tyr-284.         
Comparison of Insertion Regions of Cc2746, Sco3058 and Pa2393.  Pa2393 is a 
protein within cog2355 but is missing the His and Asp ligands at the end of 1, the 
histidine ligand at the end of 5 as well as the bridging glutamate from 3.  The structure 
of Pa2393, with no metal bound in the protein, is available from the PDB (PDB code 
3B40).  Pa2393 is similar in structure to other proteins in cog2355, has the histidine 
ligand from 6, the aromatic residues following 2 and 7, as well as the conserved 
arginine which follows 6.  As shown in Figure 4.8, the position of this insertion with 
respect to the ()8-barrel varies between the structures of Cc2746, Sco3058 and 
Pa2393.  Residues 294-303 of Cc2746 are within this insertion region but are not defined 
in the crystal structure.  Therefore, whether or not any of these ten residues in Cc2746 
contribute to the formation of the substrate binding pocket is not known.   
 1-Loop/helix.  Seven of the eight members of cog2355, for which there are 
structures, were superimposed and select parts of the structure are presented as ribbons 
in Figure 4.9.  In five of the eight protein structures within cog2355 (Rsp0802 and 
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Figure 4.8: Ribbon depiction of three microbial proteins in cog2355, highlighting the different 
positions of the insertion region noted in the amino acid sequence alignment.  Overlay of Cc2746 
(orange and light gray, PDB code 2RAG), Sco3058 (teal and gray, PDB code 3K5X) and Pa2393 
(black and purple, PDB code 3B40).  The missing segments of Cc2746 (residues 294-303) and 
Pa2393 (residues 106-110) are shown as orange and black dashed lines, respectively.  Zn ions 
are represented as spheres. 
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LmoDP discussed Chapter V, Sco3058, hRDP, and Cc2746), there is a short -helix (1-
helix) and loop (1-loop) between the first -strand and -helix of the (/)8-barrel.  The 
third residue after the HxD motif (A58 in Cc2746 and Trp-25 in Sco3058) is on the 1-
helix and faces into the active site; however, Gox2272 and Pa2393 only have a 1-loop 
and there is not an equivalent active site residue.  The number of residues between the 
HxD motif and a structural glutamine/histidine/aspartate on the 1-loop is shorter for 
Gox2272 (16 residues) and Pa2393 (18 residues) compared to the others with the 1-
helix (20-26 residues).  There is not a clear-cut explanation for the difference in 
secondary structure in Gox2272 and Pa2393 immediately following 1.   
Gox2272-W19 and Sco3058-W25 were thought to be equivalent to one another 
on the basis of the amino acid sequence alignment (Figure 4.1), but they are not in the 
same position in their respective structures (Figure 4.6A vs. 4.6B).  Only the C carbon 
from Gox2272-W19 (blue asterisk in Figure 4.6B) is within 10 Å of the chiral carbon of 
the aminoethyl moiety of 4.  The pocket surrounding carbon ―a‖ (Scheme 4.2) is more 
open in Gox2272 and Cc2746 than in the Sco3058 structure, but for different reasons.  In 
the case of Gox2272 the openness is due to W19 facing away from the active site, but 
the equivalent residue to Trp-25 in Sco3058 is a smaller Ala-58 residue in Cc2746.       
 8-Loop.  The 8-loop is the loop between 8 and 8 of the (/)8-barrel.  The 3-4 
residues immediately following 8 are noted with asterisks in Figure 4.1 and are colored 
differently for each protein in Figure 4.9.  The position of the 8-loop in Gox2272, 
Cc2746 and Pa2393 varies from that of other members of cog2355, namely, hRDP,  
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Figure 4.9:  Segments of superimposed structures of seven proteins within cog2355.  Ribbons 
are colored gray except for select residues from Sco3058 (teal W25, H49, V245, K247, F248, 
T324, P325, F326, T327), hRDP (black W25, H49, Y252, N254, Y255, V292, P293, R294, 
V295), Cc2746 (light blue A58, Q79, I283, Y284, G364, G365, G366), Gox2272 (red residues 
16-20, Q33, M244, S246, F247, G284, G285, G286), Rsp0802 (purple L16, H37, A264, S266, 
F267, A308, T309, I310), LmoDP (yellow Y12, D32, T225, L227, F228, I265 P266, D267, 
H268),  Pa2393 (olive green residues 61-64, Q80, F298, A300, Y301, G394, G395, G396) The 
phosphinate mimic from the Sco30584 complex is shown with pink carbons and an orange 
phosphorus.  The three residues which follow 7 and contribute side chains to the binding pocket 
for the C-terminal amino acid side chain of a dipeptide are highlighted on the 7-loop/helix.  A 
major contributor to the binding pocket of the side chain of the N-terminal amino acid of the 
substrate is the third residue after the HxD motif from -strand 1 and is colored on the ― egment 
of 1-helix‖.   Polar contacts between the residue on the 1-loop and the backbone of the 8-loop 
are indicated by dashed lines. 
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Sco3058, Rsp0802 and LmoDP.  A histidine (Sco3058-H49, hRDP-H49, Rsp0802-H37), 
aspartate (LmoDP-D32) or glutamine (Gox2272-Q33, Cc2746-Q79 and Pa2393-Q80) 
residue at the end of the 1-loop is within hydrogen-bonding distance to a backbone 
nitrogen of the 8-loop (Sco3058-D322), but, a glutamine at this position makes a 
second contact to the backbone oxygen on the 8-loop (Gox2272-G285).   
7-Loop/helix.  The 7-loop/helix is a loop of three residues immediately 
following 7 (residues 242-244 in Gox2272) and a subsequent single turn helix (residues 
245-248 in Gox2272).  The side chains of the residue which precedes the helix 
(Gox2272- M244) and the 2
nd
 and 3
rd
 residues of the helix (Ser-246 and Phe-247 in 
Gox2272) face towards the active site.  However, Cc2746 has a loop immediately 
following 7 (light blue ribbon in Figure 4.9), and there is not an equivalent residue to 
Sco3058-K247 or Gox2272-S246 in Cc2746.   
In Gox2272, Cc2746 and Pa2393, the three colored residues of the 8-loop are all 
glycines.  One could hypothesize that if this portion of the 8-loop is pushed downward 
and closer to the 7-loop/helix by the glutamine from the 1-loop, the side chains 
projecting from the first two of the three colored residues from the 8-loop would 
probably interfere with the position of the active site side chains which project from the 
7-helix.  In the case of Sco3058, hRDP, Rsp0802 and LmoDP, the 8 loop is further 
out, extending the size of the pocket for the C-terminal side chain of a dipeptide. 
 Cluster 1 of cog2355.  Gox2272 is part of the subset of amino acid sequences in 
Cluster 1 (Figure 3.8).  Some of the proteins in this cluster are much longer in sequence 
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(~ 600 amino acids) compared to Gox2272 (335 amino acids).  In these longer 
sequences, the C-terminal region belongs to cog2355.  However, the ~ 250 amino acids 
of the N-terminal region are part of cog2071.  BLAST hits to one of these longer 
sequences (gi|150010128), have annotations such as glutamine amidotransferase class 
II/dipeptidase, dipeptidase, and Class I glutamine amidotransferase.  The closest amino 
acid sequence to gi|150010128 belonging to a protein with a structure corresponds to  
(Lin1909, gi|220702529, PDB code 3FIJ).  Within the 3FIJ structure there is a 
mononuclear Zn center, ligated to a serine, three histidines and a water molecule, which 
is in close proximity to a potential Cys-His-Glu catalytic triad.  A protein with these 
same residues is found in the Gluconobacter oxydans genome (locus tag Gox0800) 
though it is not a fusion protein.  There are approximately 40 amino acid sequences 
which are a fusion of these two proteins, but there was not consistency in the annotations 
of proteins in the immediate genome context of these proteins.   
 Cluster 8 of cog2355.  Cc2746 is in cluster 8 of cog2355.  In Stenotrophomonas 
maltophilia, the dipeptidase is adjacent to a protein annotated as an amino acid 
permease-associated region.  In Alteromonas macleodii (gi|196158469) 
Pseudoalteromonas atlantica (gi|109897266), the dipeptidase is adjacent to a protein 
annotated as a TonB receptor.  Sometimes proteins annotated as TonB receptors include 
siderophore receptor in the annotation.  Siderophore can be partly composed of L- and D-
amino acids.  The genome contexts of proteins within cluster 8 are not all alike and do 
not reveal a specific function to all members of the cluster.  
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 Future Directions.  Cc2746 and Gox2272 remain to be cocrystallized with the 
desired inhibitors.  The human renal dipeptidase is known to hydrolyze -lactams, albeit 
less efficiently than dipeptides, but there is not a structure of hRDP complexed with a -
lactam.  With respect to -lactam hydrolysis, Gox2272 was different from Sco3058 and 
Cc2746.  The catalytic efficiency for the hydrolysis of nitrocefin by Gox2272 was at 
least 170-fold higher than for Sco3058 and Cc2746.  The crystallization of Gox2272 
with a -lactam bound would be of interest.   
 There is one protein in cluster 8 which differs from the rest of the sequences in 
the cluster, namely the protein with locus tag PFL_1383 (gi|70728763).  The equivalent 
active site residue to Cc2746-Y284 is an aspartate in PFL_1383.  An aspartate at this 
position may result in 1) the enzyme favoring the hydrolysis of dipeptides with a 
positively charged residue at the C-terminus or 2) rejection of a negatively charged -
carboxylate at the C-terminus possibly resulting in the protein functioning as an 
aminopeptidase for a peptide of at least three amino acids. 
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CHAPTER V 
 
THREE RENAL DIPEPTIDASE-LIKE PROTEINS WITH  
AN ACTIVE SITE TRYPTOPHAN  
INTRODUCTION 
 The structure of the inhibitor complex of Sco3058 with the phosphinate mimic of 
L-Ala-D-Asp clarified the question as to how the -amino group of a dipeptide was 
recognized by the microbial homologues of the human renal dipeptidase (hRDP).  The 
-amino group of the substrate is recognized by the aspartate from -strand 1.  In 
agreement with inhibitor complexes of Sco30584 and hRDPcilastatin, the C-terminal 
carboxylate of a dipeptide has electrostatic interactions with the beta metal, M, and the 
arginine on the loop following -strand 6.  The carbonyl of the amide bond makes polar 
contacts to M, and a histidine immediately following -strand 4 (His4) (23, 80). 
The hRDP enzyme binds to cilastatin-Sepharose, but the non-conservative 
His4→Leu mutant does not (77).  When His4 (His-150) of Sco3058 from S. coelicolor 
was mutated to an asparagine, the Km increased by 2.7-fold, and the kcat decreased by ~ 
200-fold compared to wild-type (80).  Those amino acid sequences within cog2355 
which are predicted to have the complete set of metal ligands for the binuclear metal 
center will be termed the ―binuclear subset‖.  All of the members of the binuclear subset 
have either an active site tryptophan or histidine at the end of 4 (His-150 in Sco3058), 
with the exception of one protein (gi|192362060) which has a tyrosine at this position.  
More often than not, the equivalent residue to His-150 in Sco3058 is a tryptophan, Trp4.   
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 Of the two proteins addressed in the literature which have Trp4, one enzyme 
from Brevibacillus borstelensis (BCS-1) was described as having good activity (L-Ala-
D-Ala, kcat = 760 s
-1
, Km = 3.7 mM, kcat/Km = 2 x 10
5
 M
-1
s
-1
) whereas the second protein 
from Acinetobacter calcoaceticus (AcDP) was low in activity (Leu-D-Leu, Km = 9.3 
mM, kcat/Km = 6.6 x 10
1 
M
-1
s
-1
) (49, 76).  These Km values are somewhat high, but the 
dipeptides which were selected may not have been ideal substrates (76).  One difference 
between BCS-1 and AcDP is the active site residue following -strand 2 (2-Tyr = Tyr-
68 in Sco3058 and hRDP). 
 Based on amino acid sequence alignments of proteins within the binuclear 
subset, it is expected that the equivalent residue to 2-Tyr is almost always an aromatic 
residue where the frequency of occurrence of Tyr > Phe > Trp.  An overlay of 
Sco3058pseudodipeptide 4 and hRDPcilastatin complexes shows that C3 of cilastatin, 
the atom in cilastatin that is closest in position to the free amino group of 4, is 4.1 Å 
from the 2-Tyr and 3.7-4.4 Å from Asp-22 (1).  All of the proteins of known amino 
acid sequence that are represented in the literature have a tyrosine at this position except 
AcDP, which has phenylalanine (2-Phe).  The hydroxyl group of this tyrosine residue 
was not expected to be important enough to account for the ~ 3-4 orders of magnitude 
difference in kcat/Km between BCS-1 and AcDP, but nevertheless, it is an active site 
residue and there seemed to be a discrepancy as to whether it was necessary to achieve 
optimal enzymatic activity (49, 76). 
 Attempts to obtain purified proteins with Trp4 from Bacillus cereus (Bc3775,  
gi|30021867), Sulfolobus sulfataricus (Sso1864, gi|15898656) and Chlamydophila 
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pneumonia (Cpn0269, gi|15618189) were unsuccessful; the proteins were produced from 
recombinant DNA but were solely in the insoluble fraction of the cell lysates.  The 
targets Bc3775 (9513b) and Sso1864 (9313a) could not be purified by the New York 
SGX Research Center for Structural Genomics (NYSGXRC) as well, failing at the 
stages of solubility and purification, respectively.  However, three other proteins with 
Trp4, namely Rsp0802 from Rhodobacter sphaeroides 2.4.1 (9523c, gi|77464378), 
LmoDP from Listeria monocytogenes serotype 4b (9513a, gi|46908635) and Bh2271 
from Bacillus halodurans C-125 (9316a, gi|15614834), were purified at NYSGXRC and 
studied here.  Unique genes cloned by NYSGXRC are identified by a four digit number 
followed by a letter.    
LmoDP and Bh2271 are from Cluster 2 (Figure 3.8) and have a 2-Phe residue, 
whereas Rsp0802 is from Cluster 3 has the 2-Tyr residue.  The native Rsp0802 
structure was solved by the Midwest Center for Structural Genomics and deposited into 
the PDB (PDB code 3FDG), but residues 61-65 or 61-75 were not defined in the two 
subunits of the homodimer.  The coordinates of a close homolog to LmoDP, Lmo2462 
from Listeria monocytogenes strain EDG-e, became available recently (PDB code 
3LU2).  However, all of the predicted metal-binding residues of Lmo2462 were 3.0-3.6 
Å from the two Zn ions, and the glutamate from 3 was not bridging the zincs as a 
bidentate ligand. 
Using the same methods outlined for Sco3058 in Chapter III, the proteins 
Rsp0802, LmoDP and Bh2271 were screened with dipeptide libraries in order to reveal 
their substrate specificity profile.  From the profile, appropriate substrates were selected 
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to ascertain the quality of enzymes with Trp4 and 2-Tyr residues.  Rsp0802, LmoDP 
and Bh2271 hydrolyzed an array of dipeptides within these libraries but showed a 
preference for those substrates with an L-amino acid at the N-terminus and a D-amino 
acid at the C-terminus.  LmoDP exhibited a somewhat stricter substrate profile with a 
preference for L-Arg/Lys at the N-terminus and D-Ala at the C-terminus.  With regard to 
the C-terminal preference, Bh2271 was more similar to LmoDP than Rsp0802, and 
dipeptides with a C-terminal D-alanine residue were also hydrolyzed faster than the other 
components of the L-Leu-D-Xaa library.  The pseudodipeptide mimic of Leu-Ala (8) was 
found to be the most effective inhibitor of Rsp0802 and LmoDP out of the set of 
phosphinate compounds 4-9 (Scheme 3.2).  In collaboration with  teve Almo’s lab at 
Albert Einstein College of Medicine, the structures of the Rsp0802pseudodipeptide 7 
(PDB code 3LY0) and LmoDPpseudodipeptide 8 (PDB code 3NEH) complexes were 
solved to 1.4 Å and 1.6 Å resolution, respectively.  The relationship between the 
substrate specificity and the active site residues (real and predicted) will be discussed.    
MATERIALS AND METHODS 
 Materials.  The compounds which were purchased commercially and the 
precursors for dipeptide library synthesis were previously described in Chapters II and 
III (56, 80).  All other purified compounds as well as the dipeptide libraries were 
synthesized by Dr. Chengfu Xu.  Metal analyses were conducted using inductively 
coupled plasma mass spectrometry (ICP-MS) as previously described (59).  ICP-MS 
standards were obtained from Inorganic Ventures Inc.  Oligonucleotide syntheses and 
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DNA sequencing were performed by the Gene Technologies Lab of Texas A&M 
University.   
Cloning and Overexpression of Rsp0802, Bh2271, LmoDP by NYSGXRC.  The 
genes for Rsp0802, LmoDP and Bh2271 were cloned into the TOPO
®
 vector 
(Invitrogen) from the genomic DNA of the aforementioned strains of R. sphaeroides, L. 
monocytogenes and B. halodurans.  According to details provided in the Structural 
Genomics Knowledgebase, the proteins were purified with His-tags on a HiTrap 
Chelating column (Ni
2+
 charged) from Amersham Biosciences.  Cell lysis was 
conducted at 4 °C in 50 mM Tris/500 mM NaCl/20 mM imidazole/0.1 % Tween 20, pH 
7.5.  The loading buffer was 20 mM Tris/500 mM NaCl/10 mM imidazole/10mM 
methionine/10% glycerol, pH 7.8, and the elution buffer was the loading buffer with 500 
mM imidazole.  In the final step, each protein was eluted through a gel filtration column 
with 10 mM Hepes/150 mM NaCl/10 mM methionine/10 % glycerol/5 mM DTT, pH 
7.5.  Bh2271 was overproduced in E. coli as a Se-Met protein.   
Ninhydrin-based Enzyme Assays.  Unless otherwise stated, assays were 
conducted at 30 °C in 50 mM Hepes, pH 7.5.  With the exception of substrates L-Ala-L-
Asp and L-Arg-L-Asp, the ninhydrin method was used to measure the concentration of 
free amino acid products at 507 nm as previously described for Sco3058 with dipeptides 
in Chapter III (61, 80).  For the assay of Rsp0802 with L-Tyr-D-Leu, the heating time 
with the ninhydrin reagent was extended to 11 minutes.  For the determination of the 
inhibition constants of Rsp0802 and LmoDP with the phosphinate mimic of Leu-Ala (8), 
LmoDP was assayed with 1 mM L-Ala-D-Ala and Rsp0802 with 2 mM L-Leu-D-Ala.  
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Both enzymes were first tested with a single concentration of 25 M of each of the six 
phosphinate inhibitors (4-9).  The concentration ranges of 8 used with LmoDP and 
Rsp0802 were 0-160 M and 0-600 M, respectively.   
Aspartic Acid Coupling System Assay.  The hydrolysis of L-Ala-L-Asp and L-
Arg-L-Asp was measured by monitoring the decrease in NADH concentration at 340 nm.  
The coupling system assay contained varying concentrations of dipeptide, 3.7 mM -
ketoglutarate, 0.36 mM NADH, 100 mM KCl, 1.0 unit of malate dehydrogenase 
(Calbiochem) and 7 units of aspartate aminotransferase (Sigma-Aldrich) in 100 mM 
Hepes, pH 7.5. 
Sample Preparation for HPLC Analysis.  All assays used in the preparation of 
samples for the quantitation of the liberated C-terminal amino acids by HPLC were 
conducted in the same manner as described for the D-aminoacylases (Chapter II).  Unless 
otherwise stated, the only differences from one enzyme to another are the enzyme 
concentration ranges and the incubation times of the libraries with the enzyme.  The 
Rsp0802 and LmoDP enzymes were removed from the samples with a VWR
®
 
centrifugal filter (polyethersulfone membrane, MWCO = 10 KDa). 
Activation of Enzymatic Activity with Divalent Cations.  The buffer used in these 
experiments was 50 mM Hepes, pH 7.5.  The substrate L-Leu-D-Ala (0.4 mM) was used 
to assess enzymatic activity.  Zn was the most abundant metal present in the purified 
proteins.  Rsp0802 and LmoDP were assayed in the absence and presence of varying 
concentrations of ZnCl2 in the assay (1, 2, 5, 10, 25 and 100 M for Rsp0802 and 0.5, 2, 
5, 10 and 20 M for LmoDP).  Twenty-five M (~ 1 mg/mL) Rsp0802 and LmoDP 
150 
 
 
were incubated with 0, 25, 50, 100 and 150 M ZnCl2 for 3 and 24 hours at 0 °C.  
Following incubation for 24 hours, the enzymes were assessed for their activity with and 
without 5 M ZnCl2 during the reaction.  
The rate of hydrolysis of 0.5 mM L-Leu-D-Ala by Bh2271 was assessed in the 
presence of 0, 1, 5, 25 and 100 M ZnCl2, CoCl2 and MnCl2 in the reaction.  The 
activity of Bh2271 could be enhanced with the addition of ZnCl2, MnCl2 or CoCl2 in the 
assay.  The enzyme (25 M) was incubated with and without 100 M MnCl2 on ice for 5 
minutes, 3.5 hours, and 20 hours on ice.  The incubated samples were assayed at 25 °C 
with and without 100 M MnCl2 in the assay.  The activity of Bh2271 was also assessed 
with 10, 25, 50 and 100 M MnCl2 to find the minimum amount needed to maximize 
activity.   
N-terminal Specificity of 3 Dipeptidases.  The 3 dipeptidases were screened for 
activity against 55 dipeptide libraries (19 L-Xaa-L-Xaa, 19 L-Xaa-D-Xaa, and 17 D-Xaa-
L-Xaa) except for Bh2271, which was not screened with the D-Xaa-L-Xaa libraries.  The 
concentration of each library component in the assay was ~ 100 M, but L-Cys, D-Cys 
and D-Ile were not included as components of any library.  For the D-Xaa-L-Xaa 
libraries, the incubation time of the libraries with enzyme was 16 hours and the 
concentration range of enzyme used was 0-2.5 M in the presence of 5 M ZnCl2 
(LmoDP) or 10 M ZnCl2 (Rsp0802).  The L-Xaa-L-Xaa and L-Xaa-D-Xaa libraries 
were incubated with 0-2 M Bh2271 for 18 hours.  The Zn-treated LmoDP (0-2.5 M) 
was incubated with the L-Xaa-L-Xaa and L-Xaa-D-Xaa libraries for 4 hours where the 
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total concentration of ZnCl2 in the assays was 5 M.  The Zn-activated Rsp0802 was 
incubated with the L-Xaa-L-Xaa (0-2.5 M Rsp0802) and L-Xaa-D-Xaa (0-1.5 M 
Rsp0802) libraries for 4.5 hours in the presence of 10 M ZnCl2.  The liberated free 
amino acids were measured via the ninhydrin method, and the absorbance at OD507nm, Q, 
was plotted as a function of enzyme concentration, Et, and fit to equation 1. 
C-terminal Specificity of Rsp0802.  Enzyme-course assays for five dipeptide 
libraries: L-Leu-D-Xaa, L-Leu-L-Xaa, L-Met-D-Xaa, L-Met-L-Xaa and D-Met-L-Xaa 
were analyzed by HPLC for determination of the C-terminal specificity preference.  
With the exception of the D-Leu-L-Xaa library, each library was incubated at 30 ºC for 5 
hours, with and without Zn-activated enzyme, in 25 mM (NH4)HCO3, pH 8.0 
supplemented with 10 M ZnCl2.  The D-Met-L-Xaa library was incubated under the 
same conditions for 16 hours.  The concentrations of enzyme used were 0-2 M (L-Leu-
D-Xaa), 0-2.5 M (L-Leu-L-Xaa, L-Met-L-Xaa, and D-Met-L-Xaa) or 0-1.5 M (L-Met-
D-Xaa).  The slope of the linear relationship between the quantity of each C-terminal 
amino acid and the concentration of enzyme was used to compare the rates of hydrolysis 
of the various components of the libraries.  The same assay conditions, methods of 
sample preparation and data analysis were used in screening the C-terminal specificity of 
LmoDP and Bh2271.    
C-terminal Specificity of LmoDP.  In a similar manner to Rsp0802, LmoDP was 
screened for its substrate preference with respect to the identity of the C-terminal amino 
acid of a dipeptide.  Seven dipeptide libraries were incubated in the absence and 
presence of the following concentration ranges of Zn-activated LmoDP: 1 nM-0.75 M 
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(L-Lys-D-Xaa), 5 nM-1.0 M (L-Lys-L-Xaa), 1 nM-0.75 M (L-Arg-D-Xaa), 20 nM-2.5 
M (L-Arg-L-Xaa), 2 nM-1.0 M (L-Met-D-Xaa), 20 nM-2.0 M (L-Met-L-Xaa) and 
0.1-2.5 M (D-Trp-L-Xaa).  The assays were supplemented with 5 M ZnCl2.  The 
libraries with an N-terminal L-amino acid were incubated for 3.5 h at 30 °C, but the D-
Trp-L-Xaa library was allowed to incubate for a total of 16 hours under the same 
conditions. 
C-terminal Specificity of Bh2271.  The L-Leu-D-Xaa and L-Leu-L-Xaa libraries 
were treated with 0-2.0 M and 0-4 M Bh2271 for 18 hours at 30 °C prior to sample 
preparation for HPLC analysis. 
Crystallization and Data Collection.  Crystallization screens of Rsp0802 and 
LmoDP were conducted by Elena Fedorov.  The structure of the Rsp0802 
pseudodipeptide 7 and LmoDPpseudodipeptide 8 complexes were solved by Dr. 
Alexander Fedorov from Dr.  teve Almo’s lab at Albert Einstein College of Medicine.  
The crystallization conditions described were taken from the protocols for the 
NYSGXRC clones 9513a and 9523c summarized on the Structural Genomic 
Knowledgebase.  The crystallization solution of Rsp0802 contained 9.8 mg/mL 
Rsp0802, 20% PEG 3350, 200 mM potassium formate at 21 °C, and the cryoprotectant 
was 20% ethylene glycol.  LmoDP crystallized at 21 °C in 100 mM Bis-Tris, pH 6.5 and 
25% PEG 3350.  The cryoprotectant for LmoDP was 20 % glycerol. 
Data Analysis.  For those assays conducted by the ninhydrin method, standards 
consisted of mixtures of each of the two appropriate amino acid products at equal molar 
ratios in the same buffer as the enzymatic assay.  The standards were heated with 
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ninhydrin alongside each set of assays for each substrate.  The initial velocity data, v, 
were fit to equation 2, where Et is the total enzyme concentration, kcat is the turnover 
number, A is the substrate concentration, and Ka is the Michaelis constant.   
RESULTS 
Purification of Rsp0802, Lmo2462 and Bh2271.  Rsp0802 was found to contain 
0.6 equivalents of Zn and less than 0.1 equivalents of Fe or Ni by ICP-MS.  The Se-Met 
Bh2271 protein had 0.8 equivalents of Zn and 0.4 equivalents of Fe.  The metal content 
of LmoDP was somewhat lower, having 0.3 equivalents of Zn and 0.15 equivalents of 
Ni.   
Activation of Rsp0802 and LmoDP Activity with Divalent Cations.  The activity 
of Rsp0802 and LmoDP, toward the hydrolysis of 0.4 mM L-Leu-D-Ala, increased with 
up to 5 M ZnCl2 added directly to the assay (Figures 5.1A and 5.1C), but their activity 
was enhanced more by pre-incubation with ZnCl2 (Figures 5.1B and 5.1D).  Rsp0802 
and LmoDP reached maximal activity enhancement within 3 hours when soaked in 2 and 
4 equivalents of ZnCl2, respectively.  After pre-incubating the enzymes with ZnCl2, 
further enhancement of activity was not achieved with additional ZnCl2 in the assay, and 
the addition of 5 M ZnCl2 to the assay resulted in less activity for LmoDP.  Enzymatic 
assays with LmoDP and Rsp0802 were conducted after soaking the enzyme with the 
aforementioned optimal equivalents of ZnCl2. 
 Activation of Bh2271 Activity with Divalent Cations.  The rates of hydrolysis of 
L-Leu-D-Ala by Bh2271 in the presence of 0-100 M ZnCl2, CoCl2 and MnCl2 are 
154 
 
 
plotted in Figure 5.2.  The activity of Bh2271 increased with up to 5 M ZnCl2 (~ 6-
fold), 100 M CoCl2 (38-fold) and 100 M MnCl2 (~ 29-fold).  The amount of Bh2271  
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Figure 5.1: Dependence of the initial velocities of LmoDP and Rsp0802 on the presence of Zn.  
The substrate was 0.4 mM L-Leu-D-Ala.   (A) Rsp0802 with various concentrations of Zn in the 
assay.  (B) Rsp0802 incubated with ZnCl2 for 3 hours (blue circles), 24 hours (red circles) and 
24 hours with 5 M ZnCl2 supplemented in the assay (red triangles).  (C) LmoDP with various 
concentrations of ZnCl2 in the assay.  (D) LmoDP incubated with ZnCl2 for 3 hours (blue 
circles), 24 hours (red circles) and 24 hours with 5 M ZnCl2 supplemented in the assay (red 
triangles).  The y-axis of each left plot (A, C) is scaled the same as the plot to its right (B, D).  
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Figure 5.2: Activation of Bh2271 in the presence of various concentrations of ZnCl2, 
CoCl2 and MnCl2 in the enzymatic reaction.  The concentration of the substrate L-Leu-D-
Ala was 0.5 mM.  The condition noted with an asterisk was used in the determination of 
the kinetic constants with dipeptides. 
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protein available was minimal, and although Zn was the metal which was naturally 
present in purified Bh2271, 25 M MnCl2 was added to the assays with this protein 
because it enhanced the activity by ~ 5-fold more than ZnCl2.  Bh2271 was soaked with 
varying equivalents of MnCl2 to determine if increased activity could be obtained 
without the need of higher concentrations in the assay.  However, there was no change in 
the activity of the soaked enzyme between 5 minutes and 20 hours of incubation with 4 
equivalents of Mn.  The enzyme was tested once more with varied concentrations of 
MnCl2 in the assay and at concentrations above 25 M, there seemed to be a point of 
diminishing returns.        
N-terminal Specificity of Rsp0802.  As depicted in Figures 5.3A-C, Rsp0802 had 
a preference for dipeptides with the amino acids L-Leu, L-Met, L-Phe and L-Tyr at the N-
terminus.  The L-Xaa-D-Xaa libraries were hydrolyzed up to 4 times faster than their L-
Xaa-L-Xaa counterparts.  When the N-terminal residue of the dipeptide substrate was a 
D-amino acid, the preferred substrates were still those with hydrophobic side chains, 
namely, D-Met, D-Leu and D-Trp.  Subsequently, the L-Leu-L-Xaa, L-Leu-D-Xaa, L-Met-
L-Xaa and D-Met-L-Xaa libraries were chosen for quantitation of the liberated C-
terminal amino acids by HPLC.  
 N-terminal Specificity of LmoDP.  In contrast to Rsp0802, LmoDP had a marked 
preference for the positively charged N-L-Arg-Xaa and especially N-L-Lys-Xaa 
dipeptide substrates.  LmoDP was also able to hydrolyze other N-L-Xaa dipeptides, but 
clearly rejected those substrates with an N-terminal L-Val, L-Ile, L-Thr, L-Pro, L-Asp and 
L-Glu.  When a D-amino acid was at the N-terminus, N-D-Trp-L-Xaa substrates were 
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Figure 5.3: N-terminal substrate specificity profiles of Rsp0802 (panels A-C), LmoDP (panels D-F) and Bh2271 (panels G-H).  The 
relative k (nM
-1
) values for the hydrolysis of dipeptide libraries from fits of the OD507nm data as a function of enzyme concentration.  (A, D 
and G) red L-Xaa-L-Xaa.  (B, E and H) blue L-Xaa-D-Xaa.  (C and F) olive D-Xaa-L-Xaa. 1
5
7
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hydrolyzed the fastest.  The relative rates of hydrolysis of the 55 dipeptide libraries are 
summarized in Figures 5.3 D-F.  Seven libraries, namely, L-Lys-L-Xaa, L-Lys-D-Xaa, L-
Arg-L-Xaa, L-Arg-D-Xaa, L-Met-L-Xaa, L-Met-D-Xaa and D-Trp-L-Xaa were further 
analyzed for the C-terminal specificity of LmoDP.   
N-terminal Specificity of Bh2271.  The N-terminal specificity profile of Bh2271 
is summarized in Figures 5.3 G-H.  Bh2271 hydrolyzed N-L-Leu-Xaa, N-L-Met-Xaa 
and N-L-Trp-Xaa dipeptides slightly faster than the other libraries given the same 
stereochemistry of Cat the C-terminus.  Bh2271 was not screened with the seventeen 
D-Xaa-L-Xaa libraries because higher concentrations of enzyme are required with these 
libraries and there was a need to conserve limited amount of enzyme sample.  The L-
Leu-D-Xaa and L-Leu-L-Xaa libraries were further examined by HPLC to establish the 
C-terminal preference of the enzyme. 
 C-terminal Specificity of Rsp0802.  The results of the C-terminal specificity 
screens of Rsp0802 against five dipeptide libraries are summarized in Figure 5.4.  For 
all the libraries, dipeptides which contained a Trp, Met, Phe, Tyr or Leu at the C-
terminus were hydrolyzed the fastest relative to the other dipeptides within the same 
library.  However, the L-Xaa-D-Xaa dipeptides were preferred over their L-Xaa-L-Xaa 
counterparts.  The dipeptide which was hydrolyzed the fastest, within the set of 
substrates in these five libraries, was L-Leu-D-Trp.  It is expected that some of the best 
substrates, contained within the dipeptide libraries screened by both methods, are L-Leu-
D-Trp, L-Met-D-Leu, L-Met-D-Trp, and L-Leu-D-Leu.  The substrates L-Met-D-Leu, L-
Leu-D-Leu and L-Tyr-D-Leu were synthesized. 
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Figure 5.4: C-terminal substrate specificity profile of Rsp0802.  The rates of hydrolysis of the selected dipeptide libraries (A) L-Leu-D-
Xaa, (B) L-Met-D-Xaa, (C) L-Leu-L-Xaa, (D) L-Met-L-Xaa and (E) D-Met-L-Xaa were obtained from the slopes of the linear correlation 
between the nmol of liberated C-terminal amino acids (a.a.) as a function of enzyme concentration.  The results presented in panels A-D 
are from 5-hour incubations with enzyme at 30 °C, and in panel E, the incubation time with enzyme was 16 hours under the same 
conditions.   
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Kinetic and Inhibition Constants of Rsp0802.  The kinetic constants for Rsp0802 
with ten selected dipeptide substrates are presented in Table 5.1.  Of the individual 
dipeptides assayed, a catalytic efficiency of ~ 10
5
 M
-1
s
-1
 was observed with the L-Met-D-
Leu substrate (kcat/Km = 1.1 x 10
5
 M
-1
s
-1
).  The Ki of Rsp0802 with the pseudodipeptide 
of Leu-Ala (8) was 130 ± 7 M.   
C-terminal Specificity of LmoDP.  LmoDP was screened for C-terminal 
specificity against seven dipeptide libraries.  As illustrated in Figures 5.5A-C, within the 
three L-D libraries screened (L-Lys-D-Xaa, L-Arg-D-Xaa and L-Met-D-Xaa), dipeptides 
with a C-terminal D-Ala were hydrolyzed the fastest, relative to other N-L-Xaa-D-Xaa 
substrates within the same library.  The screen of four libraries with a C-terminal L-
amino acid (Figure 5.5 D-G) revealed that the specificity was somewhat broad with a 
slight preference for L-Leu, L-Ala and Gly at the C-terminus.  The dipeptide substrate 
which had the fastest observed rate of hydrolysis was L-Lys-D-Ala, followed closely by 
L-Arg-D-Ala.  
Kinetic and Inhibition Constants of LmoDP.  The kinetic constants for LmoDP 
with eleven dipeptides are presented in Table 5.2.  The best of these substrates was L-
Leu-D-Ala (kcat/Km = 1.1 x 10
5
 M
-1
s
-1
).  The phosphinate mimic of Leu-Ala (8) was also 
an inhibitor of LmoDP (Ki = 12 ± 1 M).   
 C-terminal Specificity of Bh2271.  The two libraries L-Leu-L-Xaa and L-Leu-D-
Xaa were treated with Bh2271 under identical conditions.  Bh2271 hydrolyzed L-Leu-D-
Ala the fastest within these two libraries as illustrated by the screening results 
summarized in Figure 5.6.  Within the L-Leu-L-Xaa library, L-Leu-Gly was hydrolyzed 
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Table 5.1: Kinetic constants for select substrates of Rsp0802
a 
 
Substrate kcat, s
-1
 Km, mM kcat/Km M
-1
s
-1
 
L-Met-D-Leu 24 ± 0.3 0.22 ± 0.01 (1.1 ± 0.07) x 10
5
 
L-Tyr-D-Leu 5.2 ± 0.1 0.09 ± 0.01 (5.7 ± 0.3) x 10
4
 
L-Leu-D-Leu 5.2 ± 0.1 0.2 ± 0.01 (2.5 ± 0.2) x 10
4
 
L-Leu-D-Ala 55 ± 3 4.5 ± 0.5 (1.2 ± 0.1) x 10
4
 
L-Leu-D-Ser 76 ± 6 8.3 ± 1 (9.1 ± 1.3) x 10
3
 
L-Ala-D-Ala   (2.2 ± 0.1) x 10
3
 
L-Leu-D-Glu   (1.0 ± 0.02) x 10
3
 
L-Met-D-Glu   (9.5 ± 0.02) x 10
2
 
L-Arg-D-Asp   (9.6 ± 0.02) x 10
2
 
L-Arg-L-Asp   (1.9 ± 0.1) x 10
2
 
 
a
From fits of the data to equation 2.  For those entries without values of kcat and Km, 
saturation was not achieved at concentrations up to 10 mM. 
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Figure 5.5: C-terminal substrate specificity profile of LmoDP.  The rates of hydrolysis of the selected dipeptide libraries (A) L-Lys-D-Xaa, 
(B) L-Arg-D-Xaa, (C) L-Met-D-Xaa, (D) L-Lys-L-Xaa, (E) L-Arg-L-Xaa, (F) L-Met-L-Xaa and (G) D-Trp-L-Xaa were obtained from the 
slopes of the linear correlation between the nmol of liberated C-terminal amino acids (a.a) as a function of enzyme concentration.  The 
results presented in panels A-F are from 3.5-hour incubations with enzyme at 30 °C, and in panel G, the incubation time with enzyme was 
16 hours under the same conditions.  
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Table 5.2: Kinetic constants for select substrates of LmoDP
a 
 
Substrate kcat, s
-1
 Km, mM kcat/Km M
-1
s
-1
 
L-Leu-D-Ala 29 ± 0.6 0.27 ± 0.02 (1.1 ± 0.1) x 10
5
 
L-Leu-D-Ser 41 ± 1 1.1 ± 0.1 (3.6 ± 0.3) x 10
4
 
L-Arg-Gly 89 ± 4 2.9 ± 0.3 (3.1 ± 0.4) x 10
4
 
L-Met-D-Leu 98 ± 9 3.2 ± 0.3 (3.1 ± 0.3) x 10
4
 
L-Ala-D-Ala 58 ± 2 2.0 ± 0.2 (2.8 ± 0.2) x 10
4
 
L-Met-D-Glu 30 ± 2 2.6 ± 0.3 (1.2 ± 0.2) x 10
4
 
L-Tyr-D-Leu 3.8 ± 0.2 2.2 ± 0.2 (1.7 ± 0.2) x 10
3
 
L-Leu-D-Leu 112 ± 5 16 ± 1 (6.9 ± 0.6) x 10
3
 
L-Arg-D-Asp 42 ± 5 5.9 ± 1.2 (7.0 ± 1.7) x 10
3
 
L-Arg-L-Asp 1.3 ± 0.04 13 ± 1 (1.1 ± 0.08) x 10
2
 
L-Ala-L-Asp 0.07 ± 0.002 17 ± 1 (4.2 ± 0.3) x 10
0
 
 
a
From fits of the data to equation 2.   
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the fastest, followed by L-Leu-L-Ala.  Based on these results, the best substrates for 
Bh2271 were anticipated to be L-Leu-D-Ala, L-Met-D-Ala and L-Trp-D-Ala.   
Kinetic Constants of Bh2271.  The kinetic constants for Bh2271 with 8 
dipeptides are presented in Table 5.3.  The best substrate was L-Leu-D-Ala (kcat/Km = 7.4 
x 10
4
 M
-1
s
-1
).  At one time a status report showed that Bh2271 was at the stage of 
optimization of crystals, but work on Bh2271 was stopped by NYSGXRC.  The 
crystallographers in Dr.  teve Almo’s lab were not in possession of the Bh2271 protein.  
Since Bh2271 would not be crystallized by the time of the completion of this 
manuscript, the enzyme was not assayed for the inhibition constants with the 
phosphinate compounds. 
Structure of Rsp0802.  The native crystal structure of Rsp0802 (PDB code 
3FDG) was solved by the Midwest Center for Structural Genomics to 1.8 Å with two 
Mg bound in the active site.  Here, the 1.4 Å resolution X-ray crystal structure of 
Rsp0802 (PDB code 3LY0) is presented in complex with a pseudodipeptide mimic of L-
Ala-D-Ala (7) and two Zn ions (M and M) bound in the active site.  Compound 7 was a 
mixture of four possible enantiomers but both chiral centers in the molecule bound in 
Rsp0802 were in the R configuration.  The (/)8 barrel structure of the ligand-bound  
Rsp0802 is illustrated in Figure 5.7.   
There are two insertion regions within the core sequence which makes up the 
(/)8 barrel.  The first of these regions is inserted between the second -strand, 2, and 
second alpha-helix, 2, of the barrel.  Insertion 1 is not observed in hRDP and its other  
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Figure 5.6: C-terminal substrate specificity profile of Bh2271.  The rates of hydrolysis of the 
selected dipeptide libraries (A) L-Leu-D-Xaa and (B) L-Leu-L-Xaa were obtained from the slopes 
of the linear correlation between the nmol of liberated C-terminal amino acids (a.a) as a function 
of enzyme concentration.  Both libraries were incubated with Bh2271 for 18 hours at 30 °C. 
  
166 
 
 
Table 5.3: Kinetic constants for select substrates of Bh2271
a 
 
Substrate kcat, s
-1
 Km, mM kcat/Km M
-1
s
-1
 
L-Leu-D-Ala 85 ± 3 1.1 ± 0.1 (7.4 ± 0.6) x 10
4
 
L-Met-D-Glu 83 ± 2 1.4 ± 0.1 (5.7 ± 0.5) x 10
4
 
L-Leu-D-Ser 83 ± 4 1.5 ± 0.1 (5.4 ± 0.6) x 10
4
 
L-Ala-D-Ala 157 ± 7 3.5 ± 0.4 (4.5 ± 0.6) x 10
4
 
L-Leu-D-Glu 50 ± 0.7 1.8 ± 0.06 (2.9 ± 0.1) x 10
4
 
L-Met-D-Leu 99 ± 4 7.4 ± 0.6 (1.3 ± 0.1) x 10
4
 
L-Leu-D-Leu 25 ± 0.5 7.0 ± 0.3 (3.5 ± 0.2) x 10
3
 
L-Tyr-D-Leu 17 ± 1 11 ± 1 (1.5 ± 0.2) x 10
3
 
 
a
Assayed in the presence of 25 M MnCl2. 
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Figure 5.7: Ribbon diagram of the Rsp0802 dimer (PDB code 3LY0).  The (/)8-barrel is 
colored red (-helices and loops) and blue (-strands).  Insertion region 1, which contains active 
site residues (61-84), is colored teal and black.  The residues which were not defined in the PDB: 
3FDG structure (61-65) are colored black.   Zn ions are represented as green spheres.  The C-
terminal -helix (pink) and the region inserted between 2 and 3 of the (/)8-barrel (yellow) 
are also colored.   
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microbial homologues of known structure (PDB codes 3K5X, 2RAG, 1ITU).  The 
structure of part of insertion 1, namely residues 61-75 and 61-65 in different subunits 
from the PDB:3FDG coordinates, was undefined in the native structure but was resolved 
in the inhibitor-bound structure presented here.  Another insertion is also present in all 
known structures of proteins in cog2355 and is located between 2 and 3.   Insertion 1 
is colored red and black in the ribbon diagram (Figure 5.7).  The ordered loop at the N-
terminus of insertion 1 consists of residues Gln-61, Ala-62, His-63, Asp-64 and Ala-65.  
Gln-61 is within hydrogen-bonding distance to His-67 from the -helix of insertion 1.  
The N

 of H63 is 2.8 Å from the hydroxyl group of Tyr-56, and Asp-64 forms a salt 
bridge with Arg-20.  The insertion between 7 and 7, observed in Sco3058 and Cc2746, 
is not present in Rsp0802.   
The binuclear metal center within the native Rsp0802 structure (PDB code 
3FDG) is shown in Figure 5.8A.  The two metals, M and M, are bridged by the 
catalytic water molecule and Glu-137 from -strand 3.  The ligands exclusive to M are 
His-11 and Asp-13 from -strand 1 and a water molecule.  His-210, His-231 and two 
water molecules are ligands to M.  The Zn and Zn ions in the Rsp08027 complex 
(Figure 5.8B) ligate to the same residues as in the unbound structure, but moieties of the 
L-Ala-D-Ala mimic (7) replace the water molecules.  Zn is ligated to the -amino group 
of the dipeptide mimic, and Zn is coordinated to one of the phosphinate oxygens and 
the -carboxylate of the inhibitor.  The other phosphinate oxygen bridges the two Zn  
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Figure 5.8: Metal center and active site of Rsp0802 in the presence and absence of inhibitor.  
The Zn and Zn metals are green spheres.  The carbon atoms of Rsp0802 (gray) and 
pseudodipeptide (7) mimic of L-Ala-D-Ala (gold carbons) are colored differently.  (A) Native 
structure (PDB code 3FDG).  (B) Metal center of the inhibitor (7) complex.  (C) Other polar 
contacts between the inhibitor and Rsp0802 are represented as dashed lines with distances noted 
in Å.  Distances already shown in panel B are not repeated in panel C. 
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ions.  In both structures, the two metals appear to be hexacoordinate with square 
bipyramidal geometry, though the geometry of Zn is distorted. 
The active site of the Rsp08027 complex is presented in Figure 5.8C.  The -
amino group of 7 is recognized by contacts to Zn (2.3 Å) and the side chain carboxylate 
of Asp-13 (3.1 Å to each oxygen).  The N

 and N

 nitrogens of Arg-242 associate with 
both oxygens of the -carboxylate of 7 at distances of 2.7 and 3.0 Å, respectively.  One 
phosphinate oxygen bridges Zn (2.2 Å) and Zn (2.4 Å) and is also 2.7 Å from the 
catalytic Asp-304 which contacted the bridging water in the native structure.  The 
second phosphinate oxygen has polar interactions with Zn (2.2 Å) and Trp-164 (2.7 Å).  
The inhibitor has a total of eleven polar contacts at distances of 2.2-3.1 Å.  
 Active Site Pocket of Rsp0802.  The surface of the active site pocket of Rsp0802 
is shown in Figure 5.9A and 5.9B from the outside of one face and in Figure 5.9C and 
5.9D as a cross section.  One face of the active site is composed of the metal-binding 
ligands (green side chains, Figure 5.9A and C).  The hydrophobic pocket surrounding 
C of the side chain of the L-Ala moiety of the inhibitor (blue side chain surfaces, Figure 
5.9A and C) is formed from C of Gly-307 and the side chains of Tyr-56, His-63, Leu-
16 and Trp-164.  The -amino group, C and C of the N-terminal region of (7) is 
completely encapsulated within 6 Å from the C carbon.  Figures 5.9A and 5.9C are 
repeated in Figures 5.9B and 5.9D, respectively, with the surface colored by element.  
The hydrophobic pocket for the side chain of the C-terminal amino acid is mainly 
composed of the side chains of Met-72, Phe-176, Ala-264, Phe-267 and Ala-308.  
171 
 
 
 
 
Figure 5.9: Surface and stick figure depictions of the Rsp0802 substrate binding pockets.  (A 
and C) Surfaces of side chains of the catalytic aspartate (Asp-304, red), Zn ligands (91) other 
than Asp-13, residues for the pocket of the N-terminal half of a dipeptide (blue), residues for the 
pocket of the C-terminal half of the substrate (purple) and atoms with polar contacts to 7 
(yellow) are color coded.  All other atoms are colored gray.  (C) Cross-section of panel A.  (B) 
Same as panel A with all atoms colored by element (blue nitrogens, red oxygens, yellow sulfur, 
gray carbons).  (D) Same as panel C with all atoms colored by element.  (E) Side chains of 
residues are color-coded to match panels A and C.  Those heteroatoms whose identities are not 
intuitive are colored by element. 
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Structure of LmoDP8 Complex.  The X-ray crystal structure of LmoDP 
complexed with two Zn ions and the phosphinate dipeptide mimic of L-Leu-D-Ala (8) 
was solved to 1.6 Å.  Like 7 in the Rsp08027 complex, both of the chiral centers of 
inhibitor 8 identified in LmoDP active site were in the R configuration.  The 
homodimeric structure of LmoDP is depicted in Figure 5.10A; Asp-269 faces in toward 
the active site of the opposing chain (red in Figure 5.10A).  A salt bridge (3.9 Å) was 
identified between Lys-270 and Glu-145 from opposite subunits.  The backbone 
carbonyl of Asn-232 and N

 of His-201 from opposing chains were 2.8 Å apart.  
The active site contains two pentacoordinate Zn ions with a distorted trigonal 
bipyramidal geometry that are bridged by the bidentate carboxylate side chain of Glu-
105 as well as one of the phosphinate oxygens of 8.  The binuclear metal center is 
depicted in Figure 5.10B.  The Zn ion is coordinated to His-7 and both of the side 
chain oxygens of Asp-9.  The coordination sphere of Zn is completed by the non-
bridging phosphinate oxygen of 8, and the side chains of His-172 and His-192 from -
strands 5 and 6, respectively.     
 The free amino group of 8 is recognized by Asp-9 and Zn at distances of 3.1 and 
2.7 Å, respectively.  The -carboxylate is ion-paired with N and N of Arg-203, both at 
distances of 2.9 Å, and is 2.8 Å from Zn.  The phosphinate oxygen which contacts Zn 
is also 2.6 Å from N

 of Trp-132 (Trp4), whereas, the other phosphinate oxygen is 2.8 Å 
from the catalytic Asp-261 from -strand 8.  Contacts to the inhibitor not shown in 
Figure 5.10B are depicted in Figure 5.10C. 
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Figure 5.10: Representations of the LmoDP structure and its active site binuclear metal center 
complexed with inhibitor.  (A) Surface representation of the LmoDP dimer with chains A and B 
colored gray and pink, respectively.  The active site pockets (chain A) for the N- and C-terminal 
sides of a dipeptide are colored blue and purple, respectively.  Asp-269 from chain B is colored 
red.  (A and B) The inhibitor (gold carbons, orange phosphorus), Zn/Zn (green spheres) are 
colored the same.  Polar contacts are indicated by dashed lines with distances noted in Å.  (B) 
Binuclear metal center of LmoDP with inhibitor 8 bound.  Those distances not labeled are 2.0-
2.2 Å. (C) Polar contacts between LmoDP and the inhibitor.  The dashed lines in panel C which 
are not labeled in panels B or C represent contacts of 2.6-2.9 Å.  
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Figure 5.11: Surface and stick representations of the LmoDP substrate-binding pockets.  The 
side chains of residues which make up the pockets for the N- and C-terminal sides of a dipeptide 
substrate are colored blue and purple, respectively.  The catalytic Asp-261 is colored red.  The 
pocket residue from the opposite chain is noted with an asterisk. (A) and (B) Surface 
representation of the LmoDP active site pockets with inhibitor (gold carbons, orange 
phosphorus) and two zincs (black spheres).  Sections behind the clipped plane are shown with a 
flat mesh surface.  Atoms of residues which make polar contacts to the inhibitor are colored 
yellow.  Some residues are labeled to orient the reader.  (A) Focus on the pocket for the N-
terminal L-amino acid side chain of the substrate.  (B) Highlight of the pocket for the C-terminal 
side chain of the substrate.  The only visible parts of the inhibitor are the methylene group, -
carboxylate and the methyl group which represents a D-alanine side chain.  (C) Residues colored 
in panels A & B where atoms whose identities are not intuitive are colored by element.  
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A surface representation of LmoDP near the active site is shown in Figure 
5.11A-B, and stick figures of the residues colored in Figure 5.11A-B are labeled in 
Figure 5.11C.  The crevice which makes up the pocket for the side chain of an N-
terminal L-amino acid of a dipeptide is framed by C of Gly-264 and the side chains of 
Tyr-12, Phe-49, Asp-51 and Trp-132.  The more solvent-exposed pocket for the side 
chain of the C-terminal end of the substrate is composed mainly of the side chains of 
Asn-133, His-201, Tyr-225, Leu-227, Phe-228 and Ile-265.  
Overlay of Rsp0802, LmoDP and Lmo2462.  The coordinate files for Rsp0802 
(PDB code 3LY0) and LmoDP (PDB code 3NEH) were opened together.  Residues 59-
91/165-189 of Rsp0802 and 54-61/135-153 in LmoDP were deleted.  The two truncated 
structures were superimposed using the MatchMaker tool in Chimera.  The coordinates 
for the non-truncated structures were loaded into the same file and overlayed onto their 
respective truncated structures using MatchMaker.  
 Prior to the release of the LmoDP structure, the 2.2 Å resolution structure of 
native Lmo2462, which deviates from LmoDP sequence by 11 out of 308 residues, was 
deposited into the Protein Data Bank (PDB code 3LU2) by the Center for Structural 
Genomics of Infectious Diseases.  Lmo2462 and Bh2271 both have a histidine (His-225 
in Lmo2462, His-224 in Bh2271) instead of Tyr-225 observed in LmoDP.  In order to 
represent Bh2271, the Lmo2462 structure was superimposed onto the Rsp0802/LmoDP 
overlay using LmoDP as the reference structure.  The residues in Lmo2462 were then 
changed to those from the Bh2271 sequence.  The active site of the overlay of these 
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Figure 5.12:  Overlay of active sites of LmoDP, Lmo2462 and Rsp0802 with residues in 
Lmo2462 changed to residues found in Bh2271.  The carbons and residue labels from LmoDP 
(gray), Lmo2462 (purple) and Rsp0802 (light blue) are color coded.  The L-Leu-D-Ala 
phosphinate mimic (8) (gold carbons, orange phosphorus) and two Zn ions (green spheres) from 
the LmoDP structure are also shown.  Those residues which have been changed to match those 
in Bh2271 are marked by an asterisk. 
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three structures is shown in Figure 5.12 with a similar orientation to Figures 5.11A and 
5.11C. 
DISCUSSION 
 Amino Acid Sequence Alignment.  An amino acid sequence alignment of 
Sco3058 and five other amino sequences from cog2355 is presented in Figure 5.13.  The 
amino acid sequences originate from R. sphaeroides (Rsp0802), L. monocytogenes strain 
serotype 4b (LmoDP), B. halodurans (Bh2271), A. calcoaceticus (AcDP, gi|1088400), 
B. borstelensis (BCS-1, gi|9719426), Lysinibacillus sphaericus (Bsph4282, 
gi|169829713) and S. coelicolor (Sco3058, gi|21221500).  In 2008, the genome sequence 
of L. sphaericus (formerly Bacillus sphaericus) was released and found to contain a gene 
which codes for a member of cog2355 (gi|169829713), namely Bsph4282.  The 
calculated molecular weight of Bsph4282 is 34 kDa.  A dipeptidase with an estimated 
molecular weight of 38 kDa (by SDS-PAGE) was isolated from B. sphaericus, but no 
part of the protein was sequenced (92).  It is not known as to whether the isolated protein 
was Bsph4282, but Bsph4282 was included in the alignment for the purpose of 
discussion.   
 Substrate Specificity of Rsp0802, LmoDP and Bh2271.  The three dipeptidases 
Rsp0802, LmoDP and Bh2271 were successfully purified by NYSGXRC, but the 
enzymes had less than optimal metal content.  The activity of the enzymes increased 
with the presence of Zn, Co and Mn in the assay.  The activity of LmoDP and Rsp0802 
could be enhanced by pre-incubating the enzymes with ZnCl2, without the need for  
  
 
1         2              Insertion 1 
Rsp0802   ---------MTETIPVFDGHNDFLLRLLRNP---ANRETIWLKGDGTGHLDLPRMKEGGFAGGFFAIYVPSPQAHDAAHFEAMMDAPPFELPLPPMIRAEQAQ 
LmoDP     -------------MRVIDTHCDALYKLQA------GKGKYTFQDAEELDVNFERLIEAKMLLQGFAIFLDED------------------------IPVEHKW 
Bh2271    -------------MRIFDAHCDALLKLWE-------DPAREYTDDPAIEANAVRLMEGGVRAQCFAIFVGPN------------------------IPFDQKF 
AcDP      --------MKPSHIPVFDGHNDALTRLWLSDH--ADPVHAFLHERLAGHLDLKRCQQAGFVGGMFAIFLPPFSYVQQHHSNKLFDQDATDFTQQ---QIEQIC 
BCS-1     -------------MNIIDFHCDALYKMWK------SKEPLSFRDSAELHTNLERLKQGRVKLQCFALYVPPQ------------------------LKSEQQF 
Bsph4282  -------------MNIIDLHCDALLKLTT-------LEAASFAEDVRMHVNHKRLQLGQIKAQVFAIFIDPE------------------------IPQNQQF 
Sco3058   MTSLEKARELLREFPVVDGHNDLPWALREQVRYDLDARDIAADQSAHLHTDLARLRSGGVGAQYWSVYVRS--------------------------DLPGAV 
 
                                                      3                          4                             
Rsp0802   PVALAMAGHLLWMERAARGRFKVCRTAAEVRSCHADGIVSGIMHMEGAEAIGADLDALHLFHSLGLRSLGPVWSRPTVFGHGVPFRFPGSPDTGEGLTEAGRR 
LmoDP     KKAVEQVNIFKQHVLHKGGIIHHVKKWCDLENLPED-KIGAMLTLEGIEPIGRDLDKLTQLLDGGVLSVGLTWNNANLAADGI------MEERGAGLTRFGKD 
Bh2271    QVALQQAELFHEKILKKHPQFSFIERWDDLLTLDAD-QIGAILTLEGADPFGDDPTKLKTLYRLGVRSLGLTWNQANLCADGV------GEPRGGGLTEWGKA 
AcDP      LEQLDIAHQLAQRS----TDIQICTSVQDIQSCVNTQKLGIVLHMEGAEALQQNSDLLDVFYDRGLRSIGPLWNRPSLFGHGLNAKFPHSPDTGAGLTQDGKA 
BCS-1     QAVLDQIDYFYEEVLKQ-PEMKHVKEWADLDTLGDG-EIGAMLTLEGVDAIGNDLKKLRILFQLGVRSVGLTWNFANLAADGA------LEKRNAGLTAFGKE 
Bsph4282  LEVIRQMEAFHTHVLQTEG-MVHITDWAQLELLAPH-EIGAILSLEGCGAIGEDLTKLTAVLDAGVKLVGLTWNEENAVAHGA------EQEASLGLKPFGKE 
Sco3058   TATLEQIDCVRRLIDRHPGELRAALTAADMEAARAEGRIASLMGAEGGHSIDNSLATLRALYALGVRYMTLTHNDNNAWADSAT-----DEPGVGGLSAFGRE 

56                               7      Insertion 2 
Rsp0802   LVAECNRLKIMLDLSHLNEKGFDDVARLSDAPLVATHSNAHAVTPSTRNLTDRQLAMIRESRGMVGLNFATSFLREDGRRS---------------------- 
LmoDP     IIHLLNERKVFTDVSHLSVKAFWETLEQAEFVIAS-HSNAKAICSHPRNLDDEQIKAMIEHDAMIHVVFYPLFTTNNG------------------------- 
Bh2271    VVSLNNEHHVLTDVSHLSERGFWDVIEYAQFPVAT-HSNAKAICKHRRNLTDAQLKALIEAGGFIGIVFHPHFLTGTD------------------------- 
AcDP      FIKRCADKKMVIDVSHMNEQAFWDTVDLLQQPIVATHSNAHALCPQARNLTDQQLKAIRESKGIVGVNFDVAFLRSDGQRN---------------------- 
BCS-1     IVRLNNEHKVLTDVSHLCEQSFWDVMELADYPIAS-HSNARAICDHPRNLYDEQAKAMFDKGGMIHIVYYPHFVKKGG------------------------- 
Bsph4282  VIQILNDRDIIIDVSHLNEQSFWDVLPLAKHIIAS-HSNARALCDHPRNLTDAQAKALVKHGGHIHVVYFPLFISEQ-------------------------- 
Sco3058   VVREMNREGMLVDLSHVAATTMRDALDTSTAPVIFSHSSSRAVCDHPRNIPDDVLERLSANGGMAMVTFVPKFVLQAAVDWTAEADDNMRAHGFHHLDSSPEA 
 
8            
Rsp0802   -------------AEMGWEPVLRHLDHLIDRLGEDHVGMGSDFDGA-TIPQGIADVTGLPALQAAMRAHGYDEPLMRKLCHENWYGLLERSWGA--------- 
LmoDP     --------------VADTEDVIRHIDHICELGGLKNIGFGSDFDGIPDHVKGLEHVGKYQSFLETLEKH-YTKEEIEGFASRNFLNHLPK------------- 
Bh2271    --------------DASIDDVMKHIEHICSLGGQKHVGFGSDFDGIPCFVDGLEHAGRFQWFMDELLKR-YDEELVRGFAWDNFLKATPISYV---------- 
AcDP      -------------ANTSIDVILDHLDYLLDRLGEEHVAFGSDFDGA-LIGTELEDVMGLHKLIHRMQQRAYSSELIEKLCFTNWINVLYRILGE--------- 
BCS-1     --------------QATIDDLIRHIDHFCSLGGVRQIGLGSDFDGIESFVEGLEHAGMIDNLLNELLKR-YSESEVRGFASENFLQRRPR------------- 
Bsph4282  --------------DATLEQLVDHVEHLAHLVGVEHIGLGSDFDGIGVTVKGLAHAGEAQNLLEALRTR-FSAEEVQGIASQNFKRYVKKAATR--------- 
Sco3058   MKVHAAFEERVPRPVATVSTVADHLDHMREVAGVDHLGIGGDYDGTPFTPDGLGDVSGYPNLIAELLDRGWSQSDLAKLTWKNAVRVLDAAEDVSRGLRAARG 
 
Figure 5.13:  Amino acid sequence alignment of Sco3058 (residues 1-381) and select proteins from clusters 2 and 3 within cog2355.  The 
metal ligands and catalytic aspartate are colored black.  The residues which make up insertion region 1 (colored teal in the dimer figure) 
only observed in Rsp0802, are underlined.  The second insertion region between 7 and 7 of Sco3058 not observed in LmoDP, Rsp0802 
or hRDP is colored brown.  Inhibitor-contacting (red), N-terminal substrate pocket (medium blue), C-terminal substrate pocket (purple) 
residues and -strands (light blue) are colored coded.  Other conserved residues are colored gray.  Predicted active site residues are 
colored yellow.  The 8-loop has bold underlining and the residue which contacts the backbone of the 8-loop is indicated by an arrow. 
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additional ZnCl2 in the assay.  The substrate specificity profile of three microbial 
dipeptidase homologues to the human renal dipeptidase, namely, Rsp0802, LmoDP and 
Bh2271, were assessed with dipeptide libraries.  All three dipeptidases hydrolyzed a 
large fraction of the dipeptide substrates within the libraries but there were subtle 
differences in their N- or C-terminal specificities.  Their main commonality with respect 
to substrate specificity was the general preference for an L-amino acid at the N-terminus 
and a D-amino acid at the C-terminus of the substrate. 
 The N-terminal specificity of LmoDP varied from Rsp0802 and Bh2271 in that 
LmoDP preferred the positively charged residues L-Arg and L-Lys at the N-terminus.  
Rsp0802 and Bh2271 were more similar in their N-terminal preference in that they were 
less specific than LmoDP and showed only a minor preference for the hydrophobic L-
amino acids.  With respect to the preference at the C-terminus of the substrate, LmoDP 
and Bh2271 were more similar and hydrolyzed dipeptides with a C-terminal D-Ala faster 
than other components of L-Xaa-D-Xaa libraries.  This was in contrast to Rsp0802 which 
had a preference for hydrophobic D-amino acids at the C-terminus of the dipeptide 
substrates. 
 Substrate Specificity Determinants of Rsp0802.  In following the trend observed 
for Sco3058, residues that follow 1 (Leu-16) and 2 (Tyr-56) contribute to the pocket 
for the N-terminal L-amino acid side chain.  The side chains of multiple residues 
immediately after 7 (Ala-264, Ser-266 and Phe-267) face into the active site pocket for 
the C-terminal amino acid.  Two residues which contribute to the pockets for both the N- 
and C-terminal side chains of a dipeptide are located within insertion region 1 (His-63 
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and Met-72).  Also, the loop following 4 in Rsp0802 is longer than in Sco3058 and 
adds Phe-176 to the substrate pocket. 
 The structure of Rsp0802 helps explain the poor affinity of the A. calcoaceticus 
dipeptidase (AcDP) for the dipeptide L-Leu-D-Leu.  As shown in the alignment in 
Figure 5.13, the residue which follows 7 (Ala-264 in Rsp0802 and Tyr-225 in LmoDP) 
and contributes to the C-terminal D-amino acid side chain pocket, is an aspartate in 
AcDP (Asp-259 yellow and underlined in the alignment).  The methyl group of Ala-264 
is 4.6 Å from the methyl group of 7 which is representative of the side chain of D-Ala at 
the C-termini of a dipeptide.  The kcat, Km and kcat/Km values for AcDP with Leu-D-Leu 
were 0.6 s
-1
, 9.3 mM and 66 M
-1
s
-1
, respectively.  All of the L-D dipeptides tested with 
AcDP had a C-terminal D-Ala, D-Leu or D-Phe.  Given the same N-terminal glycine, the 
order of specific activity was Gly-D-Ala ≈ Gly-D-Leu > Gly-D-Phe (76).  The poor 
turnover of AcDP may have been due to protein damage as AcDP does not appear to be 
missing any critical residues. 
 Substrate Specificity Determinants of LmoDP.  The surface of LmoDP within ~ 
10 Å of the two representative C carbons of 8 is shown in Figures 5.11A and B.  A 
majority of the pocket immediately surrounding the N-terminal C are the side chains of 
Asp-51, the hydrophobic residues Phe-49, Trp-132 and the aromatic ring of Tyr-12.  The 
C–C/C–C/C–C bonds of L-Lys were overlayed onto the equivalent bonds of the 
mimic of an L-Leu side chain from 8.  This model of L-Lys at the N-terminus reveals 
that there are rotomers of lysine which allow the amino group of the L-Lys side chain to 
come within hydrogen-bonding distance to the phenolic oxygen of Tyr-12 (2.8 Å) and 
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the side chain carboxylate of Asp-51 (2.6 Å ).  The presence of the acidic Asp-51 residue 
at the perimeter of the active site and the hydrophobic nature of the N-terminal side 
chain pocket should not be conducive to allowing in dipeptides with an aspartate or 
glutamate at the N-terminus.   
 There is another example of a microbial dipeptidase in the literature which seems 
to have a preference for dipeptides with an N-terminal L-Lys.  This enzyme was isolated 
from B. sphaericus, but the protein sequence was not determined.  The enzyme had been 
assayed with a small set of dipeptides at single substrate concentrations of either 0.4 or 2 
mM.  The dipeptides L-Lys-Gly and L-Lys-D-Glu were hydrolyzed faster than the 
dipeptides L-Ala-Gly, L-Leu-Gly and L-Ala-D-Glu.  When the C-terminal amino acid 
was changed to D-Glu, an N-terminal L-Lys was preferred over L-Ala by 4-fold (92).  
The genome sequence of B. sphaericus (Lysinibacillus sphaericus C3-41) has now been 
sequenced.  When a BLAST search of the LmoDP amino acid sequence was conducted 
against the B. sphaericus genome, a hit to the protein Bsph4282 was obtained.  These 
two proteins share 45 % amino acid sequence identity.  The trend of the N-terminal 
amino acid preference in the order of L-Ala < L-Leu < L-Lys is similar to that seen in 
Figure 5.3D-E.  Coincidentally, Bsph4282 also has the equivalent residue to Asp-51 in 
LmoDP.  The difference between the activity of LmoDP and the dipeptidase from B. 
sphaericus was the lack of L-Xaa-L-Xaa hydrolysis activity for the B. sphaericus 
enzyme. 
 The reason for the rejection of dipeptides with an N-terminal isoleucine, 
threonine or valine by LmoDP is not inherently obvious.  The space directly about C 
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may be just a little small to accommodate an R-group off of this atom.  It proved 
difficult to find a conformation of N-L-Ile, N-L-Val- or N-L-Thr where the side chains 
did not clash with the backbone of the inhibitor or with one or more of the residues Trp-
132, Phe-49, Asp-9 or Gly-264. 
 The binding pocket of LmoDP is shallow and more exposed to the solvent in 
comparison to that of Rsp0802, likely owing to the absence of insertion region 1.  
Though dipeptides with an N-terminal L-Lys were hydrolyzed the fastest, it is not 
surprising that the preference was not overwhelming. The Asp-51 residue following 2 is 
the residue which is most likely the source of the preference for L-Lys and L-Arg at the 
N-terminus of the substrate.  Ile-265, and especially Tyr-225, cause the pocket for the C-
terminal D-amino acid side chain to be small and hydrophobic; L-Xaa-D-Ala is preferred 
over other L-Xaa-D-Xaas dipeptides.  
 Substrate Specificity Determinants of Bh2271.  An overlay of Rsp0802, LmoDP 
and a hypothetical active site of Bh2271 (based on the structure of Lmo2462) is shown 
in Figure 5.12.  It is not surprising that Bh2271 and Rsp0802 behaved similarly with 
respect to their preference of the N-terminal amino acid side chain of a dipeptide.  The 
ordered loop in Rsp0802 (residues 61-65) does close off the active site around the N-
terminal L-amino acid side chain, but the position that this loop takes could vary for 
larger amino acid side chains.  The N-terminal side chain pocket of Bh2271 should be 
more open and neutral because it has Gly-50 following 2 (Gly-50) instead of Asp-51 in 
LmoDP and as well as Leu-16 instead of Tyr-12 in LmoDP.   
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 The L-Leu-Gly substrate was preferred over any L-Leu-L-Xaa substrate with L-
Leu-L-Ala being the next best substrate.  The reason for this is not clear.  In LmoDP, the 
aspartate from the opposing chain faced into the active site, but was too far to be 
considered a potential substrate-contacting residue for dipeptides with the standard 20 
amino acids.  Perhaps a similar phenomenon occurs with Bh2271, but with a greater 
impact on the substrate binding pocket.   
 The residues expected to surround the D-amino acid side chain of the C-terminal 
amino acid are the equivalent residues to Ile-265/Phe-228 in LmoDP and His-224 (Tyr-
225 in LmoDP).  The substrate specificity with respect to the C-terminal amino acid 
would be similar since the pocket is small.  Given the presence of the His-224 residue in 
Bh2271 it was a little surprising that L-Leu-D-Ser was not preferred over L-Leu-D-Ala in 
the screen or with the individual dipeptide; His-224 appears to be reasonably positioned 
to be within hydrogen bonding distance of a D-Ser side chain.    
   Trp4 vs. His4 and 2-Tyr vs. 2-Phe.  From the values in Tables 5.1 and 5.2, 
Rsp0802 with a 2-Tyr (Tyr-56) does not appear to be a better dipeptidase than LmoDP 
which has a 2-Phe (Phe-49).  The kinetic parameters shown in Tables 5.1 and 5.2 
reveal that kcat/Km values for LmoDP and Rsp0802 (on the order of 10
5
 M
-1
s
-1
) are on a 
par with Sco3058, Gox2272 and Cc2746, despite the fact that they have a Trp4 instead 
of His4.  The pH profiles hRDP and Sco3058 have both shown an increase in activity up 
to pH ~ 7.5-8  and a decrease in activity above pH ~7.5-8.5 (80, 93).  The decrease in 
activity could be due to the deprotonation of the free amino group of the substrate or the 
His4 residue.  In contrast to hRDP and Sco3058, the BCS-1 enzyme with a Trp4 residue 
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was described as having optimal activity in the range of pH 8.5-10 (49).  If activity loss 
at higher pH is due to the deprotonation of His4, it may be more beneficial to have a 
tryptophan at this position in order to broaden the pH optima of the enzyme.  In fact, 
Trp4 is more common among the microbial members of cog2355 than His4. 
 Genome Context of cog2355-Cluster 2.  The more strict N-terminal specificity of 
LmoDP for L-Lys/Arg is thought to be due to Asp-51.  However, there was not a 
common factor among the genome context of LmoDP and other proteins throughout 
cog2355 with an aspartate at this position.   
Genome Context of cog2355-Cluster 3.  There are 45 amino acid sequences in 
Cluster 3 of cog2355 (Figure 3.8).  The genes adjacent to members of cluster 3 in the 
microbial genomes are commonly annotated as transporters of dipeptides, peptides, 
oligopeptides, opines and amino acids.  The only known biosynthetic pathway associated 
with proteins from Cluster 3 is for the biosynthesis of the cofactor pyrroloquinoline 
quinone (PQQ).  The biosynthesis of PQQ has been described to involve up to six genes, 
namely pqqABCDEF.  The synthesis of PQQ begins with C―C bond formation between 
C of an L-glutamate and C of an L-Tyr side chain; all of the carbon nitrogen atoms of 
PQQ come from glutamate and tyrosine (94).   
The glutamate and tyrosine residues are present as part of a peptide, coded for by 
the pqqA gene, which is ~ 23-40 amino acids long, and three amino acids link the 
glutamate and tyrosine.  However, pqqA is not required for PQQ synthesis in 
Methylobacterium extorquens and examination of the genome contexts of organisms 
which putatively have this gene cluster revealed that the pqqA gene is sometimes slightly 
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separated from the rest of the cluster or no gene in the genome is annotated as pqqA (95).  
E. coli is not a PQQ-producing organism, but it can synthesize PQQ when supplied with 
a plasmid containing the pqqABCDE operon genes from Gluconobacter oxydans 621H 
(96).  Inspection of the genome contexts of 43 proteins within Cluster 3 of cog2355, 
showed that nine members were near, and more often than not, tightly clustered with the 
pqq genes.   
In the Rhodobacter sphaeroides species, there are 8-9 genes between the pqq 
genes and the cog2355 dipeptidase, but there is not a protein annotated as pqqF.  
Similarly, in Mycobacterium smegmatis and Geodermatophilus obscurus, there are 4-5 
genes between the cog2355 dipeptidase and the pqqABCDE cluster (no pqqF).  It has 
been suggested that the pqqF protein is a peptidase which functions to hydrolyze the rest 
of the pqqA oligopeptide from the fused Tyr-Glu residues.  Using the amino acid 
sequence from the pqqC gene of Klebsiella pneumoniae as a seed sequence, the pqq 
genes in M. smegmatis and G. obscurus were identified as having a nearby, not directly 
adjacent, members of cog2355 which were not part of Cluster 3, but instead were 
members of cluster 14.  The enzyme from cog2355 may function as general dipeptidase 
as part of the recycling of the unused pqqA peptide, provided the peptide has been 
broken down into a dipeptide unit. 
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CHAPTER VI 
 
CONCLUSIONS 
SUMMARY 
Enzymes from two of the 24 Cogs which encompass the amidohydrolase 
superfamily, namely cog2355 and cog3653, were selected for this work.  These enzymes 
were broadly annotated as D-aminoacylases (DAAs) and dipeptidases.  The amino acid 
sequences within each cog were clustered into groups with a BLAST E-value cut-off of 
1 x 10
-70
 (Figures 2.11 and 3.8).  With the exception of the two dipeptidases LmoDP and 
Bh2271, the protein targets were from different groups.   
The desire was to obtain purified proteins, determine their substrate specificity 
and structure with bound inhibitors, and identify the substrate specificity determinants.  
In order to determine the substrate profiles, the proteins were screened for activity 
against libraries of N-acetyl-L-, N-acetyl-D-, N-succinyl-L- and N-succinyl-D- derivatives 
of amino acids as well as L-L, L-D and D-L dipeptide libraries.  Using HPLC, the library 
components could be separated and quantitated to compare the rates of hydrolysis of the 
compounds within the libraries.  Substrates with kcat/Km values on the order of 10
6
M
-1
s
-1
 
(N-acyl-D-Glu) and 10
4
 M
-1
s
-1
 (four N-acetyl-D-amino acids) were identified for the 
enzymes Bb3285 and Gox1177, respectively.  Dipeptide substrates with kcat/Km values of 
~10
4
-10
5
 M
-1
s
-1
 were found for Sco3058, Cc2746, Gox2272, LmoDP, Rsp0802 and 
Bh2271.  In collaboration with  teve Almo’s lab at Albert Einstein College of Medicine 
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and NYSGXRC, the structures of one member of cog3653 and five members of 
cog2355, some in complex with phosphinate inhibitors, were solved.       
D-AMINOACYLASES IN cog3653 
Summary.  The selected proteins from cog3653 were Bb3285, Sco4986, 
Gox1177,  Bb2785 and Bll7304.  When the amidohydrolase superfamily sequences were 
updated and organized by clusters with an E-value cut-off of 1 x 10
-70
, the five proteins 
were in clusters 1 (Bb3285), 2 (Sco4986), 4 (Bb2785) and 5 (Gox1177 and Bll7304).  
Three of these proteins were purified and Sco4986 was partially purified.  Bll7304 did 
not overexpress.  The substrate specificity profiles of Bb3285 and Gox1177 were 
determined using the N-acyl- and N-L-Xaa-D-Xaa libraries.  The substrate profile of 
Sco4986 was attained by comparing the rates of hydrolysis of N-acetyl-D-amino acids.  
The results indicate that Bb2785 is not a D-aminoacylase. 
Gox1177 and Sco4986 both hydrolyze several N-acetyl-D-amino acids with a 
preference for hydrophobic side chains, whereas, Bb3285 exclusively hydrolyzes N-
acyl- and N-L-Xaa- derivatives of D-Glutamate.  The reason for the strict specificity of 
Bb3285 was clarified by the structure of the Bb3285 enzyme complexed with the N-
methylphosphonate derivative of D-glutamate (1).  The Bb3285 structure also revealed 
that the substrate specificity loop was in a different conformation from the same loop in 
the DAA from A. faecalis (36, 56).  The substrate specificity loop is part of a larger 
insertion region located between 7 and 7 of the (/)8-barrel.  As shown in the amino 
acid sequence alignment in Figure 2.1, the greatest variation in these sequences occurs 
in the region that contains this insertion domain.  In the case of cog3653, the sequence 
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lengths varied considerably (~ 480-700 amino acids).  The structural coverage of 
cog3653 is still limited to proteins from Cluster 1 (Figure 2.11).     
Future Directions.  If one was to continue with cog3653 in order to get the full 
structural coverage spanning Clusters 2-6, there might be some things to consider.  With 
regard to Cluster 2 (target: Sco4986), the issue was obtaining the soluble protein to 
purify from E. coli.  Sco4986 contains 6 cysteine residues.  Perhaps it would be better to 
choose targets from cog3653 which have as few cysteines as possible.  For example 
there are five putative D-aminoacylases from Cluster 2 within the Gemmatimonas 
aurantiaca genome.  One of these (gi|226226566) does not have a cysteine residue while 
the DAA from G. aurantiaca that is closest to Sco4986 (gi|226227749) has only one 
cysteine.   
It is possible that cysteine residues contribute to the problem of insoluble protein.  
The Bb3285, Gox1177 and Bb2785 also contained several cysteines and were purified, 
but Bb3285 was not soluble on the first purification attempt.  However, each protein is 
unique.  The problem of insoluble recombinant protein was also encountered with the 
microbial dipeptidases from cog2355 as well.  There is an example in the literature 
where selected cysteine residues in human renal dipeptidase were mutated in order to 
increase the amount of soluble recombinant protein expressed in E. coli (97).  
NYSGXRC also attempted to purify Sco4986 but failed at the stage of expression (their 
vectors and growth conditions are likely both different from mine).  The number of 
potential protein targets has increased dramatically as a result of the boom in microbial 
genome sequencing projects; the choices are not as limited as they were in the past.   
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MICROBIAL HOMOLOGUES TO THE HUMAN RENAL DIPEPTIDASE 
 Summary.  Six microbial homologues to the human renal dipeptidase were 
overexpressed and purified by myself (Sco3058, Gox2272 and Cc2746) or NYSGXRC 
(LmoDP, Rsp0802 and Bh2271).  The substrate profiles were determined by screening 
the enzymes for activity with L-L, L-D and D-L dipeptide libraries.  The enzymes 
exhibited subtle differences in substrate specificity though LmoDP and Sco3058 were 
more specific than the other four proteins.  LmoDP exhibited a higher degree of 
specificity for L-Lys-D/L-Xaa and L-Arg-D/L-Xaa dipeptides, which was attributed to a 
tyrosine or aspartate following -strands 1 and 2, respectively.  The structure of the 
Sco30584 complex suggests that the enhanced preference for L-Xaa-D/L-Asp dipeptides 
by Sco3058  is due to a threonine (Thr-324) and possibly a lysine residue (Lys-247).  
The preference of Rsp0802 for dipeptides with a hydrophobic residue at the C-terminus 
could also be explained by the hydrophobic pocket which harbors the C-terminal amino 
acid of the substrate.  The structures of inhibitor-bound complexes of Gox2272 and 
Cc2746 were not solved during the timeframe of this work.   
 Future Directions.  Included in this work are dipeptidases from the larger subset 
of cog2355.  However, there is a smaller subset which includes those proteins in Clusters 
4, 7, 11, and 13 (Figure 3.8).  With the exception of two sequences in these clusters 
(gi|148556484 and gi|192362060), the predicted proteins in this subset do not have the 
predicted ligands to the alpha metal from -strand 1(absence of the HxD motif).  
Proteins in this subset mainly have an LxY, LxI, LxF, HxT or RxT in lieu of the HxD 
motif.  Two Pseudomonas aeruginosa proteins within this smaller subset of cog2355, 
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namely Pa5396 from cluster 7 (PDB code 2I5G) and Pa2393 from cluster 13 (PDB code 
3B40), have structures deposited in the PDB.   
Pa5396 and Pa2393 have a glutamine (clusters 4, 7 and 11) or leucine (cluster 
13) instead of the bridging glutamate seen in the larger subset.  The tryptophan/histidine 
from 4, which contacts the phosphinate inhibitors, is replaced by a tyrosine in clusters 
4, 7, 13, and likely a histidine or tyrosine in cluster 11.  Neither Pa2393 nor Pa5396 had 
metal bound in the active site.  The only metal ligand conserved in Pa2393 is the 
histidine from 6, and Pa5396 has the two histidines from 5 and 6.  When the 
glutamate which bridges the two metals in hRDP (E125) was mutated to glutamine, the 
enzyme retained 11% of the wild-type activity.  The E125D mutant had 0.1 % the 
activity of the wild-type hRDP (98).  The metal content of the wild-type E125Q/E125D 
mutants was not presented, but perhaps the glutamine was able to participate as ligand to 
at least the beta metal.  Pa5396 may be able to bind metal, and perhaps the addition of 
metal in the medium during high levels of overexpression would allow result in a protein 
with metal in the active site.  
Pa2393 has the 8-loop and 7-loop helix which contributes residues to the 
binding pocket of the C-terminal half of a dipeptide.  The loop following 8 in Pa5396 
differs from the other seven structures.  Instead of forming a portion of the substrate-
binding pocket with residues on the 8-loop, the residues following 8 encapsulate the 
active site.  A ribbon representation of all eight crystallized members of cog2355 is  
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Figure 6.1:  Segments of superimposed structures of the eight cog2355 proteins hRDP, 
Sco3058, Gox2272, Cc2746, LmoDP, Rsp0802, Pa2393 and Pa5396.  Ribbons are colored gray 
for each protein except Pa5396 (dark blue).  The phosphinate mimic from the Sco30584 
complex is shown with pink carbons and an orange phosphorus.   
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shown in Figure 6.1.  This figure is similar to the one shown in Figure 4.9, but with 
Pa5396 added.  These two proteins could be candidates for in silico screening with 
metabolites or a thermofluor assay with L- and D- amino acids.  Since the active site of 
Pa5396 is encapsulated, it may be considered dockable for in silico screening.  The 
knowledge of the structure-specificity relationship of the dipeptides described in 
Chapters II-V can be used to curate the docking results.  The substrates for proteins 
within clusters 4, 7, 11 and 13 may contain an amino acid as part of the substrate.  
 Since their structures are already known, Pa5396 and Pa2393 would make good 
templates for potentially interesting rational protein evolution experiments.  Perhaps by 
changing select residues in these two proteins, they could be transformed into 
dipeptidases with metal bound.       
GENOME CONTEXT 
 A detailed search through some of the genome contexts of the microbial renal 
dipeptidase-like proteins within cog2355 reveals that these proteins are sometimes found 
near clusters of genes involved in identified or putative biosynthetic pathways.  At this 
point in time there is no experimental evidence, at least of which I am aware, that would 
lead one to conjecture that the renal dipeptidase-like proteins are required in a 
biosynthetic pathway.  However, it is hard to imagine that it is purely coincidental that 
the genes of cog2355 proteins are sometimes found clustered with genes that are known 
or predicted to be involved in biosynthetic pathways that use small peptides or 
oligopeptides as precursor molecules (e.g. sirodesmin, gliotoxin, pyrroloquinoline 
quinone) (87, 88, 94, 96).  The Pa5396 gene is clustered with genes required for the 
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catabolism of glycine betaine (99).  Pa2393 gene is also called pvdM because it is 
located adjacent to several genes required for the biosynthesis of the siderophore 
pyoverdine (100).  Pyoverdine is a derivatized oligopeptide composed of L- and D-amino 
acids.  The enzymes in cog2355 may play a role in the recycling of unused peptide 
precursors.  These dipeptidases are also commonly clustered tightly with proteins 
annotated as transporters or peptide/dipeptide transporters or D-amino acid deaminases, 
as was the case for some of the D-aminoacylases in Cluster 2 of cog3653. 
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